datetime,title,source,link,sentiment_class,sentiment_score
1/18/2005 1:07:00 PM,Abbott Announces Groundbreaking New Trial in Stroke Prevention,PR Newswire,/news/stocks/abbott-announces-groundbreaking-new-trial-in-stroke-prevention-1030561630,positive,0.6003790497779846
5/27/2005 1:52:00 PM,Abbott Announces FDA Approval of Zemplar(R) (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication,PR Newswire,/news/stocks/abbott-announces-fda-approval-of-zemplar-r-paricalcitol-capsules-for-earlier-treatment-of-kidney-disease-complication-1027837759,positive,0.8861788511276245
7/26/2005 1:07:00 PM,Clinicians Stress the Importance of Tests for Reproductive Health and Thyroid Disorders During 'Trends in Women's Health Workshop',PR Newswire,/news/stocks/clinicians-stress-the-importance-of-tests-for-reproductive-health-and-thyroid-disorders-during-trends-in-women-s-health-workshop-1030691916,neutral,0.856970489025116
3/31/2006 4:02:00 PM,Abbott and Morgan Stanley Welcome the 14th Annual International Biotechnology Convention to Chicago for Its Midwestern Debut,PR Newswire,/news/stocks/abbott-and-morgan-stanley-welcome-the-14th-annual-international-biotechnology-convention-to-chicago-for-its-midwestern-debut-1029679158,neutral,0.7559151649475098
10/11/2006 3:12:00 PM,"Abbott Awards Virginia Mother $130,000 in National Similac(R) Contest",PR Newswire,/news/stocks/abbott-awards-virginia-mother-130-000-in-national-similac-r-contest-1030131913,positive,0.7108286023139954
5/22/2007 3:04:00 PM,"Neue Datenauswertung zeigt, dass die Behandlung mit Abbotts HUMIRA(R) (Adalimumab) krankheitsbedingte Krankenhauseinweisungen von Morbus Crohn Patienten signifikant verringert",PR Newswire,/news/stocks/neue-datenauswertung-zeigt-dass-die-behandlung-mit-abbotts-humira-r-adalimumab-krankheitsbedingte-krankenhauseinweisungen-von-morbus-crohn-patienten-signifikant-verringert-1027484730,neutral,0.8359221816062927
6/15/2007 1:27:00 PM,"Drei Studien legen nah, dass Abbotts HUMIRA(R) (Adalimumab) möglicherweise die arbeitsbezogene Leistungsfähigkeit von Patienten mit rheumatoider Arthritis verbessert",PR Newswire,/news/stocks/drei-studien-legen-nah-dass-abbotts-humirar-adalimumab-moeglicherweise-die-arbeitsbezogene-leistungsfahigkeit-von-patienten-mit-rheumatoider-arthritis-verbessert-1000168994,neutral,0.805419921875
5/21/2008 4:15:00 PM,"Abbott stellt Langzeitergebnisse einer Erweiterungsstudie vor, die zeigen dass die Remission bei erwachsenen, mit HUMIRA(R) (Adalimumab) behandelten Morbus-Crohn-Patienten anhält",PR Newswire,/news/stocks/abbott-stellt-langzeitergebnisse-einer-erweiterungsstudie-vor-die-zeigen-dass-die-remission-bei-erwachsenen-mit-humira-r-adalimumab-behandelten-morbus-crohn-patienten-anhaelt-1028299853,neutral,0.8147690296173096
9/28/2016 7:10:21 PM,BRIEF-Abbott receives FDA approval for the FreeStyle Libre Pro System (ABT),Reuters,/news/stocks/brief-abbott-receives-fda-approval-for-the-freestyle-libre-pro-system-abt-1001424116,positive,0.8763571381568909
9/29/2016 10:20:22 PM,"BRIEF-Terumo Corp looks to purchase portion of Abbott Laboratories' medical device business - Nikkei (4543, ABT)",Reuters,/news/stocks/brief-terumo-corp-looks-to-purchase-portion-of-abbott-laboratories-medical-device-business-nikkei-4543-abt-1001427697,neutral,0.9081998467445374
10/4/2016 2:20:21 PM,"EU ruling on $25 bln Abbott, St Jude deal due by Nov. 9 (ABT, STJ)",Reuters,/news/stocks/eu-ruling-on-$25-bln-abbott-st-jude-deal-due-by-nov-9-abt-stj-1001435092,neutral,0.746904194355011
10/4/2016 9:00:22 PM,"EU mergers and takeovers (Oct 4) (DISI, SGRO, F34, BG, WAB, LEY, RAX, APO, ABT, STJ)",Reuters,/news/stocks/eu-mergers-and-takeovers-oct-4-disi-sgro-f34-bg-wab-ley-rax-apo-abt-stj-1001435877,neutral,0.9506843686103821
10/11/2016 2:10:24 PM,"St. Jude warns of heart-device battery issue linked to 2 deaths (ABT, STJ)",Reuters,/news/stocks/st-jude-warns-of-heart-device-battery-issue-linked-to-2-deaths-abt-stj-1001448994,negative,0.9396238923072815
10/12/2016 4:30:28 PM,"BRIEF-Celgene & Agios collaborates with Abbott to develop diagnostic tests for leukemia (ABT, CELG)",Reuters,/news/stocks/brief-celgene-&-agios-collaborates-with-abbott-to-develop-diagnostic-tests-for-leukemia-abt-celg-1001451992,positive,0.7513789534568787
10/17/2016 10:20:20 PM,"Omnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs (CVS, ABT)",Reuters,/news/stocks/omnicare-to-pay-$28-mln-to-settle-charges-it-got-kickbacks-from-abbott-labs-cvs-abt-1001460348,negative,0.6512697339057922
10/17/2016 10:30:22 PM,"UPDATE 1-Omnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs (CVS, ABT, PMC)",Reuters,/news/stocks/update-1-omnicare-to-pay-$28-mln-to-settle-charges-it-got-kickbacks-from-abbott-labs-cvs-abt-pmc-1001460491,negative,0.6473917365074158
10/18/2016 3:30:23 PM,"St. Jude and Abbott to sell some medical devices for $1.12 bln (ABT, STJ, 4543)",Reuters,/news/stocks/st-jude-and-abbott-to-sell-some-medical-devices-for-$1-12-bln-abt-stj-4543-1001462642,neutral,0.8852362036705017
10/18/2016 4:30:21 PM,"BRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp (ABT, 4543, STJ)",Reuters,/news/stocks/brief-st-jude-and-abbott-to-divest-two-businesses-to-terumo-corp-abt-4543-stj-1001462695,neutral,0.9384089112281799
10/18/2016 6:20:24 PM,"UPDATE 1-St. Jude and Abbott to sell some medical devices for $1.12 bln (STJ, ABT, 4543)",Reuters,/news/stocks/update-1-st-jude-and-abbott-to-sell-some-medical-devices-for-$1-12-bln-stj-abt-4543-1001462861,neutral,0.7726425528526306
10/19/2016 3:20:21 PM,"BRIEF-St. Jude Medical Q3 earnings per share $0.73 (STJ, ABT)",Reuters,/news/stocks/brief-st-jude-medical-q3-earnings-per-share-$0-73-stj-abt-1001465254,neutral,0.7270779013633728
10/19/2016 4:00:36 PM,Abbott's third-quarter revenue rises nearly 3 percent (ABT),Reuters,/news/stocks/abbotts-third-quarter-revenue-rises-nearly-3-percent-abt-1001465328,positive,0.9457979202270508
10/19/2016 4:30:27 PM,BRIEF-Abbott Q3 GAAP loss per share $0.24 from continuing ops (ABT),Reuters,/news/stocks/brief-abbott-q3-gaap-loss-per-share-$0-24-from-continuing-ops-abt-1001465422,negative,0.9729099869728088
10/19/2016 5:40:23 PM,"UPDATE 1-Abbott's third-quarter results edge past Street (ALR, STJ, ABT)",Reuters,/news/stocks/update-1-abbotts-third-quarter-results-edge-past-street-alr-stj-abt-1001465489,positive,0.8089420199394226
10/19/2016 5:50:22 PM,"BRIEF-St. Jude says Muddy Waters misleading patients for own financial gain (STJ, ABT)",Reuters,/news/stocks/brief-st-jude-says-muddy-waters-misleading-patients-for-own-financial-gain-stj-abt-1001465487,neutral,0.714200496673584
10/19/2016 8:36:22 PM,"BRIEF-Abbott says pursuing all necessary regulatory approvals to buy Alere (ABT, STJ, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-pursuing-all-necessary-regulatory-approvals-to-buy-alere-2016-10,positive,0.699219286441803
10/20/2016 10:16:21 PM,"BRIEF-China clears Abbott's acquisition of Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-china-clears-abbotts-acquisition-of-alere-2016-10,neutral,0.9142568111419678
10/21/2016 11:08:22 PM,"BRIEF-Alere shareholders approve merger with Abbott (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-shareholders-approve-merger-with-abbott-2016-10,neutral,0.8850191235542297
10/24/2016 3:52:21 PM,"Muddy Waters says outside experts found St Jude devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-muddy-waters-says-outside-experts-found-st-jude-devices-can-be-hacked-2016-10,neutral,0.9144279360771179
10/24/2016 4:22:19 PM,"UPDATE 1-Hired experts support claims St. Jude heart devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-hired-experts-support-claims-st-jude-heart-devices-can-be-hacked-2016-10,neutral,0.5858928561210632
10/24/2016 7:28:21 PM,"UPDATE 2-Hired experts back claims St. Jude heart devices can be hacked (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-2-hired-experts-back-claims-st-jude-heart-devices-can-be-hacked-2016-10,neutral,0.8106907606124878
11/3/2016 9:18:20 PM,"Abbott offers EU concessions over $25 bln St Jude deal (ABT, STJ)",Reuters,http://www.businessinsider.com/r-abbott-offers-eu-concessions-over-25-bln-st-jude-deal-2016-11,positive,0.8516746759414673
11/3/2016 9:18:20 PM,"EU mergers and takeovers (Nov 3) (ABT, STJ, AF, MT)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-3-2016-11,neutral,0.9431787133216858
11/7/2016 3:10:18 PM,BRIEF-Abbott says Japan approves its absorbable heart stent (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-japan-approves-its-absorbable-heart-stent-2016-11,positive,0.8731085062026978
11/7/2016 10:50:18 PM,BRIEF-Absolute Software Q1 revenue $22.5 mln (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-q1-revenue-225-mln-2016-11,neutral,0.9225978851318359
11/23/2016 10:04:18 PM,EU regulator conditionally approves Abbott's purchase of St Jude,Reuters,http://www.businessinsider.com/r-eu-regulator-conditionally-approves-abbotts-purchase-of-st-jude-2016-11,neutral,0.8805225491523743
11/25/2016 12:48:20 AM,"EU mergers and takeovers (Nov 24) (ABT, STJ, SMIN, SAF)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-24-2016-11,neutral,0.9435164928436279
11/25/2016 7:28:21 AM,"UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11,neutral,0.7884476184844971
11/30/2016 2:40:09 PM,BRIEF-Abbott announces CE Mark for i-STAT Alinity (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-for-i-stat-alinity-2016-11,neutral,0.8648571968078613
11/30/2016 3:04:04 PM,"EU mergers and takeovers (Nov 30) (ABT, ALR)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-nov-30-2016-11,neutral,0.9356656074523926
12/7/2016 7:46:05 PM,"BRIEF-Abbott says seeks to terminate Alere acquisition (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-seeks-to-terminate-alere-acquisition-2016-12,neutral,0.5951492786407471
12/7/2016 7:56:05 PM,"Abbott seeks to abort planned acquisition of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-seeks-to-abort-planned-acquisition-of-alere-2016-12,neutral,0.8837077021598816
12/7/2016 8:04:27 PM,"Abbott wants out of a $5.8 billion deal with Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-abbott-seeks-to-abort-planned-acquisition-of-alere-2016-12,neutral,0.5422967672348022
12/7/2016 9:40:09 PM,"BRIEF-Alere comments on Abbott's lawsuit (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-comments-on-abbotts-lawsuit-2016-12,neutral,0.9244094491004944
12/9/2016 9:58:09 PM,BRIEF-Abbott raising qtrly dividend to 26.5 cents per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-raising-qtrly-dividend-to-265-cents-per-share-2016-12,positive,0.9124774932861328
12/9/2016 11:10:03 PM,"US IG breaks records for sixth year (BNP, ABI, C, ACA, T, ABT, GS)",Reuters,http://www.businessinsider.com/r-us-ig-breaks-records-for-sixth-year-2016-12,positive,0.7575860023498535
12/10/2016 12:14:03 AM,"BRIEF-St. Jude Medical announces quarterly dividend (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-st-jude-medical-announces-quarterly-dividend-2016-12,neutral,0.8352779746055603
12/16/2016 11:38:03 PM,"BRIEF-Abbott Laboratories enters into a bridge term loan agreement (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-enters-into-a-bridge-term-loan-agreement-2016-12,positive,0.8578774333000183
12/27/2016 9:34:03 PM,Abbott gets U.S. antitrust approval to buy St. Jude Medical,Reuters,http://www.businessinsider.com/r-abbott-gets-us-antitrust-approval-to-buy-st-jude-medical-2016-12,neutral,0.6591947674751282
12/27/2016 10:24:03 PM,"UPDATE 1-Abbott gets U.S. antitrust approval to buy St. Jude Medical (STJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-abbott-gets-us-antitrust-approval-to-buy-st-jude-medical-2016-12,positive,0.8154493570327759
12/29/2016 10:22:03 PM,"LPC: US syndicated lending flat in 2016 after late-year spurt (T, TWX, ABT, STJ, ALR, MQG)",Reuters,http://www.businessinsider.com/r-lpc-us-syndicated-lending-flat-in-2016-after-late-year-spurt-2016-12,negative,0.9570138454437256
12/30/2016 11:20:03 AM,"BRIEF-China conditionally approves Abbott Laboratories' acquisition of St Jude (STJ, ABT)",Reuters,http://www.businessinsider.com/r-brief-china-conditionally-approves-abbott-laboratories-acquisition-of-st-jude-2016-12,neutral,0.6254661083221436
12/30/2016 7:14:07 PM,"BRIEF-Abbott Acquisition of St. Jude Medical set to close on Jan 4, 2017 (ABT, STJ)",Reuters,http://www.businessinsider.com/r-brief-abbott-acquisition-of-st-jude-medical-set-to-close-on-jan-4-2017-2016-12,neutral,0.9366479516029358
1/9/2017 6:16:08 PM,Abbott releases cyber updates for St. Jude devices after government probe,Reuters,http://www.businessinsider.com/r-abbott-releases-cyber-updates-for-st-jude-devices-after-government-probe-2017-1,negative,0.5559038519859314
1/9/2017 6:28:06 PM,"BRIEF-St. Jude to deploy cyber-security updates for Merlin remote monitoring system (JUD, ABT)",Reuters,http://www.businessinsider.com/r-brief-st-jude-to-deploy-cyber-security-updates-for-merlin-remote-monitoring-system-2017-1,neutral,0.668312132358551
1/9/2017 6:50:03 PM,UPDATE 1-St. Jude release cyber updates for heart devices after gov't probe (ABT),Reuters,http://www.businessinsider.com/r-update-1-st-jude-release-cyber-updates-for-heart-devices-after-govt-probe-2017-1,neutral,0.8352510333061218
1/10/2017 1:22:07 PM,"BRIEF-Abbott announces CE mark for its ""Alinity s"" blood and plasma screening system (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-for-its-alinity-s-blood-and-plasma-screening-system-2017-1,neutral,0.6024339199066162
1/25/2017 2:04:05 PM,BRIEF-Abbott reports Q4 sales of $5.3 billion (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-reports-q4-sales-of-53-billion-2017-1,neutral,0.8928382396697998
1/25/2017 2:04:05 PM,Abbott Labs' sales rise 2.8 pct (ABT),Reuters,http://www.businessinsider.com/r-abbott-labs-sales-rise-28-pct-2017-1,positive,0.9438811540603638
1/25/2017 2:40:05 PM,UPDATE 1-Abbott's sales miss estimates as nutrition products drag (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbotts-sales-miss-estimates-as-nutrition-products-drag-2017-1,negative,0.9699678421020508
1/25/2017 4:34:09 PM,BRIEF-Abbott CEO says is optimistic about the Trump administration: Conf Call (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-ceo-says-is-optimistic-about-the-trump-administration-conf-call-2017-1,neutral,0.8448742032051086
1/25/2017 4:40:08 PM,EU clears Abbott acquisition of Alere subject to divestments,Reuters,http://www.businessinsider.com/r-eu-clears-abbott-acquisition-of-alere-subject-to-divestments-2017-1,neutral,0.9406671524047852
1/25/2017 5:20:08 PM,"Siemens to pick banks for Healthineers listing - sources (SIE, GS, PHIA, GE, 6502, ABT, BAX, BSX, AMBU , XRAY, DHR, EOAN, GNMK, BAYN)",Reuters,http://www.businessinsider.com/r-siemens-to-pick-banks-for-healthineers-listing---sources-2017-1,neutral,0.9233325123786926
1/25/2017 5:28:06 PM,"BRIEF-European Commission clears Abbott acquisition of Alere (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-european-commission-clears-abbott-acquisition-of-alere-2017-1,neutral,0.9171264171600342
1/25/2017 5:56:05 PM,"UPDATE 1-Siemens to pick banks for blockbuster Healthineers listing - sources (SIE, GS, PHIA, GE, 6502, ABT, BAX, BSX, AMBU , XRAY, DHR, EOAN, GNMK, BAYN)",Reuters,http://www.businessinsider.com/r-update-1-siemens-to-pick-banks-for-blockbuster-healthineers-listing---sources-2017-1,neutral,0.8406310081481934
1/25/2017 6:30:06 PM,"EU mergers and takeovers (Jan 25) (ABT, ALR, FFH, POW, ACA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-jan-25-2017-1,neutral,0.9459611177444458
2/2/2017 2:09:09 PM,Abbott Says FDA Oks Molecular Test To Detect Zika Virus In Whole Blood ,RTTNews,/news/stocks/abbott-says-fda-oks-molecular-test-to-detect-zika-virus-in-whole-blood-1001717793,neutral,0.8125033378601074
2/2/2017 2:30:07 PM,BRIEF-FDA grants Abbott first commercial authorization for molecular test to detect zika virus using whole blood (ABT),Reuters,http://www.businessinsider.com/r-brief-fda-grants-abbott-first-commercial-authorization-for-molecular-test-to-detect-zika-virus-using-whole-blood-2017-2,positive,0.7798402309417725
2/6/2017 10:46:08 PM,BRIEF-Absolute reports qtrly loss per share $0.05 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-reports-qtrly-loss-per-share-005-2017-2,negative,0.9486017823219299
2/12/2017 9:09:19 PM,Abbott Laboratories may see boost from St. Jude's acquisition: Barron's,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/5Y2fv5kyM_8/us-usa-abbott-barron-s-idUSKBN15R0YJ,positive,0.8560921549797058
2/17/2017 7:00:11 PM,BRIEF-ABBOTT SETS QUARTERLY DIVIDEND OF $0.265 PER SHARE (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-2,neutral,0.831188440322876
2/17/2017 10:34:11 PM,BRIEF-Abbott Laboratories says board of directors shall consist of 12 persons from 11 (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-board-of-directors-shall-consist-of-12-persons-from-11-2017-2,neutral,0.9528579711914062
2/21/2017 3:24:11 PM,"BRIEF-Abbott Laboratories commences exchange offers, consent solicitations for St. Jude Medical notes (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-commences-exchange-offers-consent-solicitations-for-st-jude-medical-notes-2017-2,neutral,0.9069861769676208
2/22/2017 7:36:13 PM,"EU mergers and takeovers (Feb 22) (KKR, 6501, 6581, JNJ, ABT, TECD, AVT, SIE, MENT, NKT, AKE, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM, BX, NG.",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-22-2017-2,neutral,0.950030505657196
2/24/2017 8:22:12 PM,"BRIEF-FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi (SAN, BAYN, LLY)",Reuters,http://www.businessinsider.com/r-brief-ftc-approves-final-order-settling-charges-for-boehringer-ingelheims-asset-swap-with-sanofi-2017-2,positive,0.7393410801887512
3/1/2017 1:06:19 PM,"Diagnostic company Alere says to delay filing annual report (ALR, ABT)",Reuters,http://www.businessinsider.com/r-diagnostic-company-alere-says-to-delay-filing-annual-report-2017-3,negative,0.8765705823898315
3/1/2017 1:48:20 PM,"UPDATE 1-Diagnostic company Alere says to delay filing annual report (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-diagnostic-company-alere-says-to-delay-filing-annual-report-2017-3,negative,0.8983137011528015
3/7/2017 3:00:00 PM,Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture,PR Newswire,/news/stocks/abbott-announces-results-of-early-tenders-and-consents-in-exchange-offers-and-execution-of-supplemental-indenture-1001811376,neutral,0.9343706965446472
3/8/2017 3:24:22 PM,BRIEF-Abbott says findings from Lotus I study may have important implications for women undergoing IVF (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-findings-from-lotus-i-study-may-have-important-implications-for-women-undergoing-ivf-2017-3,positive,0.7643162608146667
3/8/2017 10:15:00 PM,Abbott to Present at Barclays Capital 2017 Global Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-barclays-capital-2017-global-healthcare-conference-1001817379,neutral,0.9393100738525391
3/16/2017 1:00:00 PM,The Most Promising Biotech Innovation of 2017,PR Newswire,/news/stocks/the-most-promising-biotech-innovation-of-2017-1001841725,positive,0.6493896842002869
3/17/2017 12:50:43 PM,BRIEF-Abbott Laboratories says CEO Miles White total compensation for 2016 $20.3 mln vs. $19.4 mln in 2015 (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-ceo-miles-white-total-compensation-for-2016-203-mln-vs-194-mln-in-2015-2017-3,negative,0.5510578155517578
3/18/2017 5:18:44 PM,Higher heart risk seen with Abbott dissolving stent after two years: study,Reuters,http://www.businessinsider.com/r-higher-heart-risk-seen-with-abbott-dissolving-stent-after-two-years-study-2017-3,negative,0.5167106986045837
3/18/2017 5:30:00 PM,"Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease",PR Newswire,/news/stocks/late-breaking-data-on-abbott-s-mitraclip-system-show-continued-benefit-for-people-with-mitral-regurgitation-most-common-heart-valve-disease-1001847847,positive,0.9500546455383301
3/18/2017 7:50:49 PM,UPDATE 1-Higher heart risk seen with Abbott dissolving stent after 2 years -study (ABT),Reuters,http://www.businessinsider.com/r-update-1-higher-heart-risk-seen-with-abbott-dissolving-stent-after-2-years--study-2017-3,positive,0.8012188673019409
3/18/2017 8:02:32 PM,Abbott: MitraClip Reduces Severity Of Mitral Regurgitation In One-year Study ,RTTNews,/news/stocks/abbott-mitraclip-reduces-severity-of-mitral-regurgitation-in-one-year-study-1001847888,positive,0.9213196635246277
3/19/2017 7:00:00 PM,Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care,PR Newswire,/news/stocks/late-breaking-data-shows-the-cardiomems-hf-system-is-effective-in-reducing-heart-failure-hospitalizations-and-cost-of-care-1001848216,positive,0.9440487027168274
3/21/2017 12:10:00 PM,"Technical Reports on Medical Equipment Stocks -- EnteroMedics, Abbott Labs, Boston Scientific, and Medtronic",PR Newswire,/news/stocks/technical-reports-on-medical-equipment-stocks-enteromedics-abbott-labs-boston-scientific-and-medtronic-1001853280,neutral,0.9407570958137512
3/21/2017 3:07:42 PM,Not All's Well With Abbott's Absorb Stent? ,RTTNews,/news/stocks/not-all-s-well-with-abbott-s-absorb-stent-1001854402,neutral,0.7473858594894409
3/22/2017 2:00:00 PM,Recent Developments in the Electrophysiology Markets,PR Newswire,/news/stocks/recent-developments-in-the-electrophysiology-markets-1001858039,neutral,0.8884700536727905
3/22/2017 2:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1001857979,neutral,0.9381691813468933
4/12/2017 7:12:52 AM,"Smithfield makes move on market for pig-human transplants (288, ABT, MDT, UTHR)",Reuters,http://www.businessinsider.com/r-smithfield-makes-move-on-market-for-pig-human-transplants-2017-4,neutral,0.8406532406806946
4/13/2017 4:39:08 PM,BRIEF-U.S. FDA says issued a warning letter to Abbott Laboratories (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-issued-a-warning-letter-to-abbott-laboratories-2017-4,negative,0.4330165982246399
4/14/2017 11:43:03 AM,"Abbott Laboratories to buy Alere for $4.4 bln - FT (ALR, ABT)",Reuters,http://www.businessinsider.com/r-abbott-laboratories-to-buy-alere-for-44-bln---ft-2017-4,neutral,0.9259006381034851
4/14/2017 11:43:03 AM,"RPT-Abbott Laboratories to buy Alere for $4.4 bln - FT (ABT, ALR)",Reuters,http://www.businessinsider.com/r-rpt-abbott-laboratories-to-buy-alere-for-44-bln---ft-2017-4,neutral,0.892203152179718
4/14/2017 12:00:00 PM,Abbott and Alere Amend Terms of Merger Agreement,PR Newswire,/news/stocks/abbott-and-alere-amend-terms-of-merger-agreement-1001922403,neutral,0.8153412342071533
4/14/2017 12:14:11 PM,Abbott Agrees To Buy Alere At Lower Price ,RTTNews,/news/stocks/abbott-agrees-to-buy-alere-at-lower-price-1001922419,neutral,0.8573834300041199
4/14/2017 2:29:04 PM,"BRIEF-Abbott and Alere amend terms of merger agreement (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-and-alere-amend-terms-of-merger-agreement-2017-4,neutral,0.8149015307426453
4/14/2017 2:49:02 PM,"UPDATE 1-Abbott Laboratories to buy Alere for about $4.48 bln (ABT, ALR)",Reuters,http://www.businessinsider.com/r-update-1-abbott-laboratories-to-buy-alere-for-about-448-bln-2017-4,neutral,0.8864434957504272
4/17/2017 3:13:03 PM,"US STOCKS-Wall Street looks set to open slightly higher (NFLX, UAL, INCY, LLY, PFE, ALR, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-looks-set-to-open-slightly-higher-2017-4,positive,0.939262330532074
4/17/2017 4:55:07 PM,"US STOCKS-Wall St edges higher as tech, financials gain (NFLX, UAL, INCY, LLY, ALR, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-edges-higher-as-tech-financials-gain-2017-4,positive,0.9337784647941589
4/19/2017 1:45:00 PM,Abbott Reports First-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2017-results-1001930390,neutral,0.885169506072998
4/19/2017 1:49:58 PM,Abbott Laboratories Q1 Profit Climbs 37%,RTTNews,/news/stocks/abbott-laboratories-q1-profit-climbs-37-1001930386,positive,0.8396872282028198
4/19/2017 2:01:08 PM,BRIEF-Abbott Q1 adjusted earnings per share $0.48 from continuing operations (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q1-adjusted-earnings-per-share-048-from-continuing-operations-2017-4,neutral,0.6830244064331055
4/19/2017 2:11:11 PM,"Abbott posts 29.7 pct rise in quarterly sales (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-posts-297-pct-rise-in-quarterly-sales-2017-4,positive,0.9443538188934326
4/19/2017 2:41:06 PM,"UPDATE 1-Abbott sales, profit propped up by St. Jude acquisition (ABT, ALR)",Reuters,http://www.businessinsider.com/r-update-1-abbott-sales-profit-propped-up-by-st-jude-acquisition-2017-4,positive,0.951124370098114
4/19/2017 4:59:04 PM,"BRIEF-Abbott CFO says ""We're not going to really be in a good position to give a lot of detailed guidance (on Alere) until minimum Q4"" - Conf Call (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-cfo-says-were-not-going-to-really-be-in-a-good-position-to-give-a-lot-of-detailed-guidance-on-alere-until-minimum-q4---conf-call-2017-4,neutral,0.9157002568244934
4/20/2017 9:05:06 PM,"LPC: US healthcare lending rouses from policy-induced sedation (ALR, HUM, MDT, PPG, AKZA, ABT, AET, CI, CAH)",Reuters,http://www.businessinsider.com/r-lpc-us-healthcare-lending-rouses-from-policy-induced-sedation-2017-4,neutral,0.5680893063545227
4/25/2017 3:11:10 PM,"US STOCKS-Wall St set to open higher as earnings take center stage (CAT, MCD, BIIB, CNC, T, TSN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-center-stage-2017-4,positive,0.9364098906517029
4/26/2017 12:20:00 PM,"Medical Equipment Stocks on Investors' Radar -- Abbott, Boston Scientific, Medtronic, and EnteroMedics",PR Newswire,/news/stocks/medical-equipment-stocks-on-investors-radar-abbott-boston-scientific-medtronic-and-enteromedics-1001950583,neutral,0.9271352887153625
4/26/2017 2:00:00 PM,Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery,PR Newswire,/news/stocks/abbott-introduces-science-based-nutrition-drinks-to-help-patients-have-a-better-recovery-from-surgery-1001951188,neutral,0.5691701173782349
4/26/2017 2:35:06 PM,BRIEF-Abbott Laboratories develops 2 new science-based nutrition drinks for patients undergoing surgery (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-develops-2-new-science-based-nutrition-drinks-for-patients-undergoing-surgery-2017-4,positive,0.5524371862411499
4/28/2017 3:05:09 PM,"Global med-tech firms, India locked in tussle after stent price sting (ABT, BSX, JNJ, MDT, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-global-med-tech-firms-india-locked-in-tussle-after-stent-price-sting-2017-4,negative,0.9078989624977112
4/28/2017 4:31:12 PM,"LPC: US loan market welcomes M&A surge (BX, FRE, ALR, DH, MDT, PPG, AKZA, ABT, TSN, AKRX, PNRA, BCR, BDX, CAH, WFM)",Reuters,http://www.businessinsider.com/r-lpc-us-loan-market-welcomes-ma-surge-2017-4,positive,0.9391486048698425
5/4/2017 10:56:05 PM,"Tesla in talks to resolve issues with legacy Grohmann clients (TSLA, BMW, VOW3, DAI, INTC, ABT)",Reuters,http://www.businessinsider.com/r-tesla-in-talks-to-resolve-issues-with-legacy-grohmann-clients-2017-5,positive,0.6668403744697571
5/5/2017 2:30:00 PM,Dodge Momentum Index Loses Steam in April,PR Newswire,/news/stocks/dodge-momentum-index-loses-steam-in-april-636172,negative,0.9661093950271606
5/8/2017 12:00:00 PM,"Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes",PR Newswire,/news/stocks/abbott-announces-national-reimbursement-for-freestyle-libre-in-france-providing-access-to-revolutionary-technology-for-people-with-diabetes-1001988590,positive,0.8789304494857788
5/8/2017 3:00:00 PM,Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor,PR Newswire,/news/stocks/abbott-announces-ce-mark-and-first-use-of-the-worlds-first-smartphone-compatible-insertable-cardiac-monitor-645568,neutral,0.6659406423568726
5/8/2017 3:28:02 PM,BRIEF-Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-ce-mark-and-first-use-of-the-worlds-first-smartphone-compatible-insertable-cardiac-monitor-2017-5,neutral,0.5803126096725464
5/8/2017 10:44:05 PM,BRIEF-Absolute Software Corp qtrly loss per share $0.01 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-corp-qtrly-loss-per-share-001-2017-5,negative,0.9665237069129944
5/9/2017 3:00:00 PM,"Abbott Announces CE Mark for TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™",PR Newswire,/news/stocks/abbott-announces-ce-mark-for-tacticath-contact-force-ablation-catheter-sensor-enabled-1001994389,positive,0.6492142677307129
5/9/2017 3:20:10 PM,BRIEF-Abbott reports CE Mark for tacticath contact force ablation catheter (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-reports-ce-mark-for-tacticath-contact-force-ablation-catheter-2017-5,neutral,0.9029169082641602
5/9/2017 7:26:03 PM,"India government panel rejects Boston Scientific plea on stent price caps (BSX, ABT, MDT)",Reuters,http://www.businessinsider.com/r-india-government-panel-rejects-boston-scientific-plea-on-stent-price-caps-2017-5,negative,0.5014508366584778
5/12/2017 10:56:09 PM,Retired baseball player DeCinces found guilty of insider trading (ABT),Reuters,http://www.businessinsider.com/r-retired-baseball-player-decinces-found-guilty-of-insider-trading-2017-5,negative,0.6958757042884827
5/18/2017 12:46:07 PM,"UPDATE 1-India's drug pricing regulator clamps down on drug cocktails (ABT, SAN, SUNPHARMA, LUPIN, GLENMARK, CADILAHC, ABBOTINDIA, 500672)",Reuters,http://www.businessinsider.com/r-update-1-indias-drug-pricing-regulator-clamps-down-on-drug-cocktails-2017-5,negative,0.7762997150421143
6/2/2017 12:25:00 PM,"Medical Equipment Stocks on Investors' Radar -- Abbott Labs, Boston Scientific, Medtronic, and EnteroMedics",PR Newswire,/news/stocks/medical-equipment-stocks-on-investors-radar-abbott-labs-boston-scientific-medtronic-and-enteromedics-1002062835,neutral,0.932457447052002
6/5/2017 11:00:03 PM,"BRIEF-Alere Q4 loss per share $1.38 from continuing operations (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-q4-loss-per-share-138-from-continuing-operations-2017-6,negative,0.9710893630981445
6/9/2017 4:15:00 PM,Abbott Declares 374th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-374th-consecutive-quarterly-dividend-1002082291,neutral,0.5096662044525146
6/9/2017 8:22:03 PM,BRIEF-Abbott sets quarterly dividend of $0.265 per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-6,neutral,0.831188440322876
6/21/2017 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1002112082,neutral,0.9235584139823914
6/29/2017 7:32:00 PM,Abbott Secures Health Canada License for FreeStyle® Libre System for People with Diabetes,PR Newswire,/news/stocks/abbott-secures-health-canada-license-for-freestyle-libre-system-for-people-with-diabetes-1002136241,positive,0.730926513671875
6/29/2017 7:42:05 PM,BRIEF-Abbott secures Health Canada license for Freestyle Libre system for people with diabetes (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-secures-health-canada-license-for-freestyle-libre-system-for-people-with-diabetes-2017-6,positive,0.9024317860603333
6/29/2017 10:38:03 PM,BRIEF-Abbott Laboratories names John Stratton to its board (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-names-john-stratton-to-its-board-2017-6,neutral,0.9425482749938965
7/7/2017 10:22:03 PM,"BRIEF-Alere shareholders approve amended merger with Abbott (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-shareholders-approve-amended-merger-with-abbott-2017-7,neutral,0.8636514544487
7/13/2017 1:37:38 PM,Abbott And Bigfoot Collaborate To Develop Breakthrough Diabetes Tech ,RTTNews,/news/stocks/abbott-and-bigfoot-collaborate-to-develop-breakthrough-diabetes-tech-1002170725,positive,0.6928734183311462
7/13/2017 1:42:08 PM,"BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systems (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-bigfoot-biomedical-enter-deal-to-develop-diabetes-management-systems-2017-7,positive,0.7462939620018005
7/17/2017 12:13:36 PM,Quidel To Buy Alere Triage Assets ,RTTNews,/news/stocks/quidel-to-buy-alere-triage-assets-1002177806,neutral,0.9277477264404297
7/17/2017 2:38:03 PM,"BRIEF-Abbott says commences tender offer for Series B preferred stock of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-commences-tender-offer-for-series-b-preferred-stock-of-alere-2017-7,neutral,0.8523828983306885
7/20/2017 1:49:09 PM,Abbott Laboratories Reveals 36% Gain In Q2 Earnings,RTTNews,/news/stocks/abbott-laboratories-reveals-36-gain-in-q2-earnings-1002190762,positive,0.9339887499809265
7/20/2017 1:58:06 PM,BRIEF-Abbott Q2 adjusted EPS $0.62 from continuing operations excluding items (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q2-adjusted-eps-062-from-continuing-operations-excluding-items-2017-7,negative,0.5228263139724731
7/20/2017 2:04:10 PM,"Abbott's quarterly profit halves as costs soar (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbotts-quarterly-profit-halves-as-costs-soar-2017-7,negative,0.9695666432380676
7/20/2017 2:38:03 PM,UPDATE 1-Abbott raises full-year profit forecast (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-raises-full-year-profit-forecast-2017-7,positive,0.717746913433075
7/20/2017 2:40:25 PM,"Abbott Q2 Profit Falls, But Results Top View; Lifts 2017 Profit Outlook ",RTTNews,/news/stocks/abbott-q2-profit-falls-but-results-top-view-lifts-2017-profit-outlook-1002191109,negative,0.9055041074752808
7/20/2017 2:52:03 PM,"US STOCKS-Wall St set to open higher on earnings optimism (MSFT, AMZN, V, EBAY, COF, PM, AXP, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-on-earnings-optimism-2017-7,positive,0.9356843829154968
7/20/2017 4:14:07 PM,"US STOCKS-Wall St flat as earnings from some big names disappoint (QCOM, PM, HD, V, EBAY, COF, MSFT, AMZN, AXP, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-earnings-from-some-big-names-disappoint-2017-7,negative,0.9668863415718079
7/20/2017 5:28:03 PM,"US STOCKS-Wall St flat as consumer stocks, weak earnings weigh (HD, SHLD, AMZN, BBY, PM, QCOM, V, MSFT, EBAY, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-consumer-stocks-weak-earnings-weigh-2017-7,negative,0.9664203524589539
7/20/2017 7:08:05 PM,"US STOCKS-S&P, Dow flat as retailers weigh; Nasdaq edges higher (HD, SHLD, AMZN, BBY, LOW, QCOM, V, MSFT, EBAY, VZ, T, ABT, TRV)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-flat-as-retailers-weigh-nasdaq-edges-higher-2017-7,negative,0.6303790211677551
7/21/2017 7:10:03 PM,"BRIEF-Alere Inc enters into purchase agreement with Siemens Diagnostics ​‍​ (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-alere-inc-enters-into-purchase-agreement-with-siemens-diagnostics--2017-7,positive,0.8833592534065247
7/25/2017 2:36:03 PM,BRIEF-Roxwood Medical enters into an exclusive agreement with Abbott for distribution of roxwood products in United States (ABT),Reuters,http://www.businessinsider.com/r-brief-roxwood-medical-enters-into-an-exclusive-agreement-with-abbott-for-distribution-of-roxwood-products-in-united-states-2017-7,positive,0.8926622867584229
7/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Medtronic, and MiMedx",PR Newswire,/news/stocks/breakfast-technical-briefing-on-medical-equipment-stocks-abbott-labs-boston-scientific-medtronic-and-mimedx-1002205248,neutral,0.9485335946083069
7/31/2017 11:47:03 PM,BRIEF-Abbott Laboratories says entered into term loan agreement with lenders (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-entered-into-term-loan-agreement-with-lenders-2017-7,positive,0.9197254776954651
8/1/2017 9:00:00 AM,Entries for 21st Japan Media Arts Festival Now Open,PR Newswire,/news/stocks/entries-for-21st-japan-media-arts-festival-now-open-538297,neutral,0.917057991027832
8/1/2017 5:22:03 PM,"BRIEF-FDA approves Idhifa for treating relapsed/refractory Acute Myeloid Leukemia (ABT, CELG)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-idhifa-for-treating-relapsed-refractory-acute-myeloid-leukemia-2017-8,positive,0.9066159129142761
8/1/2017 6:12:16 PM,"UPDATE 1-FDA approves leukemia treatment developed by Celgene, Agios (CELG, ABT)",Reuters,http://www.businessinsider.com/r-update-1-fda-approves-leukemia-treatment-developed-by-celgene-agios-2017-8,positive,0.792262613773346
8/2/2017 2:47:03 PM,"UPDATE 1-No more freebies? India plans crackdown on marketing by drugmakers (SUNPHARMA, ABT, GSK, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-update-1-no-more-freebies-india-plans-crackdown-on-marketing-by-drugmakers-2017-8,neutral,0.5731285214424133
8/7/2017 5:57:05 PM,"Siemens to update medical scanner software to deal with security bugs (SIE, MSFT, ABT)",Reuters,http://www.businessinsider.com/r-siemens-to-update-medical-scanner-software-to-deal-with-security-bugs-2017-8,neutral,0.8070129752159119
8/9/2017 7:07:03 PM,"UPDATE 1-Mexico watchdog finds big pharma faces no competition on some drugs (GSK, PFE, MRK, ABT, LLY, SAN, AZN)",Reuters,http://www.businessinsider.com/r-update-1-mexico-watchdog-finds-big-pharma-faces-no-competition-on-some-drugs-2017-8,positive,0.8694553971290588
8/10/2017 3:00:00 PM,"The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient",PR Newswire,/news/stocks/the-cost-of-malnutrition-study-shows-nutrition-program-could-save-hospitals-up-to-3-800-per-patient-1002248626,positive,0.7704034447669983
8/10/2017 7:12:04 PM,A nutrition scientist predicts a future in which pizza is nutritious as a superfood (ABT),Business Insider,http://www.businessinsider.com/abbott-nutrition-director-predicts-nutritious-pizza-2017-8,neutral,0.5906274318695068
8/14/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002255099,neutral,0.6587722301483154
8/14/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002255095,neutral,0.6587722301483154
8/14/2017 2:12:03 PM,BRIEF-Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-2017-8,positive,0.6104642152786255
8/15/2017 2:00:00 PM,"North West London Pathology and Abbott Partner for Diagnostics Products and Services, including Alinity™, in Three NHS Trusts",PR Newswire,/news/stocks/north-west-london-pathology-and-abbott-partner-for-diagnostics-products-and-services-including-alinity-in-three-nhs-trusts-1002258378,neutral,0.8465076684951782
8/16/2017 12:32:03 PM,"BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​ (ENZ, ABT)",Reuters,http://www.businessinsider.com/r-brief-enzo-biochem-says-federal-judge-in-a-us-court-has-entered-an-order-in-action-entitled-enzo-life-sciences-v-abbott-laboratories--2017-8,neutral,0.6471764445304871
8/16/2017 11:37:17 PM,"UPDATE 2-Seven charged in U.S. insider trading ring (BAC, RY, ABT, MON, BAYN)",Reuters,http://www.businessinsider.com/r-update-2-seven-charged-in-us-insider-trading-ring-2017-8,negative,0.6792130470275879
8/17/2017 10:17:08 PM,BRIEF-Absolute Software reports Q4 loss per share ‍$0.05​ (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-reports-q4-loss-per-share-005-2017-8,negative,0.9650026559829712
8/18/2017 5:17:03 PM,"CANADA STOCKS-TSX slides as investors shun riskier assets, gold shines (MFC, BMO, ABT, ABX, AEM)",Reuters,http://www.businessinsider.com/r-canada-stocks-tsx-slides-as-investors-shun-riskier-assets-gold-shines-2017-8,negative,0.969192385673523
8/18/2017 10:57:08 PM,"CANADA STOCKS-TSX slides as inflation, stronger loonie cloud sentiment (MFC, ABX, G, GIB., ABT, CNR)",Reuters,http://www.businessinsider.com/r-canada-stocks-tsx-slides-as-inflation-stronger-loonie-cloud-sentiment-2017-8,negative,0.9697690606117249
8/28/2017 12:15:00 PM,"Technical Snapshots for These Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Edwards Lifesciences, and Medtronic",PR Newswire,/news/stocks/technical-snapshots-for-these-medical-equipment-stocks-abbott-labs-boston-scientific-edwards-lifesciences-and-medtronic-1002287926,neutral,0.9427250623703003
8/28/2017 3:00:00 PM,Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients,PR Newswire,/news/stocks/abbott-introduces-heartmate-3-left-ventricular-assist-system-the-latest-milestone-in-therapy-for-advanced-heart-failure-patients-1002288513,positive,0.6773526668548584
8/28/2017 3:14:03 PM,Abbott Receives FDA Approval For MagLev HeartMate 3 System - Quick Facts ,RTTNews,/news/stocks/abbott-receives-fda-approval-for-maglev-heartmate-3-system-quick-facts-1002288603,positive,0.8939849734306335
8/29/2017 6:02:03 PM,Abbott releases new round of cyber updates for St. Jude pacemakers (ABT),Reuters,http://www.businessinsider.com/r-abbott-releases-new-round-of-cyber-updates-for-st-jude-pacemakers-2017-8,neutral,0.9016954302787781
8/29/2017 6:22:03 PM,"BRIEF-Abbott says has notified physicians of updates to its implantable pacemakers, defibrillators (ABT)",Reuters,http://www.businessinsider.com/r-brief-abbott-says-has-notified-physicians-of-updates-to-its-implantable-pacemakers-defibrillators-2017-8,positive,0.7132834196090698
8/29/2017 6:27:05 PM,UPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakers (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-releases-new-round-of-cyber-updates-for-st-jude-pacemakers-2017-8,neutral,0.7715451717376709
8/29/2017 7:07:03 PM,BRIEF-U.S. FDA says has approved St. Jude medical’s firmware update ‍​ (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-has-approved-st-jude-medicals-firmware-update--2017-8,positive,0.8248240351676941
8/29/2017 9:02:00 PM,Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts,PR Newswire,/news/stocks/abbott-and-the-abbott-fund-donate-1-million-to-support-hurricane-harvey-relief-efforts-1002292643,positive,0.6594590544700623
8/30/2017 6:02:03 PM,BRIEF-Abbott initiates study of AMPLATZER device to correct congenital heart defect in newborns (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-initiates-study-of-amplatzer-device-to-correct-congenital-heart-defect-in-newborns-2017-8,neutral,0.5996293425559998
8/31/2017 3:00:00 PM,Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan,PR Newswire,/news/stocks/revolutionary-glucose-monitoring-technology-freestyle-libre-now-reimbursed-across-japan-1002298698,neutral,0.7970337271690369
9/1/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002301877,neutral,0.6587722301483154
9/1/2017 2:22:03 PM,"BRIEF-Abbott extends cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-extends-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-2017-9,neutral,0.7457770705223083
9/7/2017 3:07:03 PM,BRIEF-Absolute announces approval of normal course issuer bid (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-announces-approval-of-normal-course-issuer-bid-2017-9,neutral,0.7670500874519348
9/7/2017 5:49:00 PM,Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index (DJSI),PR Newswire,/news/stocks/abbott-named-industry-leader-for-responsible-and-sustainable-business-for-five-consecutive-years-on-the-dow-jones-sustainability-index-djsi-1002350837,positive,0.6765038371086121
9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,neutral,0.8491860628128052
9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,neutral,0.7386980652809143
9/14/2017 6:28:00 PM,Abbott Declares 375th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-375th-consecutive-quarterly-dividend-1002371534,neutral,0.7579688429832458
9/14/2017 6:37:19 PM,BRIEF-Abbott sets quarterly dividend of $0.265 per share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-sets-quarterly-dividend-of-0265-per-share-2017-9,neutral,0.831188440322876
9/18/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002378415,neutral,0.6587722301483154
9/18/2017 2:17:03 PM,"BRIEF-Abbott announces extension of cash tender offer (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-announces-extension-of-cash-tender-offer-2017-9,neutral,0.5694447755813599
9/19/2017 3:52:04 AM,"BRIEF-Alere announces intent to voluntarily delist Series B Convertible Perpetual Preferred Stock from the NYSE (ALR, ABT)",Reuters,http://www.businessinsider.com/r-brief-alere-announces-intent-to-voluntarily-delist-series-b-convertible-perpetual-preferred-stock-from-the-nyse-2017-9,neutral,0.8649206757545471
9/20/2017 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1002387305,neutral,0.9299495220184326
9/22/2017 2:00:00 PM,Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD,PR Newswire,/news/stocks/abbott-secures-fda-approval-for-mri-compatibility-for-the-company-s-ellipse-icd-1002422445,positive,0.9414418339729309
9/22/2017 2:22:04 PM,BRIEF-Abbott secures FDA approval for MRI-compatibility for the co's Ellipse ICD (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-secures-fda-approval-for-mri-compatibility-for-the-cos-ellipse-icd-2017-9,positive,0.9365102648735046
9/26/2017 8:07:14 PM,"Pregnant women still unaware of epilepsy drug risks - EMA hearing (SAN, ABT, SUNPHARMA)",Reuters,http://www.businessinsider.com/r-pregnant-women-still-unaware-of-epilepsy-drug-risks---ema-hearing-2017-9,neutral,0.932658314704895
9/27/2017 9:24:00 PM,New Marine Refuges in Canada's Atlantic Ocean,PR Newswire,/news/stocks/new-marine-refuges-in-canadas-atlantic-ocean-452702,neutral,0.7185810208320618
9/27/2017 11:02:32 PM,BRIEF-U.S. FDA says approved Freestyle Libre Flash glucose monitoring system‍​ (ABT),Reuters,http://www.businessinsider.com/r-brief-us-fda-says-approved-freestyle-libre-flash-glucose-monitoring-system-2017-9,neutral,0.5841571688652039
9/27/2017 11:42:00 PM,No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.,PR Newswire,/news/stocks/no-more-routine-finger-sticks-1-for-americans-with-diabetes-abbott-s-freestyle-libre-approved-in-the-u-s-1002678029,positive,0.5194217562675476
9/27/2017 11:57:06 PM,"FDA approves Abbott's blood glucose monitoring device (ABT, DXCM, MDT)",Reuters,http://www.businessinsider.com/r-fda-approves-abbotts-blood-glucose-monitoring-device-2017-9,positive,0.7945519685745239
9/28/2017 12:41:00 AM,No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.,PR Newswire,/news/stocks/no-more-routine-finger-sticks-1-for-americans-with-diabetes-abbott-s-freestyle-libre-approved-in-the-u-s-1002681727,positive,0.5194217562675476
9/28/2017 12:42:17 AM,"UPDATE 1-FDA approves Abbott's blood glucose monitoring device (ABT, DXCM, MDT)",Reuters,http://www.businessinsider.com/r-update-1-fda-approves-abbotts-blood-glucose-monitoring-device-2017-9,positive,0.8577069640159607
9/28/2017 4:26:29 AM,Abbott : FDA Oks FreeStyle Libre Flash Glucose Monitoring System ,RTTNews,/news/stocks/abbott-fda-oks-freestyle-libre-flash-glucose-monitoring-system-1002694665,neutral,0.877737820148468
9/28/2017 1:32:03 PM,"US STOCKS-Futures flat ahead of GDP, jobs data (DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-ahead-of-gdp-jobs-data-2017-9,negative,0.9538384675979614
9/28/2017 3:07:03 PM,"US STOCKS-Wall St set to open lower after economic data (ACN, DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-after-economic-data-2017-9,negative,0.9485030174255371
9/28/2017 4:07:03 PM,"US STOCKS-Wall St opens lower after economic data (ACN, DXCM, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-lower-after-economic-data-2017-9,negative,0.95928555727005
9/28/2017 4:36:03 PM,"The FDA just approved a device that can monitor blood sugar without finger pricks (ABT, DXCM)",Business Insider,http://www.businessinsider.com/fda-approves-abbotts-no-routine-finger-stick-diabetes-device-2017-9,positive,0.7065391540527344
9/28/2017 5:42:05 PM,"US STOCKS-McDonald's props up Dow; financial, tech stocks slip (MCD, AAPL, AMGN, ABT, RAD)",Reuters,http://www.businessinsider.com/r-us-stocks-mcdonalds-props-up-dow-financial-tech-stocks-slip-2017-9,negative,0.9535194039344788
9/28/2017 6:47:15 PM,"UPDATE 1-Alere to pay more than $13 million to resolve U.S. SEC probe (ALR, ABT)",Reuters,http://www.businessinsider.com/r-update-1-alere-to-pay-more-than-13-million-to-resolve-us-sec-probe-2017-9,positive,0.6981862783432007
9/28/2017 7:12:07 PM,"US STOCKS-McDonald's lifts Dow; Trump tax trade fades (MCD, AAPL, AMGN, ABT, 6502)",Reuters,http://www.businessinsider.com/r-us-stocks-mcdonalds-lifts-dow-trump-tax-trade-fades-2017-9,neutral,0.8387042284011841
9/28/2017 7:52:12 PM,"Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR)",Reuters,http://www.businessinsider.com/r-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9,positive,0.8352386355400085
9/28/2017 8:27:17 PM,"BRIEF-Canadian Competition Bureau clears Abbott Laboratories' takeover of Alere (ALR, ABT, SIE, QDEL)",Reuters,http://www.businessinsider.com/r-brief-canadian-competition-bureau-clears-abbott-laboratories-takeover-of-alere-2017-9,neutral,0.9395930767059326
9/28/2017 8:27:17 PM,"UPDATE 1-Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR, QDEL, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9,positive,0.8061344027519226
9/28/2017 8:47:13 PM,"US STOCKS-Wall St edges up on healthcare, tax plan hopes (MCD, AMGN, ABT, ALR)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-edges-up-on-healthcare-tax-plan-hopes-2017-9,positive,0.9245316982269287
9/28/2017 10:17:12 PM,"US STOCKS-S&P ekes out record on healthcare gains, tax plan hopes (MCD, AMGN, ABT, ALR)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-ekes-out-record-on-healthcare-gains-tax-plan-hopes-2017-9,positive,0.9141103625297546
9/29/2017 3:20:00 PM,"Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017",PR Newswire,/news/stocks/abbott-acquisition-of-alere-set-to-close-on-tuesday-october-3-2017-1002852832,neutral,0.9501937627792358
9/29/2017 3:27:51 PM,Abbott Plans To Close Acquisition Of Alere On Oct. 3 ,RTTNews,/news/stocks/abbott-plans-to-close-acquisition-of-alere-on-oct-3-1002852855,neutral,0.9504098296165466
9/29/2017 3:47:03 PM,"BRIEF-Abbott acquisition of Alere set to close on October 3, 2017 (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-acquisition-of-alere-set-to-close-on-october-3-2017-2017-9,neutral,0.9434974789619446
10/2/2017 2:00:00 PM,Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-announces-extension-of-cash-tender-offer-for-all-outstanding-shares-of-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002914359,neutral,0.6587722301483154
10/2/2017 2:27:04 PM,"BRIEF-Abbott extends previous cash tender offer for outstanding Series B shares of Alere Inc (ABT, ALR)",Reuters,http://www.businessinsider.com/r-brief-abbott-extends-previous-cash-tender-offer-for-outstanding-series-b-shares-of-alere-inc-2017-10,positive,0.6470407843589783
10/4/2017 2:00:00 PM,Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002993764,neutral,0.4990743398666382
10/4/2017 2:00:00 PM,Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.,PR Newswire,/news/stocks/abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-1002993748,neutral,0.4990743398666382
10/4/2017 2:27:06 PM,BRIEF-Abbott completes cash tender offer for Series B Convertible Perpetual Preferred Stock of Alere Inc (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-completes-cash-tender-offer-for-series-b-convertible-perpetual-preferred-stock-of-alere-inc-2017-10,neutral,0.5310655832290649
10/5/2017 9:34:00 PM,Alere Inc. -- Moody's to withdraw Alere's ratings following debt redemption,Moodys,/news/bonds/alere-inc-moody-s-to-withdraw-alere-s-ratings-following-debt-redemption-1003103718,negative,0.7239508628845215
10/16/2017 3:00:00 PM,Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System,PR Newswire,/news/stocks/patients-battling-complex-regional-pain-syndrome-find-a-host-of-new-benefits-in-abbott-s-proclaim-drg-system-1004488056,positive,0.7904146313667297
10/16/2017 3:00:00 PM,Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System,PR Newswire,/news/stocks/patients-battling-complex-regional-pain-syndrome-find-a-host-of-new-benefits-in-abbott-s-proclaim-drg-system-1001762160,positive,0.7904146313667297
10/16/2017 3:12:09 PM,BRIEF-Abbott Laboratories says ‍announced U.S. Launch of company's proclaim DRG neurostimulator system​ (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-laboratories-says-announced-us-launch-of-companys-proclaim-drg-neurostimulator-system-2017-10,positive,0.6879041194915771
10/18/2017 1:45:00 PM,Abbott Reports Third-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-third-quarter-2017-results-1004762307,neutral,0.8457959890365601
10/18/2017 1:51:52 PM,Abbott Laboratories Q3 Earnings Rise 32%,RTTNews,/news/stocks/abbott-laboratories-q3-earnings-rise-32-1004762329,positive,0.9238182902336121
10/18/2017 1:52:03 PM,"US STOCKS-Dow set to open above 23,000 for the first time (IBM, ABT, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-set-to-open-above-23000-for-the-first-time-2017-10,neutral,0.5328107476234436
10/18/2017 1:57:05 PM,Abbott Labs posts quarterly profit vs. year-ago loss (ABT),Reuters,http://www.businessinsider.com/r-abbott-labs-posts-quarterly-profit-vs-year-ago-loss-2017-10,negative,0.564685046672821
10/18/2017 2:06:45 PM,Abbot Narrows FY17 Adj. Earnings Outlook - Quick Facts ,RTTNews,/news/stocks/abbot-narrows-fy17-adj-earnings-outlook-quick-facts-1004763442,neutral,0.9155842065811157
10/18/2017 2:22:03 PM,UPDATE 1-Abbott tops profit estimates on strong medical device sales (ABT),Reuters,http://www.businessinsider.com/r-update-1-abbott-tops-profit-estimates-on-strong-medical-device-sales-2017-10,positive,0.9249950647354126
10/18/2017 2:57:03 PM,"US STOCKS-Dow set to crack 23,000-mark at open for the first time (IBM, ABT, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-set-to-crack-23000-mark-at-open-for-the-first-time-2017-10,neutral,0.6545166969299316
10/18/2017 3:02:03 PM,BRIEF-Abbott Q3 adjusted EPS $0.66 from continuing operations (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-q3-adjusted-eps-066-from-continuing-operations-2017-10,negative,0.5735979080200195
10/18/2017 4:07:03 PM,"US STOCKS-Dow opens above 23,000, powered by IBM (IBM, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-opens-above-23000-powered-by-ibm-2017-10,positive,0.8828760385513306
10/18/2017 5:07:03 PM,BRIEF-Abbott CFO says Alere is expected to contribute around $475 mln to reported sales this year (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-cfo-says-alere-is-expected-to-contribute-around-475-mln-to-reported-sales-this-year-2017-10,positive,0.5843843221664429
10/18/2017 5:52:04 PM,"US STOCKS-Dow hovers above 23,000, boosted by IBM (IBM, WFC, BAC, GS, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-hovers-above-23000-boosted-by-ibm-2017-10,positive,0.9304640293121338
10/18/2017 7:22:03 PM,"US STOCKS-Dow stays above 23,000-mark on IBM surge (IBM, CVX, WFC, BAC, GS, ABT, CVS, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-stays-above-23000-mark-on-ibm-surge-2017-10,neutral,0.6107966303825378
10/18/2017 9:17:08 PM,"US STOCKS-Dow trades above 23,000-mark as IBM's stock jumps (IBM, ABT, CVS)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-trades-above-23000-mark-as-ibms-stock-jumps-2017-10,positive,0.7056205868721008
10/18/2017 10:32:11 PM,"US STOCKS-Dow closes above 23,000 for first time; IBM jumps (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-closes-above-23000-for-first-time-ibm-jumps-2017-10,positive,0.7123480439186096
10/18/2017 11:02:14 PM,"US STOCKS-Dow closes above 23,000 for first time; IBM soars (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-closes-above-23000-for-first-time-ibm-soars-2017-10,positive,0.8210557699203491
10/19/2017 1:32:12 AM,"US STOCKS-Dow ends above 23,000 for first time; IBM jumps (IBM, ABT, EBAY)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-ends-above-23000-for-first-time-ibm-jumps-2017-10,positive,0.6964641809463501
10/19/2017 8:59:00 PM,A Great Place to Do Great Things: Developing Game-Changing Technology at Abbott,PR Newswire,/news/stocks/a-great-place-to-do-great-things-developing-game-changing-technology-at-abbott-1004938345,neutral,0.8049785494804382
10/20/2017 8:12:04 PM,"Wall St Weekahead-Recent hurricanes take toll on quarterly earnings (HOG, COST, USB, ABT, AIG, DOV, SNA, PG, STZ, USG, OC, EXP, HD, DAL)",Reuters,http://www.businessinsider.com/r-wall-st-weekahead-recent-hurricanes-take-toll-on-quarterly-earnings-2017-10,negative,0.8993569612503052
10/23/2017 3:00:00 PM,Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.,PR Newswire,/news/stocks/abbott-launches-the-first-and-only-smartphone-compatible-insertable-cardiac-monitor-in-the-u-s-1005334020,neutral,0.5363439917564392
10/23/2017 3:13:18 PM,Abbott Announces FDA Clearance For Confirm Rx Insertable Cardiac Monitor ,RTTNews,/news/stocks/abbott-announces-fda-clearance-for-confirm-rx-insertable-cardiac-monitor-1005334913,positive,0.8106440901756287
10/23/2017 3:27:06 PM,BRIEF-Abbott says ‍secured FDA clearance for confirm Rx Insertable Cardiac Monitor​ (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-says-secured-fda-clearance-for-confirm-rx-insertable-cardiac-monitor-2017-10,positive,0.8925492167472839
10/30/2017 12:00:00 PM,Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1],PR Newswire,/news/stocks/abbott-introduces-next-generation-of-most-widely-used-heart-stent-for-people-with-coronary-artery-disease-in-europe-1-1006165257,neutral,0.7020994424819946
10/30/2017 12:00:00 PM,Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1],PR Newswire,/news/stocks/abbott-introduces-next-generation-of-most-widely-used-heart-stent-for-people-with-coronary-artery-disease-in-europe-1-1001807352,neutral,0.7020994424819946
10/30/2017 6:20:00 PM,Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery,PR Newswire,/news/stocks/analysis-of-landmark-study-showed-patients-treated-for-left-main-coronary-artery-disease-with-xience-stent-felt-better-faster-and-had-similar-long-term-outcomes-to-open-heart-surgery-1006198590,positive,0.9439030289649963
10/30/2017 6:20:00 PM,Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery,PR Newswire,/news/stocks/analysis-of-landmark-study-showed-patients-treated-for-left-main-coronary-artery-disease-with-xience-stent-felt-better-faster-and-had-similar-long-term-outcomes-to-open-heart-surgery-1002135158,positive,0.9439030289649963
10/31/2017 2:00:00 PM,Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems,PR Newswire,/news/stocks/abbott-announces-fda-clearance-for-its-alinity-ci-series-next-generation-diagnostic-systems-1006305187,positive,0.8131046295166016
10/31/2017 2:17:08 PM,BRIEF-Abbott gets FDA clearance for its Alinity ci-series instruments (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-gets-fda-clearance-for-its-alinity-ci-series-instruments-2017-10,positive,0.878924548625946
11/1/2017 6:00:00 PM,Minneapolis-based Pohlad family acquires PaR Systems from MML Capital Partners,PR Newswire,/news/stocks/minneapolis-based-pohlad-family-acquires-par-systems-from-mml-capital-partners-1001815862,neutral,0.9303572773933411
11/3/2017 5:52:03 PM,"LPC: US healthcare brightens tame US high-grade M&A lending (CVS, AET, CAH, MDT, ABT, HUM, CI, BDX, GILD, AMZN)",Reuters,http://www.businessinsider.com/r-lpc-us-healthcare-brightens-tame-us-high-grade-ma-lending-2017-11,positive,0.9182173609733582
11/6/2017 2:00:00 PM,Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan,PR Newswire,/news/stocks/abbott-s-mitraclip-approved-as-first-transcatheter-mitral-valve-repair-device-in-japan-1007055739,positive,0.8649452924728394
11/6/2017 2:30:00 PM,Homewood Health Proud to Honour Military Women and Their Families,PR Newswire,/news/stocks/homewood-health-proud-to-honour-military-women-and-their-families-640293,neutral,0.6349862217903137
11/13/2017 10:27:08 PM,BRIEF-Absolute Software Corp reports Q1 loss per share of $0.00 (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-software-corp-reports-q1-loss-per-share-of-000-2017-11,negative,0.9673601984977722
11/15/2017 6:52:00 AM,Huawei Creates a Smart City Nervous System for More Than 100 Cities with Leading New ICT,PR Newswire,/news/stocks/huawei-creates-a-smart-city-nervous-system-for-more-than-100-cities-with-leading-new-ict-527774,positive,0.5855828523635864
11/15/2017 2:57:08 PM,BRIEF-Absolute and EVRY sign Managed Service Provider and Reseller agreements (ABT),Reuters,http://www.businessinsider.com/r-brief-absolute-and-evry-sign-managed-service-provider-and-reseller-agreements-2017-11,neutral,0.6084706783294678
11/17/2017 6:52:00 PM,Counsel Proposes Merger of Funds and Other Changes to its Investment Lineup,PR Newswire,/news/stocks/counsel-proposes-merger-of-funds-and-other-changes-to-its-investment-lineup-492232,neutral,0.9172117710113525
12/6/2017 2:00:00 PM,"Symitar, Synergent Broaden Scope of Core Processing Partnership",PR Newswire,/news/stocks/symitar-synergent-broaden-scope-of-core-processing-partnership-1001595828,positive,0.8320035934448242
12/13/2017 2:00:00 PM,SC Johnson Goes Above and Beyond Regulatory and Industry Standards with Skin Allergen Transparency,PR Newswire,/news/stocks/sc-johnson-goes-above-and-beyond-regulatory-and-industry-standards-with-skin-allergen-transparency-582919,neutral,0.7680912613868713
12/15/2017 4:17:00 PM,Abbott Raising Quarterly Dividend for 46th Straight Year,PR Newswire,/news/stocks/abbott-raising-quarterly-dividend-for-46th-straight-year-1011552695,negative,0.4838351607322693
12/15/2017 5:22:03 PM,BRIEF-Abbott Increases Quarterly Dividend To 28 Cents Per Share (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-increases-quarterly-dividend-to-28-cents-per-share-2017-12,positive,0.8425056338310242
12/18/2017 3:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1011617639,neutral,0.9284790754318237
12/19/2017 8:35:00 PM,Global Television Gives The Gift of Connected Viewing With New Global Go App For Apple TV,PR Newswire,/news/stocks/global-television-gives-the-gift-of-connected-viewing-with-new-global-go-app-for-apple-tv-578956,neutral,0.5944015383720398
12/29/2017 9:00:00 AM,"Bottos: Where Blockchain, AI and Big Data Meet",PR Newswire,/news/stocks/bottos-where-blockchain-ai-and-big-data-meet-629955,neutral,0.9467527270317078
1/2/2018 3:00:00 PM,"Abbott Launches Alinity™ h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration",PR Newswire,/news/stocks/abbott-launches-alinity-h-series-integrated-hematology-system-combining-speed-accuracy-and-seamless-integration-1012407868,positive,0.7029204368591309
1/2/2018 3:17:04 PM,BRIEF-Abbott Launches Alinity H-Series Integrated Hematology System (ABT),Reuters,http://www.businessinsider.com/r-brief-abbott-launches-alinity-h-series-integrated-hematology-system-2018-1,neutral,0.8424521684646606
1/2/2018 4:07:03 PM,"US STOCKS-Wall Street kicks off 2018 on a strong note (DIS, NFLX, DISCA, WYNN, LVS, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-kicks-off-2018-on-a-strong-note-2018-1,positive,0.9354658722877502
1/2/2018 5:57:05 PM,"US STOCKS-Wall Street off to strong start to 2018 as techs gain (AAPL, MSFT, DIS, NFLX, DISCA, CMCSA, WYNN, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-off-to-strong-start-to-2018-as-techs-gain-2018-1,positive,0.9395616054534912
1/2/2018 7:07:03 PM,"US STOCKS-Wall Street carries momentum into 2018 as techs climb (AAPL, MSFT, AMZN, DIS, NFLX, DISCA, JCP, JWN, KSS, WYNN, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-carries-momentum-into-2018-as-techs-climb-2018-1,positive,0.934982180595398
1/2/2018 10:32:03 PM,"US STOCKS-Wall St begins 2018 with gains; tech drives momentum (AAPL, MSFT, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-begins-2018-with-gains-tech-drives-momentum-2018-1,positive,0.922548770904541
1/2/2018 10:57:03 PM,"US STOCKS-Wall St starts year on strong note; Nasdaq ends above 7,000 (AAPL, MSFT, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-starts-year-on-strong-note-nasdaq-ends-above-7000-2018-1,positive,0.8978672027587891
1/3/2018 12:07:03 AM,"US STOCKS-Wall St starts year on strong note; Nasdaq ends above 7,000 (AAPL, AMZN, JCP, JWN, KSS, WYNN, ABT, ALL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-starts-year-on-strong-note-nasdaq-ends-above-7000-2018-1,positive,0.8874229788780212
1/3/2018 3:00:00 PM,New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices,PR Newswire,/news/stocks/new-fda-mr-conditional-labeling-approvals-further-expand-abbott-s-portfolio-of-mri-ready-devices-1012434762,positive,0.9282454252243042
1/4/2018 3:00:00 PM,"Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients",PR Newswire,/news/stocks/abbott-s-revolutionary-continuous-glucose-monitoring-system-freestyle-libre-now-available-to-medicare-patients-1002309458,neutral,0.7639288306236267
1/8/2018 1:41:13 PM,Mylan To Close $1 Bln Share Repurchase Plan ,RTTNews,/news/stocks/mylan-to-close-1-bln-share-repurchase-plan-1012662174,neutral,0.9074066877365112
1/16/2018 8:09:00 AM,APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease,PR Newswire,/news/stocks/aprinoia-therapeutics-closes-us-11-million-series-b-financing-to-advance-its-tau-pet-imaging-tracer-and-tau-therapeutic-programs-for-alzheimer-s-disease-1001654713,positive,0.8650912046432495
1/24/2018 10:05:42 AM,"Earnings In Focus: Jan. 24 (ABT, CMCSA, F, GE, WHR) ",RTTNews,/news/stocks/earnings-in-focus-jan-24-abt-cmcsa-f-ge-whr-1013830542,neutral,0.9186986684799194
1/24/2018 1:45:00 PM,Abbott Reports Fourth-Quarter 2017 Results,PR Newswire,/news/stocks/abbott-reports-fourth-quarter-2017-results-1013848766,neutral,0.8160856366157532
1/24/2018 1:51:27 PM,Abbott Laboratories Reports Rise In Q4 Bottom Line,RTTNews,/news/stocks/abbott-laboratories-reports-rise-in-q4-bottom-line-1013848773,positive,0.932689368724823
1/24/2018 7:44:04 PM,Abbott Labs Posting Strong Gain On Better Than Expected Q4 Results ,RTTNews,/news/stocks/abbott-labs-posting-strong-gain-on-better-than-expected-q4-results-1013884225,positive,0.9458433389663696
1/25/2018 2:00:00 PM,Industry Frontrunners Recognized at Frost & Sullivan Best Practices Awards Gala,PR Newswire,/news/stocks/industry-frontrunners-recognized-at-frost-&-sullivan-best-practices-awards-gala-452202,neutral,0.5475541353225708
1/29/2018 10:00:00 AM,Aliyah Media Releases Inaugural Issue,PR Newswire,/news/stocks/aliyah-media-releases-inaugural-issue-701016,neutral,0.9454635977745056
2/7/2018 3:00:00 PM,Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™,PR Newswire,/news/stocks/abbott-s-app-for-freestyle-libre-system-now-available-in-europe-for-both-iphone-and-android-1015048487,neutral,0.7693790793418884
2/12/2018 11:24:00 PM,"Abbott Laboratories -- Moody's upgrades Abbott Laboratories to Baa2, positive outlook",Moodys,/news/bonds/abbott-laboratories-moody-s-upgrades-abbott-laboratories-to-baa2-positive-outlook-1015557925,positive,0.9266865849494934
2/16/2018 5:20:00 PM,Abbott Declares 377th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-377th-consecutive-quarterly-dividend-1016035646,negative,0.48371273279190063
2/27/2018 3:00:00 PM,Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon,PR Newswire,/news/stocks/abbott-and-surmodics-announce-agreement-for-next-generation-drug-coated-balloon-1017303628,positive,0.82097327709198
3/1/2018 3:00:00 PM,Abbott to Present at the Barclays Capital 2018 Global Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-the-barclays-capital-2018-global-healthcare-conference-1002125366,neutral,0.9360700845718384
3/7/2018 12:07:00 AM,FDA Approves the World's Smallest Mechanical Heart Valve for Pediatric Patients with Heart Defects,PR Newswire,/news/stocks/fda-approves-the-world-s-smallest-mechanical-heart-valve-for-pediatric-patients-with-heart-defects-1018188096,positive,0.7282470464706421
3/7/2018 12:34:48 AM,Abbott's Masters HP15mm Heart Valve Gets FDA Approval ,RTTNews,/news/stocks/abbott-s-masters-hp15mm-heart-valve-gets-fda-approval-1018190047,positive,0.8888041377067566
3/7/2018 7:14:11 AM,"FDA Approves New HIV Drug, Mark Your Calendar For BHVN, Watch Out For ZFGN ",RTTNews,/news/stocks/fda-approves-new-hiv-drug-mark-your-calendar-for-bhvn-watch-out-for-zfgn-1018228185,neutral,0.8933728933334351
3/9/2018 5:29:00 PM,Moody's: Outlook for US medical products and devices industry changed to positive,Moodys,/news/bonds/moody-s-outlook-for-us-medical-products-and-devices-industry-changed-to-positive-1018563273,positive,0.8155415058135986
3/11/2018 3:59:00 PM,New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump,PR Newswire,/news/stocks/new-long-term-data-show-improved-survival-and-lower-rates-of-stroke-and-pump-thrombosis-for-abbott-s-heartmate-3-heart-pump-1018613251,positive,0.9502686858177185
3/11/2018 6:20:10 PM,Abbott Announces New Clinical Trial Data From MOMENTUM 3 Clinical Study ,RTTNews,/news/stocks/abbott-announces-new-clinical-trial-data-from-momentum-3-clinical-study-1018613448,neutral,0.880842924118042
3/12/2018 5:30:17 AM,"SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch ",RTTNews,/news/stocks/svra-disappoints-sny-regn-s-praluent-price-to-be-cut-obsv-on-watch-1018614563,negative,0.9278159737586975
3/19/2018 2:00:00 PM,Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation,PR Newswire,/news/stocks/abbott-s-mitraclip-therapy-receives-national-reimbursement-in-japan-to-treat-patients-with-mitral-regurgitation-1018917372,positive,0.9092075228691101
3/20/2018 8:16:36 AM,"ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch ",RTTNews,/news/stocks/arna-soars-after-hours-remoxy-now-2-steps-away-from-approval-apls-on-watch-1018936376,negative,0.741555392742157
3/21/2018 2:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-498259,neutral,0.9381691813468933
3/29/2018 3:00:00 PM,Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor,PR Newswire,/news/stocks/abbott-initiates-trial-to-evaluate-improved-survival-and-outcomes-with-the-cardiomems-monitor-524836,positive,0.9043037295341492
4/11/2018 3:00:00 PM,Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease,PR Newswire,/news/stocks/abbott-initiates-groundbreaking-study-to-assess-superiority-of-high-resolution-imaging-versus-standard-of-care-angiography-in-treating-coronary-artery-disease-1021172127,positive,0.9331611394882202
4/11/2018 3:00:00 PM,Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease,PR Newswire,/news/stocks/abbott-initiates-groundbreaking-study-to-assess-superiority-of-high-resolution-imaging-versus-standard-of-care-angiography-in-treating-coronary-artery-disease-564323,positive,0.9331611394882202
4/17/2018 3:30:00 PM,Abbott's New Ensure® Max Protein Helps Americans Go for Their #HealthGoals,PR Newswire,/news/stocks/abbott-s-new-ensure-max-protein-helps-americans-go-for-their-healthgoals-1021437748,neutral,0.5662375092506409
4/18/2018 11:54:07 AM,"Earnings In Focus: Apr. 18 (ABT, PIR, STLD) ",RTTNews,/news/stocks/earnings-in-focus-apr-18-abt-pir-stld-1021488769,neutral,0.8983453512191772
4/18/2018 1:45:00 PM,Abbott Reports First-Quarter 2018 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2018-results-1021494590,neutral,0.8943395614624023
4/18/2018 1:53:13 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1021494609,positive,0.8761040568351746
4/20/2018 4:10:00 PM,Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023,PR Newswire,/news/stocks/abbott-extends-title-sponsorship-of-abbott-world-marathon-majors-through-2023-1021687316,neutral,0.7855037450790405
4/20/2018 4:10:00 PM,Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023,PR Newswire,/news/stocks/abbott-extends-title-sponsorship-of-abbott-world-marathon-majors-through-2023-601878,neutral,0.7855037450790405
4/23/2018 3:00:00 PM,"Sanquin Selects Abbott's ""Alinity™ s"" Solution for Blood and Plasma Screening",PR Newswire,/news/stocks/sanquin-selects-abbott-s-alinity-s-solution-for-blood-and-plasma-screening-1021997877,neutral,0.7425082921981812
4/23/2018 3:00:00 PM,"Sanquin Selects Abbott's ""Alinity™ s"" Solution for Blood and Plasma Screening",PR Newswire,/news/stocks/sanquin-selects-abbott-s-alinity-s-solution-for-blood-and-plasma-screening-1021997884,neutral,0.7425082921981812
4/23/2018 3:14:23 PM,"BRIEF-Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/1ePRzKsAt4s/brief-abbott-laboratories-co-sanquin-sign-multiple-year-contract-for-supply-of-primary-serological-equipment-and-consumables-idUSFWN1S00XX,positive,0.9366729855537415
4/25/2018 10:15:00 PM,Briggs & Stratton Declares Dividend And Approves $50 Million Share Repurchase Authorization,PR Newswire,/news/stocks/briggs-stratton-declares-dividend-and-approves-50-million-share-repurchase-authorization-1002295564,neutral,0.8215069770812988
4/27/2018 9:20:00 AM,Asarina Pharma: First Patients Begin Phase IIB Trials of World's First-ever Therapy Developed Specifically to Treat PMDD,PR Newswire,/news/stocks/asarina-pharma-first-patients-begin-phase-iib-trials-of-worlds-first-ever-therapy-developed-specifically-to-treat-pmdd-629671,positive,0.648237407207489
4/30/2018 11:35:00 PM,BRIEF-Abbott Laboratories Says Shareholders Rejected Proposal Requesting Board Of Directors Adopt Policy That Board Chairman Be Independent Director,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/AG3gcXKD7e8/brief-abbott-laboratories-says-shareholders-rejected-proposal-requesting-board-of-directors-adopt-policy-that-board-chairman-be-independent-director-idUSFWN1S71D6,neutral,0.7892274856567383
5/2/2018 3:00:00 PM,Abbott's XIENCE Sierra™ Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease,PR Newswire,/news/stocks/abbott-s-xience-sierra-heart-stent-receives-national-reimbursement-in-japan-to-treat-people-with-coronary-artery-disease-1023137871,positive,0.9354805946350098
5/3/2018 3:00:00 PM,Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter,PR Newswire,/news/stocks/abbott-expands-cardiac-arrhythmias-portfolio-with-fda-clearance-of-advanced-mapping-catheter-1023265258,positive,0.8911195993423462
5/7/2018 3:00:00 PM,University of Kansas Opens New Space to Serve Students in Leavenworth,PR Newswire,/news/stocks/university-of-kansas-opens-new-space-to-serve-students-in-leavenworth-1002365549,positive,0.7866606116294861
5/22/2018 12:01:00 PM,Argus Worldwide unit to launch global aggregator in Q3 2018,PR Newswire,/news/stocks/argus-worldwide-unit-to-launch-global-aggregator-in-q3-2018-1001717725,neutral,0.8423947095870972
5/22/2018 12:20:00 PM,Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions,PR Newswire,/news/stocks/five-year-study-data-confirm-positive-outcomes-for-patients-when-abbott-diagnostic-tool-was-used-to-guide-heart-stenting-decisions-1025084050,positive,0.9454496502876282
5/22/2018 12:38:06 PM,Abbott Reports Five-year Results From FAME 2 Study - Quick Facts ,RTTNews,/news/stocks/abbott-reports-five-year-results-from-fame-2-study-quick-facts-1025084309,neutral,0.8275675773620605
5/23/2018 12:00:00 PM,Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study,PR Newswire,/news/stocks/abbott-s-investigational-tendyne-device-for-mitral-valve-replacement-demonstrates-positive-outcomes-at-30-days-in-global-study-1001718575,positive,0.9478781819343567
5/23/2018 3:00:00 PM,Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease,PR Newswire,/news/stocks/newest-generation-of-leading-heart-stent-is-now-approved-in-the-u-s-for-people-with-coronary-artery-disease-1025137098,positive,0.66018146276474
5/31/2018 2:00:00 PM,Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management,PR Newswire,/news/stocks/abbott-introduces-the-afinion-2-analyzer-rapid-test-system-for-diabetes-management-1025975690,neutral,0.7586048245429993
6/8/2018 4:15:00 PM,Abbott Declares 378th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-378th-consecutive-quarterly-dividend-1026809161,negative,0.4967936873435974
6/14/2018 2:22:25 PM,Allergan appoints former Abbott executive to its board,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/JEFsTLIk0-g/allergan-appoints-former-abbott-executive-to-its-board-idUSL4N1TG4LJ,neutral,0.9233586192131042
6/20/2018 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1027253924,neutral,0.9235584139823914
7/12/2018 3:10:22 PM,Abbott : FDA Oks MitraClip Device To Treat People With Leaky Heart Valves ,RTTNews,/news/stocks/abbott-fda-oks-mitraclip-device-to-treat-people-with-leaky-heart-valves-1027362735,positive,0.6907880306243896
7/16/2018 3:01:24 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-quarterly-earnings-preview-1027369928,neutral,0.9313719272613525
7/18/2018 1:51:42 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1027377751,positive,0.854049801826477
7/18/2018 2:02:01 PM,Abbott Raises FY18 Earnings Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-raises-fy18-earnings-outlook-quick-facts-1027377815,neutral,0.7150269746780396
9/14/2018 6:24:00 PM,Abbott Ireland Financing DAC -- Moody's assigns Baa1 to Abbott Lab's proposed Euro notes offering,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-assigns-baa1-to-abbott-lab-s-proposed-euro-notes-offering-1027536592,neutral,0.780244767665863
9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053,positive,0.7368782758712769
9/23/2018 8:07:01 PM,Abbott Announces Positive Study Results On MitraClip Device ,RTTNews,/news/stocks/abbott-announces-positive-study-results-on-mitraclip-device-1027556777,positive,0.938310980796814
10/15/2018 3:01:24 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q3-earnings-preview-1027616801,neutral,0.9313719272613525
10/17/2018 1:51:39 PM,Abbott Laboratories Q3 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-inline-with-estimates-1027625064,neutral,0.4244677424430847
10/17/2018 1:52:35 PM,Abbott Labs quarterly profit falls 6.6 pct on tax expense,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/YljO2ZUQy5E/abbott-labs-quarterly-profit-falls-6-6-pct-on-tax-expense-idUSL3N1WX3W1,negative,0.9688464999198914
10/17/2018 2:09:29 PM,Abbott Sees Q4 Profit In Line With View; Narrows FY18 Profit Outlook ,RTTNews,/news/stocks/abbott-sees-q4-profit-in-line-with-view-narrows-fy18-profit-outlook-1027625238,positive,0.8427887558937073
10/17/2018 2:25:46 PM,UPDATE 1-Abbott Labs quarterly profit falls on higher tax expense,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oGwesaRaTRY/update-1-abbott-labs-quarterly-profit-falls-on-higher-tax-expense-idUSL3N1WX3WJ,negative,0.9736383557319641
10/26/2018 8:56:11 PM,"Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/82Fp5LcIPz0/abbott-abbvie-settle-u-s-case-over-tricor-marketing-for-25-mln-idUSL2N1X61H0,positive,0.4742342233657837
10/26/2018 9:39:15 PM,"UPDATE 1-Abbott, AbbVie to pay $25 mln to settle TriCor marketing case",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/wZr-U3s9SiY/update-1-abbott-abbvie-to-pay-25-mln-to-settle-tricor-marketing-case-idUSL2N1X61K5,neutral,0.8521546721458435
10/26/2018 11:16:01 PM,"UPDATE 2-Abbott, AbbVie settle TriCor marketing case for $25 mln",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/L0FT0bDriM0/update-2-abbott-abbvie-settle-tricor-marketing-case-for-25-mln-idUSL2N1X61K5,neutral,0.8409739136695862
10/27/2018 1:54:35 AM,"Abbott, AbbVie settle TriCor marketing case for $25 million",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LBOGWyYVxhI/abbott-abbvie-settle-tricor-marketing-case-for-25-million-idINKCN1N02XY,neutral,0.8910031318664551
1/14/2019 3:15:31 PM,Abbott: FDA Approves Amplatzer Piccolo Occluder Medical Device - Quick Facts ,RTTNews,/news/stocks/abbott-fda-approves-amplatzer-piccolo-occluder-medical-device-quick-facts-1027865566,neutral,0.5128490924835205
1/15/2019 7:38:34 AM,"First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch ",RTTNews,/news/stocks/first-device-for-congenital-heart-defect-aimt-us-shutdown-asln-on-watch-1027867299,neutral,0.8465320467948914
1/22/2019 3:01:31 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-earnings-preview-1027886006,neutral,0.9050445556640625
1/23/2019 1:52:18 PM,Abbott Laboratories Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-inline-with-estimates-1027889262,negative,0.4216991364955902
1/23/2019 1:53:13 PM,Abbott Lab's fourth-quarter revenue rises 2.3 pct,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3k1xkSrp8-s/abbott-labs-fourth-quarter-revenue-rises-2-3-pct-idUSL3N1ZN44H,positive,0.9336045980453491
1/23/2019 1:58:20 PM,Abbott Sees Q1 Profit Below View ,RTTNews,/news/stocks/abbott-sees-q1-profit-below-view-1027889275,negative,0.9226826429367065
1/23/2019 2:38:08 PM,"UPDATE 1-Abbott Lab's revenue misses estimate, forecasts lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/izfR6ggE7as/update-1-abbott-labs-revenue-misses-estimate-forecasts-lackluster-first-qtr-profit-idUSL3N1ZN44X,negative,0.9698317050933838
1/23/2019 4:09:11 PM,Abbott Labs says M&A not a high priority now,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/yfsf50TwYSA/abbott-labs-says-ma-not-a-high-priority-now-idUSL3N1ZN4KU,neutral,0.8910659551620483
1/23/2019 5:12:47 PM,"UPDATE 2-Abbott Lab's revenue misses estimate, forecasts lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Nkd799eGFNc/update-2-abbott-labs-revenue-misses-estimate-forecasts-lackluster-first-qtr-profit-idUSL3N1ZN44X,negative,0.9704723954200745
1/23/2019 8:36:12 PM,"UPDATE 3-Abbott misses revenue estimates, sees lackluster first-qtr profit",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/UIJMgV5kwYo/update-3-abbott-misses-revenue-estimates-sees-lackluster-first-qtr-profit-idUSL3N1ZN44X,negative,0.9685717225074768
2/20/2019 3:10:54 PM,"Abbott, Novo Provide Digital Solution To People With Diabetes Using Insulin ",RTTNews,/news/stocks/abbott-novo-provide-digital-solution-to-people-with-diabetes-using-insulin-1027968392,neutral,0.7672519683837891
4/15/2019 3:01:27 PM,Abbott Laboratories is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-q1-earnings-preview-stock-1028110936,neutral,0.9352886080741882
4/17/2019 1:50:58 PM,Abbott Lab's first-quarter sales beat expectations,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/j5PUtwdGjFk/abbott-labs-first-quarter-sales-beat-expectations-idUSL3N21Z31Q,positive,0.9463421702384949
4/17/2019 1:51:17 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1028118122,positive,0.8761040568351746
4/17/2019 2:22:57 PM,UPDATE 1-Abbott Labs beats first-quarter expectations on higher diabetes devices sales,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/DtDG_ORW9bc/update-1-abbott-labs-beats-first-quarter-expectations-on-higher-diabetes-devices-sales-idUSL3N21Z32E,positive,0.9431856274604797
4/17/2019 4:36:45 PM,Abbott Labs beats first-quarter expectations on higher diabetes devices sales,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Szn4Dlx1mFM/abbott-labs-beats-first-quarter-expectations-on-higher-diabetes-devices-sales-idINKCN1RT1QG,positive,0.9462073445320129
4/17/2019 6:21:02 PM,UPDATE 2-Abbott Labs quarterly beat overshadowed by unchanged forecast,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/P0-negm31FE/update-2-abbott-labs-quarterly-beat-overshadowed-by-unchanged-forecast-idUSL3N21Z32E,negative,0.7587646245956421
5/2/2019 2:32:07 PM,Abbott Gets WHO Prequalification Approval For HIV Point-of-Care Test ,RTTNews,/news/stocks/abbott-gets-who-prequalification-approval-for-hiv-point-of-care-test-1028161785,positive,0.9205919504165649
5/3/2019 7:09:00 PM,"Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories' senior unsecured rating to A3, stable outlook",Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-upgrades-abbott-laboratories-senior-unsecured-rating-to-a3-stable-outlook-1028166304,positive,0.928305447101593
6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925,neutral,0.9193856716156006
6/26/2019 11:42:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1028311633,neutral,0.7941276431083679
7/12/2019 3:00:28 PM,Notable Earnings Next Week ,RTTNews,/news/stocks/notable-earnings-next-week-1028349139,neutral,0.7209571003913879
7/12/2019 7:46:29 PM,4 Healthcare Stocks That Are Feeling Sick  ,InvestorPlace,/news/stocks/4-healthcare-stocks-that-are-feeling-sick-1028350342,negative,0.7167696356773376
7/15/2019 12:10:13 PM,4 Best Marijuana ETFs for Conservative Portfolios,InvestorPlace,/news/stocks/4-best-marijuana-etfs-for-conservative-portfolios-1028246284,neutral,0.5795719623565674
7/15/2019 3:01:21 PM,Abbott Laboratories earnings preview: what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-q2-earnings-preview-1028352623,neutral,0.9070191979408264
7/16/2019 12:00:00 PM,FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/7kzw9VMUIJE/focus-abbott-to-hike-production-of-lower-cost-glucose-monitors-as-diabetes-soars-idUSL2N24E003,positive,0.9196043610572815
7/16/2019 12:34:09 PM,Abbott to hike production of lower-cost glucose monitors as diabetes soars,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Wos3UYGEQkU/abbott-to-hike-production-of-lower-cost-glucose-monitors-as-diabetes-soars-idINKCN1UB102,positive,0.8432729840278625
7/17/2019 1:38:38 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1028360121,positive,0.854049801826477
7/17/2019 1:40:40 PM,Abbott Labs quarterly profit jumps 37%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/hL_CRX_sieM/abbott-labs-quarterly-profit-jumps-37-idUSL4N24I2K5,positive,0.7269315123558044
7/17/2019 1:57:51 PM,Abbott Labs Raises 2019 Outlook ,RTTNews,/news/stocks/abbott-labs-raises-2019-outlook-1028360179,neutral,0.8399092555046082
7/17/2019 2:03:06 PM,"UPDATE 1-Abbott beats profit estimates, raises FY forecast on diabetes device strength",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/t6fsD3v0594/update-1-abbott-beats-profit-estimates-raises-fy-forecast-on-diabetes-device-strength-idUSL4N24I2MU,positive,0.8089398145675659
7/17/2019 5:13:52 PM,"Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat",InvestorPlace,/news/stocks/abbott-laboratories-earnings-have-abt-stock-up-1028363016,positive,0.850700855255127
7/17/2019 5:53:48 PM,UPDATE 3-Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ldfag7-9Ewo/update-3-abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idUSL4N24I2MU,positive,0.9379815459251404
7/17/2019 6:07:40 PM,Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/CFHZiT1PIvg/abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idINKCN1UC1NL,positive,0.8952982425689697
7/17/2019 6:19:54 PM,Abbott hits record high as diabetes device fuels profit beat,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/MzkXsooQR94/abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idUSKCN1UC1D7,positive,0.8952982425689697
7/17/2019 7:41:03 PM,"5 Top Stock Trades for Thursday: TSLA, GLD, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-tsla-gld-abt-1028363004,neutral,0.9221410155296326
9/5/2019 3:10:29 PM,Abbott Begins Trial To Evaluate Transcatheter Tricuspid Valve Repair ,RTTNews,/news/stocks/abbott-begins-trial-to-evaluate-transcatheter-tricuspid-valve-repair-1028502041,neutral,0.5863930583000183
9/10/2019 3:20:05 PM,Abbott Develops Algorithm For Diagnosing Heart Attacks - Quick Facts ,RTTNews,/news/stocks/abbott-develops-algorithm-for-diagnosing-heart-attacks-quick-facts-1028513039,neutral,0.9171174168586731
9/16/2019 7:16:06 AM,"Sanofi, Abbott To Integrate Glucose Sensing And Insulin Delivery Technologies ",RTTNews,/news/stocks/sanofi-abbott-to-integrate-glucose-sensing-and-insulin-delivery-technologies-1028525254,neutral,0.5441559553146362
9/23/2019 11:22:22 AM,"3 Big Stock Charts for Monday: MSCI, Macerich and Abbott Laboratories",InvestorPlace,/news/stocks/3-big-stock-charts-for-monday-msci-macerich-and-abbott-laboratories-1028546669,neutral,0.9259938597679138
9/25/2019 2:56:28 PM,Abbott's Newly Approved Blood Test Could Help Identify Heart Attacks Sooner ,RTTNews,/news/stocks/abbott-s-newly-approved-blood-test-could-help-identify-heart-attacks-sooner-1028552418,positive,0.7896828055381775
9/26/2019 2:22:12 PM,FDA Approves Abbott's Spinal Cord Stimulation System For Chronic Pain ,RTTNews,/news/stocks/fda-approves-abbott-s-spinal-cord-stimulation-system-for-chronic-pain-1028555850,positive,0.6798719167709351
10/1/2019 3:08:33 PM,4 Healthcare Stocks to Buy Now,InvestorPlace,/news/stocks/4-healthcare-stocks-to-buy-now-1028569344,neutral,0.8973767757415771
10/3/2019 3:56:03 PM,Are These 10 High-Yielding S&P Dividend Stocks Traps or Treasures?,InvestorPlace,/news/stocks/are-these-10-high-yielding-sp-500-stocks-traps-or-treasures-1028575945,neutral,0.902236819267273
10/14/2019 3:27:28 PM,Abbott: Omada To Provide FreeStyle Libre As Exclusive CGM - Quick Facts ,RTTNews,/news/stocks/abbott-omada-to-provide-freestyle-libre-as-exclusive-cgm-quick-facts-1028596648,neutral,0.792050838470459
10/16/2019 7:00:00 AM,Abbott Laboratories to Host Earnings Call,Accesswire,/news/stocks/abbott-laboratories-to-host-earnings-call-1028605077,neutral,0.9336061477661133
10/16/2019 1:34:18 PM,Abbott Laboratories Q3 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-inline-with-estimates-1028603184,neutral,0.4244677424430847
10/16/2019 1:39:34 PM,Abbott Labs quarterly profit rises 70.5%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/enmYfpnxbi4/abbott-labs-quarterly-profit-rises-70-5-idUSL3N2712WQ,positive,0.8646870851516724
10/16/2019 1:46:10 PM,Abbott Labs quarterly profit rises 70.5%,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ZkoAuAExVoI/abbott-labs-quarterly-profit-rises-70-5-idUSKBN1WV1HQ,positive,0.8646870851516724
10/16/2019 1:49:57 PM,Abbott Sees Q4 Profit In Line With View; Narrows FY Profit View ,RTTNews,/news/stocks/abbott-sees-q4-profit-in-line-with-view-narrows-fy-profit-view-1028603247,positive,0.8936378359794617
10/16/2019 2:18:47 PM,"Abbott Labs misses revenue estimates, trims profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/-KcutBbbznY/abbott-labs-misses-revenue-estimates-trims-profit-forecast-idUSKBN1WV1HQ,negative,0.9699843525886536
10/16/2019 3:36:02 PM,Abbott Labs trims profit forecast after revenue miss,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3-DefZ5cmqQ/abbott-labs-trims-profit-forecast-after-revenue-miss-idUSKBN1WV1HQ,negative,0.95613694190979
10/16/2019 6:18:45 PM,Abbott revenue misses as heart devices eclipse diabetes gains,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/gX5fWtwULfo/abbott-revenue-misses-as-heart-devices-eclipse-diabetes-gains-idUSKBN1WV1HQ,negative,0.9618918895721436
10/16/2019 7:49:53 PM,"5 Top Stock Trades for Thursday: ADBE, NFLX, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-adbe-nflx-abt-1028605297,neutral,0.9283514618873596
10/30/2019 5:13:03 PM,7 Buy-and-Hold Stocks to Play Investing’s Biggest Trends,InvestorPlace,/news/stocks/7-buy-and-hold-stocks-to-play-investings-biggest-trends-1028645322,neutral,0.8700729012489319
11/12/2019 12:23:00 PM,Abbott Ireland Financing DAC -- Moody's assigns A3 ratings to Abbott's unsecured euro note offering,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-assigns-a3-ratings-to-abbott-s-unsecured-euro-note-offering-1028680010,neutral,0.8061602711677551
11/12/2019 10:06:08 PM,Abbott Laboratories Profit Climbs In Q1,RTTNews,/news/stocks/abbott-laboratories-profit-climbs-in-q1-1028682897,positive,0.8848466277122498
11/13/2019 1:55:36 PM,Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Z-IfAkwXHN4/abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AE,neutral,0.5840625166893005
11/13/2019 2:08:39 PM,Abbott CEO Miles White To Step Down After Two Decades ,RTTNews,/news/stocks/abbott-ceo-miles-white-to-step-down-after-two-decades-1028685182,neutral,0.7718305587768555
11/13/2019 2:23:09 PM,UPDATE 1-Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CBYJ9mSDSgU/update-1-abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AZ,neutral,0.5442236065864563
11/13/2019 3:50:21 PM,UPDATE 2-Abbott CEO Miles White to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qtUz5_lIa1U/update-2-abbott-ceo-miles-white-to-step-down-next-year-idUSL4N27T3AZ,neutral,0.5679416656494141
12/11/2019 7:18:55 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Is a Long-Term Winner,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-is-a-long-term-winner-1028756681,neutral,0.7968711256980896
12/20/2019 6:50:00 PM,"LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR",Moodys,/news/bonds/lifescan-global-corporation-moody-s-revises-lifescan-s-outlook-to-negative-affirms-b2-cfr-1028779871,negative,0.5515680909156799
12/30/2019 4:06:03 PM,7 High-Yield Dividend Stocks for Growth and Income in the 2020s,InvestorPlace,/news/stocks/7-dividend-stocks-growth-income-2020s-1028788477,neutral,0.892297625541687
1/7/2020 4:47:31 PM,Abbott : FDA Okays Less Invasive Surgical Approach To Avoid Open Heart Surgery ,RTTNews,/news/stocks/abbott-fda-okays-less-invasive-surgical-approach-to-avoid-open-heart-surgery-1028800228,positive,0.8998091816902161
1/10/2020 3:25:18 PM,7 High-Yield Dividend Stocks Set for Growth,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-growth-1028550794,neutral,0.9129140973091125
1/17/2020 11:51:46 AM,"3 Big Stock Charts for Friday: IBM, Abbott Labs, and FuelCell Energy",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-ibm-abbott-labs-and-fuelcell-energy-1028826112,neutral,0.910954475402832
1/22/2020 1:36:06 PM,Abbott Laboratories Q4 adjusted earnings Inline With Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-inline-with-estimates-1028835506,negative,0.4216991364955902
1/22/2020 1:38:15 PM,Abbott quarterly profit soars 60%,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/nfACISOXtQE/abbott-quarterly-profit-soars-60-idUSL4N29R394,positive,0.8828465342521667
1/22/2020 1:55:45 PM,Abbott Laboratories Guides FY20 Adj. EPS In Line - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-guides-fy20-adj-eps-in-line-quick-facts-1028835571,neutral,0.8819144368171692
1/22/2020 4:32:17 PM,Incoming Abbott CEO says not looking to do any deals,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/et7arTDzMV4/incoming-abbott-ceo-says-not-looking-to-do-any-deals-idUSL4N29R3XF,neutral,0.823148787021637
1/22/2020 5:56:09 PM,UPDATE 3-Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4h33eivjmcg/update-3-abbott-hits-all-time-high-on-quarterly-revenue-beat-idUSL4N29R3A4,positive,0.9390949010848999
1/22/2020 6:02:34 PM,Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/NC2dvKG9-3c/abbott-hits-all-time-high-on-quarterly-revenue-beat-idUSKBN1ZL1OG,positive,0.9341721534729004
1/22/2020 6:30:29 PM,Abbott hits all-time high on quarterly revenue beat,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/t28TUa3gqZo/abbott-hits-all-time-high-on-quarterly-revenue-beat-idINKBN1ZL2IT,positive,0.9341721534729004
1/22/2020 7:58:09 PM,Abbott Labs Earnings: ABT Stock Jumps 3% on Q4 Beat,InvestorPlace,/news/stocks/abbott-labs-earnings-abt-stock-jumps-3-on-q4-beat-1028837411,positive,0.935211718082428
1/23/2020 3:23:49 PM,Abbott Announces Positive Results In Chronic Pain Study ,RTTNews,/news/stocks/abbott-announces-positive-results-in-chronic-pain-study-1028839855,positive,0.9445976614952087
2/3/2020 3:55:51 PM,Abbott's Trial To Assess New Therapy Option For People At Risk Of Stroke ,RTTNews,/news/stocks/abbott-s-trial-to-assess-new-therapy-option-for-people-at-risk-of-stroke-1028868304,positive,0.6623350381851196
2/3/2020 10:14:28 PM,Abbott Laboratories Reports Rise In Q2 Earnings,RTTNews,/news/stocks/abbott-laboratories-reports-rise-in-q2-earnings-1028869359,positive,0.9436618089675903
2/18/2020 1:07:52 PM,New Abbott ICD and CRT-D devices CE Mark'd,Seeking Alpha,https://seekingalpha.com/news/3542646-new-abbott-icd-and-crt-d-devices-ce-markd?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5951370000839233
2/20/2020 2:21:11 PM,"Abbott's FreeStyle Libre Shows Positive Outcomes For Type 1, Type 2 Diabetes ",RTTNews,/news/stocks/abbott-s-freestyle-libre-shows-positive-outcomes-for-type-1-type-2-diabetes-1028923585,positive,0.9415872097015381
3/3/2020 5:37:27 PM,Race in full-stride for tests to identify coronavirus illness,Seeking Alpha,https://seekingalpha.com/news/3548128-race-in-full-stride-for-tests-to-identify-coronavirus-illness?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8913335204124451
3/3/2020 6:37:30 PM,Investor guide to coronavirus plays - diagnostic tests,Seeking Alpha,https://seekingalpha.com/news/3548182-investor-guide-to-coronavirus-plays-diagnostic-tests?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9304789304733276
3/3/2020 8:38:58 PM,FDA cautions on SweynTooth vulnerability in certain medical devices,Seeking Alpha,https://seekingalpha.com/news/3548257-fda-cautions-on-sweyntooth-vulnerability-in-certain-medical-devices?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.564661979675293
3/4/2020 8:29:38 PM,Outlook brightens for availability of coronavirus tests in U.S.,Seeking Alpha,https://seekingalpha.com/news/3548695-outlook-brightens-for-availability-of-coronavirus-tests-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.928633987903595
3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8478836417198181
3/5/2020 2:26:51 PM,Abbott FlaxNav system CE Mark'd,Seeking Alpha,https://seekingalpha.com/news/3549031-abbott-flaxnav-system-ce-markd?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8342470526695251
3/5/2020 3:48:52 PM,Abbott Receives EU Approval For FlexNav Delivery System ,RTTNews,/news/stocks/abbott-receives-eu-approval-for-flexnav-delivery-system-1028968823,positive,0.9089516997337341
3/9/2020 5:52:45 PM,Coronavirus testing available in every state - CDC,Seeking Alpha,https://seekingalpha.com/news/3549837-coronavirus-testing-available-in-every-state-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9187211990356445
3/11/2020 3:03:41 PM,Parallax Health up 13% on planned coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3550582-parallax-health-up-13-on-planned-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9504404067993164
3/17/2020 1:39:04 AM,FDA to allow states to authorize coronavirus tests,Seeking Alpha,https://seekingalpha.com/news/3552325-fda-to-allow-states-to-authorize-coronavirus-tests?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5838106870651245
3/18/2020 11:42:04 PM,"U.S. approves Abbott coronavirus test; company set to ship 150,000",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BLKpAogjtzI/u-s-approves-abbott-coronavirus-test-company-set-to-ship-150000-idUSL4N2BB5N0,positive,0.5628191828727722
3/19/2020 2:23:23 AM,"Abbott Labs to ship 150K coronavirus tests, ramping up for more",Seeking Alpha,https://seekingalpha.com/news/3553199-abbott-labs-to-ship-150k-coronavirus-tests-ramping-up-for?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8907138109207153
3/19/2020 1:26:25 PM,Israel OKs use of generic Abbott drug to treat coronavirus despite patent,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/QknHict6AS8/israel-oks-use-of-generic-abbott-drug-to-treat-coronavirus-despite-patent-idUSL8N2BC5D6,positive,0.6740491986274719
3/26/2020 9:41:11 PM,Trump says G-20 nations coordinating on Covid-19: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3555710-trump-says-gminus-20-nations-coordinating-on-covidminus-19-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8148167133331299
3/28/2020 12:38:30 AM,Abbott launches five-minute coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3556045-abbott-launches-five-minute-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9196807742118835
3/28/2020 1:25:48 AM,Abbott wins U.S. approval for test that can detect coronavirus in minutes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vCNdg9Yguao/abbott-wins-u-s-approval-for-test-that-can-detect-coronavirus-in-minutes-idUSL1N2BK3C0,positive,0.7416059374809265
3/28/2020 6:19:02 PM,Abbott wins U.S. approval for test that can detect coronavirus in minutes,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/x4V71Y2u5a0/abbott-wins-u-s-approval-for-test-that-can-detect-coronavirus-in-minutes-idINKBN21F0SO,positive,0.7416059374809265
3/30/2020 2:00:28 PM,Stock Alert: Abbott Shares Up 9% In Early Trading ,RTTNews,/news/stocks/stock-alert-abbott-shares-up-9-in-early-trading-1029044191,positive,0.9423307776451111
3/30/2020 3:06:04 PM,Abbott surges 13% after FDA approval of 5-minute coronavirus test (ABT),Business Insider,https://markets.businessinsider.com/news/stocks/abbott-stock-price-spikes-fda-approval-5-minute-coronavirus-test-2020-3-1029044661,positive,0.9309288263320923
3/30/2020 6:16:03 PM,Abbott Labs News: ABT Stock Surges 7% on 5-Minute Coronavirus Test,InvestorPlace,/news/stocks/abbott-labs-news-coronavirus-test-sends-abt-stock-up-1029046278,positive,0.8341442346572876
3/30/2020 8:16:47 PM,Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?,InvestorPlace,/news/stocks/stock-market-today-healthcare-stocks-leads-the-way-buy-zoom-1029046564,neutral,0.8414232134819031
3/30/2020 8:36:04 PM,FDA Approves Abbott's 5-minute Coronavirus Test ,RTTNews,/news/stocks/fda-approves-abbott-s-5-minute-coronavirus-test-1029046047,neutral,0.7703428268432617
3/30/2020 8:47:44 PM,"5 Top Stock Trades for Tuesday: ZM, WORK, TWTR, ABT, DDD",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-zm-work-twtr-abt-ddd-1029046562,neutral,0.9322763085365295
3/30/2020 9:20:08 PM,U.S. Covid-19 testing reaches more than 1M: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3556550-u-s-covidminus-19-testing-reaches-1m-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.883658766746521
3/31/2020 11:32:18 AM,"3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals-1029048681,neutral,0.9266859889030457
3/31/2020 6:02:00 PM,FDA OKs emergency use of 2-minute coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3556928-fda-oks-emergency-use-of-2-minute-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5922223329544067
3/31/2020 9:39:47 PM,"White House crisis update: Ventilator figures, bracing for casualties",Seeking Alpha,https://seekingalpha.com/news/3557035-white-house-crisis-update-ventilator-figures-bracing-for-casualties?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7178640961647034
4/1/2020 3:03:22 PM,Danaher Stock Still Offers Investors the Best of Both Worlds,InvestorPlace,/news/stocks/short-term-catalysts-danaher-stock-buy-1029055589,positive,0.6039780974388123
4/4/2020 12:37:09 PM,Amazon advances pandemic response,Seeking Alpha,https://seekingalpha.com/news/3558428-amazon-advances-pandemic-response?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7308698892593384
4/5/2020 11:10:41 PM,"FEMA sending 1,700 ventilators to hot spots: coronavirus briefing",Seeking Alpha,https://seekingalpha.com/news/3558463-fema-sending-1700-ventilators-to-hot-spots-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5807507038116455
4/8/2020 4:59:07 PM,Abbott's CGM Available For Hospitalized Patients With Diabetes During COVID-19 ,RTTNews,/news/stocks/abbott-s-cgm-available-for-hospitalized-patients-with-diabetes-during-covid-19-1029076628,neutral,0.7343789935112
4/8/2020 6:57:57 PM,Walgreens Coronavirus Testing Sites to Open in 7 States,InvestorPlace,/news/stocks/walgreens-coronavirus-testing-sites-to-open-in-7-states-1029077617,neutral,0.8598189949989319
4/9/2020 1:24:42 PM,Abbott's TriClip device CE Mark'd for tricuspid valve repair,Seeking Alpha,https://seekingalpha.com/news/3559680-abbotts-triclip-device-ce-markd-for-tricuspid-valve-repair?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5643813014030457
4/9/2020 3:45:38 PM,Abbott's TriClip Transcatheter Tricuspid Valve Repair System Gets CE Mark ,RTTNews,/news/stocks/abbott-s-triclip-transcatheter-tricuspid-valve-repair-system-gets-ce-mark-1029080265,positive,0.8220722079277039
4/13/2020 4:58:21 PM,Study shows viability of saliva testing for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3560222-study-shows-viability-of-saliva-testing-for-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6925150156021118
4/13/2020 10:02:58 PM,Trump agreed to mitigation efforts at first recommendation: Coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3560344-trump-agreed-to-mitigation-efforts-first-recommendation-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8017809987068176
4/15/2020 1:19:33 PM,Abbott launches third COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3560863-abbott-launches-third-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.741961658000946
4/15/2020 3:01:19 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q1-1029094181,neutral,0.9313719272613525
4/15/2020 3:24:31 PM,"Abbott launches antibody test for coronavirus, plans to deliver 20 mln tests by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/0u7G4DLrzkE/abbott-launches-antibody-test-for-coronavirus-plans-to-deliver-20-mln-tests-by-june-idUSL3N2C33BC,neutral,0.7532082200050354
4/15/2020 3:25:41 PM,Abbott Launches Antibody Blood Test For COVID-19 - Quick Facts ,RTTNews,/news/stocks/abbott-launches-antibody-blood-test-for-covid-19-quick-facts-1029094443,neutral,0.8222742080688477
4/15/2020 4:06:12 PM,What looming recession? Abbott at pre-selloff levels,Seeking Alpha,https://seekingalpha.com/news/3560951-what-looming-recession-abbott-pre-selloff-levels?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5228032469749451
4/15/2020 4:08:02 PM,"UPDATE 1-Abbott launches COVID-19 antibody test, plans 20 mln tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/O7cNaqqfFDM/update-1-abbott-launches-covid-19-antibody-test-plans-20-mln-tests-per-month-by-june-idUSL3N2C33E9,neutral,0.8036240339279175
4/15/2020 4:14:40 PM,"Abbott launches COVID-19 antibody test, plans 20 million tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Ze6PNTtKo1g/abbott-launches-covid-19-antibody-test-plans-20-million-tests-per-month-by-june-idINKCN21X23N,neutral,0.8438596725463867
4/15/2020 5:50:34 PM,"UPDATE 2-Abbott launches COVID-19 antibody test, plans 20 mln tests per month by June",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/I7UKtzo9v2A/update-2-abbott-launches-covid-19-antibody-test-plans-20-mln-tests-per-month-by-june-idUSL3N2C33E9,neutral,0.8003025650978088
4/15/2020 8:18:25 PM,Stock Market Today: Apple’s New iPhone; Abbott’s New Coronavirus Test,InvestorPlace,/news/stocks/stock-market-today-apples-new-iphone-abbotts-new-coronavirus-test-1029096340,neutral,0.8921477794647217
4/15/2020 9:30:13 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3560977-notable-earnings-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8825733065605164
4/15/2020 9:30:22 PM,Abbott Laboratories Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3560986-abbott-laboratories-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8010336756706238
4/16/2020 11:31:49 AM,"Abbott Laboratories EPS beats by $0.04, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3561213-abbott-laboratories-eps-beats-0_04-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4785439670085907
4/16/2020 11:49:14 AM,Abbott reports strong Q1 but pulls guidance,Seeking Alpha,https://seekingalpha.com/news/3561223-abbott-reports-strong-q1-pulls-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9575649499893188
4/16/2020 1:34:23 PM,Abbott Laboratories Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q1-adjusted-earnings-beat-estimates-1029097900,positive,0.8761040568351746
4/16/2020 1:42:35 PM,"Abbott posts 16% fall in profit, suspends 2020 forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xJQL4XW0fUA/abbott-posts-16-fall-in-profit-suspends-2020-forecast-on-coronavirus-concerns-idUSL3N2C431S,negative,0.970340371131897
4/16/2020 2:12:06 PM,Abbott Laboratories Q1 Adj. Earnings Beat View; Suspends FY20 Outlook ,RTTNews,/news/stocks/abbott-laboratories-q1-adj-earnings-beat-view-suspends-fy20-outlook-1029098192,negative,0.8664891719818115
4/16/2020 2:14:33 PM,"Abbott beats quarterly profit, but pulls forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/itHrJQhk93Q/abbott-beats-quarterly-profit-but-pulls-forecast-on-coronavirus-concerns-idUSKCN21Y1MP,negative,0.9379894137382507
4/16/2020 2:20:58 PM,"Abbott beats quarterly profit, but pulls forecast on coronavirus concerns",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LFOrt-cK9ug/abbott-beats-quarterly-profit-but-pulls-forecast-on-coronavirus-concerns-idINKCN21Y1RQ,negative,0.9379894137382507
4/16/2020 3:20:44 PM,Triage Your Portfolio With Abbott Laboratories,InvestorPlace,/news/stocks/triage-portfolio-abbott-abt-stock-coronavirus-1029099447,neutral,0.9345636963844299
4/16/2020 3:27:08 PM,Abbott beats profit estimates but suspends forecast on coronavirus concerns,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/L7HyDG87o_c/abbott-beats-profit-estimates-but-suspends-forecast-on-coronavirus-concerns-idUSKCN21Y1MP,negative,0.9181691408157349
4/16/2020 3:56:48 PM,Abbott beats profit estimates but suspends forecast on coronavirus concerns,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/eIrKPYOECQo/abbott-beats-profit-estimates-but-suspends-forecast-on-coronavirus-concerns-idINKCN21Y1RQ,negative,0.9181691408157349
4/16/2020 5:39:18 PM,Abbott Labs Earnings: ABT Stock Jumps on Q1 Beats,InvestorPlace,/news/stocks/abbott-labs-earnings-abt-stock-jumps-on-q1-beats-1029099911,positive,0.888702929019928
4/16/2020 5:49:15 PM,Coronavirus test ramp-up to help Abbott weather 'toughest quarter',Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3KmQLi2gvYY/coronavirus-test-ramp-up-to-help-abbott-weather-toughest-quarter-idUSKCN21Y1MP,positive,0.943947970867157
4/17/2020 8:43:32 AM,Roche To Launch New Serology Test To Detect COVID-19 Antibodies ,RTTNews,/news/stocks/roche-to-launch-new-serology-test-to-detect-covid-19-antibodies-1029101168,positive,0.5131881237030029
4/17/2020 3:03:57 PM,Steer Clear of Co-Diagnostics Stock and Its Multitude of Red Flags,InvestorPlace,/news/stocks/steer-clear-of-codx-stock-red-flags-1029103013,neutral,0.8514864444732666
4/17/2020 6:54:35 PM,U.S. COVID-19 testing capacity still constrained - AACC,Seeking Alpha,https://seekingalpha.com/news/3561778-u-s-covidminus-19-testing-capacity-still-constrained-aacc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8910448551177979
4/26/2020 5:45:13 PM,Italy picks U.S. firm Abbott Laboratories to supply coronavirus blood tests,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/RCgb9OlFawo/italy-picks-u-s-firm-abbott-laboratories-to-supply-coronavirus-blood-tests-idUSL5N2CE0F6,positive,0.7022097110748291
5/1/2020 7:41:50 PM,Fluidigm up 54% on potential early blood test for coronavirus,Seeking Alpha,https://seekingalpha.com/news/3567791-fluidigm-up-54-on-potential-early-blood-test-for-coronavirus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9407898187637329
5/5/2020 6:18:48 PM,3 Healthcare Stocks Popping Off Support,InvestorPlace,/news/stocks/3-healthcare-stocks-popping-off-support-1029167820,negative,0.9234455227851868
5/5/2020 8:35:00 PM,"LifeScan Global Corporation -- Moody's downgrades LifeScan's CFR to B3, stable outlook",Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-s-cfr-to-b3-stable-outlook-1029167567,negative,0.747166633605957
5/5/2020 9:50:25 PM,"5 Top Stock Trades for Wednesday: ATVI, SHOP, CHGG, ABT, ABBV",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-atvi-shop-chgg-abt-abbv-1029168272,neutral,0.934794008731842
5/8/2020 4:33:14 PM,FDA OKs emergency use of COVID-19 test with saliva specimens,Seeking Alpha,https://seekingalpha.com/news/3572277-fda-oks-emergency-use-of-covidminus-19-test-saliva-specimens?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7452181577682495
5/8/2020 5:05:45 PM,Study suggests Abbott COVID-19 antibody test highly likely to give correct results,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4MGSoIQQE_M/study-suggests-abbott-covid-19-antibody-test-highly-likely-to-give-correct-results-idUSL4N2CQ3A1,positive,0.8927896022796631
5/8/2020 6:00:48 PM,Study suggests Abbott COVID-19 antibody test highly likely to give correct results,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Wshf3tm5Q3Y/study-suggests-abbott-covid-19-antibody-test-highly-likely-to-give-correct-results-idINKBN22K27B,positive,0.8927896022796631
5/11/2020 1:41:20 PM,FDA OKs emergency use of Abbott blood test on automated analyzer,Seeking Alpha,https://seekingalpha.com/news/3572723-fda-oks-emergency-use-of-abbott-blood-test-on-automated-analyzer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7339271306991577
5/11/2020 3:47:17 PM,FDA Approves Abbott's Covid-19 Antibody Blood Test On Alinity I System ,RTTNews,/news/stocks/fda-approves-abbott-s-covid-19-antibody-blood-test-on-alinity-i-system-1029187807,positive,0.5273949503898621
5/11/2020 3:49:31 PM,Don’t Buy Into the Bitcoin Halvening Hype,InvestorPlace,/news/stocks/dont-buy-into-the-bitcoin-halvening-hype-1029188397,neutral,0.9192159175872803
5/12/2020 1:25:30 PM,Abbott nabs another emergency use nod for COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3573389-abbott-nabs-another-emergency-use-nod-for-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7721761465072632
5/12/2020 3:16:12 PM,Abbott: FDA Issues Emergency Use Authorization For Its Fifth COVID-19 Test ,RTTNews,/news/stocks/abbott-fda-issues-emergency-use-authorization-for-its-fifth-covid-19-test-1029192471,neutral,0.5502665042877197
5/13/2020 4:46:17 PM,Abbott defends COVID-19 test after reports of false negatives in study,Seeking Alpha,https://seekingalpha.com/news/3574022-abbott-defends-covidminus-19-test-after-reports-of-false-negatives-in-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9325700998306274
5/15/2020 1:54:57 AM,FDA alerts on potential false negative results on Abbott ID Now system,Seeking Alpha,https://seekingalpha.com/news/3574860-fda-alerts-on-potential-false-negative-results-on-abbott-id-now-system?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.49537307024002075
5/15/2020 8:29:05 AM,"Britain approves Abbott, Roche antibody test",Seeking Alpha,https://seekingalpha.com/news/3574894-britain-approves-abbott-roche-antibody-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6672878861427307
5/15/2020 9:01:46 AM,FDA : Abbott's Rapid Coronavirus Test May Deliver Inaccurate Results ,RTTNews,/news/stocks/fda-abbott-s-rapid-coronavirus-test-may-deliver-inaccurate-results-1029205188,negative,0.9522191286087036
5/19/2020 10:10:54 AM,Stop the Insanity with Co-Diagnostics Stock Already,InvestorPlace,/news/stocks/codx-stock-1029214738,neutral,0.8498938083648682
5/19/2020 5:51:31 PM,Co-Diagnostics Stock Positioned for Continued Growth in 2020,InvestorPlace,/news/stocks/codx-stock-positioned-for-continued-growth-in-2020-1029216835,positive,0.9373425245285034
5/19/2020 10:04:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1029217111,neutral,0.7941276431083679
5/20/2020 4:50:49 PM,Glaxo teams up with early-stage gene editing firm to develop coronavirus test,Seeking Alpha,https://seekingalpha.com/news/3576432-glaxo-teams-up-early-stage-gene-editing-firm-to-develop-coronavirus-test?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6371937990188599
5/21/2020 11:29:19 AM,Abbott COVID-19 blood test OK'd in Canada,Seeking Alpha,https://seekingalpha.com/news/3576706-abbott-covidminus-19-blood-test-okd-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.748545229434967
5/21/2020 1:36:28 PM,Abbott: Health Canada Approves New COVID-19 Antibody Test - Quick Facts ,RTTNews,/news/stocks/abbott-health-canada-approves-new-covid-19-antibody-test-quick-facts-1029223041,positive,0.602652907371521
5/21/2020 4:51:43 PM,Roche and Abbott land COVID-19 test deal in Britain,Seeking Alpha,https://seekingalpha.com/news/3576871-roche-and-abbott-land-covidminus-19-test-deal-in-britain?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.719417929649353
5/21/2020 6:29:07 PM,Britain signs deals for 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Xr7ANHgY-UI/britain-signs-deals-for-10-million-antibody-tests-from-roche-and-abbott-idUSL9N2AV00Q,positive,0.8641166090965271
5/21/2020 6:49:47 PM,Britain signs deals for 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/gq9TcUb-dLQ/britain-signs-deals-for-10-million-antibody-tests-from-roche-and-abbott-idINKBN22X27T,positive,0.8641166090965271
5/21/2020 7:16:04 PM,UPDATE 2-Britain to buy 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/bJw8a0u-7C8/update-2-britain-to-buy-10-million-antibody-tests-from-roche-and-abbott-idUSL8N2D33ZE,positive,0.7858210206031799
5/21/2020 7:18:20 PM,Britain to buy 10 million antibody tests from Roche and Abbott,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/ZYNomcO5frQ/britain-to-buy-10-million-antibody-tests-from-roche-and-abbott-idINKBN22X27T,neutral,0.6114895343780518
5/21/2020 11:44:50 PM,Abbott says new data on rapid coronavirus test used in White House shows high accuracy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/JALjcIwQx9M/abbott-says-new-data-on-rapid-coronavirus-test-used-in-white-house-shows-high-accuracy-idUSL1N2D32F0,positive,0.9473784565925598
6/2/2020 6:43:52 PM,AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives,InvestorPlace,/news/stocks/abbvie-will-be-in-big-trouble-when-its-patent-cliff-arrives-1029274239,negative,0.9463762640953064
6/3/2020 5:35:17 PM,Make This Biotech Play if You Like Co-Diagnostics’ Chances,InvestorPlace,/news/stocks/make-this-biotech-play-if-you-like-co-diagnostics-codx-stock-chances-1029278063,neutral,0.9303073287010193
6/12/2020 2:30:32 PM,Abbott Laboratories declares $0.36 dividend,Seeking Alpha,https://seekingalpha.com/news/3582659-abbott-laboratories-declares-0_36-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.918679416179657
6/13/2020 2:58:41 PM,Medtronic next-gen closed-loop insulin system successful in U.S. trial,Seeking Alpha,https://seekingalpha.com/news/3582830-medtronic-next-gen-closed-loop-insulin-system-successful-in-u-s-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9340391159057617
6/14/2020 2:37:04 AM,Abbott : Data Shows FreeStyle Libre System Reduces HbA1C Levels In Type 2 Diabetes People ,RTTNews,/news/stocks/abbott-data-shows-freestyle-libre-system-reduces-hba1c-levels-in-type-2-diabetes-people-1029305937,positive,0.7890742421150208
6/16/2020 3:15:54 PM,Abbott's FreeStyle Libre System Reduces Diabetic Ketoacidosis-Related Hospitalization Rates ,RTTNews,/news/stocks/abbott-s-freestyle-libre-system-reduces-diabetic-ketoacidosis-related-hospitalization-rates-1029313250,positive,0.7586326599121094
6/22/2020 3:14:00 PM,Abbott Laboratories -- Moody's assigns A3 rating to Abbott Laboratories' note offering,Moodys,/news/bonds/abbott-laboratories-moody-s-assigns-a3-rating-to-abbott-laboratories-note-offering-1029329698,neutral,0.9015730619430542
6/29/2020 2:30:11 PM,Getting Into the Testing Business May Spell Disaster for XpresSpa Stock,InvestorPlace,/news/stocks/testing-business-disaster-xspa-stock-1029351022,negative,0.9284770488739014
6/29/2020 3:15:54 PM,"Abbott, Tandem Diabetes Care Partner To Develop Integrated Diabetes Solutions ",RTTNews,/news/stocks/abbott-tandem-diabetes-care-partner-to-develop-integrated-diabetes-solutions-1029350327,neutral,0.585667073726654
7/1/2020 3:09:05 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Bets Big on Booze,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-bets-big-on-booze-1029360049,neutral,0.5211629867553711
7/6/2020 1:39:21 PM,"FDA Approves Abbott's NexGen Gallant ICD, CRT-D Devices - Quick Facts ",RTTNews,/news/stocks/fda-approves-abbott-s-nexgen-gallant-icd-crt-d-devices-quick-facts-1029368539,neutral,0.674926221370697
7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965,positive,0.5999964475631714
7/15/2020 3:01:26 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-quarterly-earnings-preview-stock-1029397201,neutral,0.9050445556640625
7/16/2020 1:34:33 PM,Abbott Laboratories Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q2-adjusted-earnings-beat-estimates-1029401049,positive,0.854049801826477
7/16/2020 1:47:17 PM,Abbott Laboratories Sees FY20 Adj. Earnings Above Estimates - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-sees-fy20-adj-earnings-above-estimates-quick-facts-1029401092,positive,0.9021270871162415
8/4/2020 9:16:14 AM,3 Key Questions to Answer Before Buying Sorrento Therapeutics Stock,InvestorPlace,/news/stocks/srne-stock-3-things-to-consider-before-buying-sorrento-therapeutics-1029465725,neutral,0.9405843615531921
8/4/2020 3:20:01 PM,Abbott Begins Study To Evaluate New Device To Treat Recurrent Atrial Fibrillation ,RTTNews,/news/stocks/abbott-begins-study-to-evaluate-new-device-to-treat-recurrent-atrial-fibrillation-1029467338,positive,0.8158273100852966
8/7/2020 10:16:18 AM,The Next Bull Run Will Be Harder For Sorrento Therapeutics,InvestorPlace,/news/stocks/srne-stock-sorrento-therapeutics-bull-run-1029481915,negative,0.7657444477081299
8/18/2020 4:46:58 PM,Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment,InvestorPlace,/news/stocks/abt-stock-is-a-surefire-covid-19-diagnostics-investment-1029514265,neutral,0.832312822341919
8/20/2020 5:48:21 PM,Let High Flyer Fulgent Genetics Take a Breather Before Dipping In,InvestorPlace,/news/stocks/let-high-flyer-fulgent-genetics-stock-take-a-breather-before-dipping-in-1029522068,neutral,0.8889185786247253
8/20/2020 6:46:35 PM,Only Testing Can Save JetBlue Airways,InvestorPlace,/news/stocks/only-testing-can-save-jblu-stock-1029522315,neutral,0.8613033294677734
8/24/2020 6:47:14 PM,The 4 Best Dividend Aristocrats to Buy Now,InvestorPlace,/news/stocks/4-best-dividend-aristocrats-to-buy-now-abt-rost-pep-vfc-1029529077,neutral,0.8545804619789124
8/27/2020 6:04:47 AM,FDA Approves Abbott's $5 COVID-19 Antigen Portable Rapid Test ,RTTNews,/news/stocks/fda-approves-abbott-s-5-covid-19-antigen-portable-rapid-test-1029538141,positive,0.7253884077072144
8/27/2020 12:24:06 PM,"Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-eypt-clvs-abt-vbiv-lpcn-1029539208,neutral,0.9390809535980225
8/27/2020 3:56:15 PM,Stock Alert: Abbott Shares Hit All-Time High ,RTTNews,/news/stocks/stock-alert-abbott-shares-hit-all-time-high-1029540544,positive,0.906067430973053
8/27/2020 4:27:01 PM,Abbott soars 10% after its 15-minute COVID-19 test wins FDA approval,Business Insider,https://www.businessinsider.com/abbott-stock-price-minute-covid19-test-wins-fda-approval-coronavirus-2020-8,positive,0.686437726020813
8/27/2020 9:07:26 PM,"4 Top Stock Trades for Friday: WMT, ULTA, ABT, QDEL",InvestorPlace,/news/stocks/4-top-stock-trades-for-friday-wmt-ulta-abt-qdel-1029542121,neutral,0.9288247227668762
8/28/2020 9:16:04 AM,XpresSpa Group’s Stock Drop Ignores the Potential of Pivot to Virus Testing,InvestorPlace,/news/stocks/xpresspa-groups-stock-falls-20-time-to-buy-xspa-stock-1029543408,negative,0.9442181587219238
8/28/2020 1:37:59 PM,7 Top Stocks Under $5,InvestorPlace,/news/stocks/7-top-stocks-to-buy-under-5-1029544433,negative,0.5136507153511047
8/31/2020 12:10:58 PM,"Sorrento’s Covid-19 Test, Acquisitions Should Help SRNE Stock Surge",InvestorPlace,/news/stocks/sorrentos-covid-19-test-acquisitions-should-help-srne-stock-surge-1029547892,positive,0.9103133082389832
9/1/2020 9:16:45 AM,Carnival Stock Could Rebound Significantly Once a Vaccine Arrives,InvestorPlace,/news/stocks/ccl-stock-could-rebound-from-here-as-a-covid-19-vaccine-nears-1029551126,positive,0.9517030119895935
9/1/2020 3:30:29 PM,Abbott Announces Availability Of FreeStyle Libre 2 ICGM System For Medicare Patients ,RTTNews,/news/stocks/abbott-announces-availability-of-freestyle-libre-2-icgm-system-for-medicare-patients-1029552515,neutral,0.5260348320007324
9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234,neutral,0.6847983002662659
9/9/2020 2:07:00 PM,Moody's – US healthcare risk heat map - Overall outlook improves as patients return and COVID testing accelerates,Moodys,/news/bonds/moody-s-us-healthcare-risk-heat-map-overall-outlook-improves-as-patients-return-and-covid-testing-accelerates-1029573470,positive,0.9544988870620728
9/14/2020 6:44:44 PM,Thermo Fisher Is a Buy Despite Recent Setbacks,InvestorPlace,/news/stocks/despite-recent-setbacks-tmo-stock-is-a-buy-1029587798,positive,0.8477721810340881
9/15/2020 5:24:53 PM,The Key Question Surrounding XpresSpa Group Right Now,InvestorPlace,/news/stocks/key-question-surrounding-xspa-stock-right-now-1029591780,neutral,0.9259263873100281
9/16/2020 1:22:00 PM,"Moody's – Outlook for the US medical products and devices industry revised to positive on higher earnings, increased demand",Moodys,/news/bonds/moody-s-outlook-for-the-us-medical-products-and-devices-industry-revised-to-positive-on-higher-earnings-increased-demand-1029593947,positive,0.9409870505332947
9/18/2020 9:31:13 AM,20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening,InvestorPlace,/news/stocks/20-20-genesystems-stock-leveraging-ai-for-more-accurate-cancer-screening-1029601945,neutral,0.7066363096237183
9/18/2020 1:26:13 PM,Is Sorrento Stock Really Worth the Speculation?,InvestorPlace,/news/stocks/sorrento-srne-stock-worth-speculation-1029602943,neutral,0.9195567965507507
9/24/2020 11:44:26 AM,7 High-Potential Undervalued Stocks to Buy,InvestorPlace,/news/stocks/7-high-potential-undervalued-stocks-to-buy-1029619857,positive,0.6774172186851501
9/25/2020 6:19:26 PM,7 Sin Stocks To Buy That Will Outperform the S&P 500,InvestorPlace,/news/stocks/7-sin-stocks-to-buy-that-will-outperform-the-sp-500-1029624209,positive,0.9204394221305847
9/30/2020 10:54:07 AM,Abbott Labs Stock is Not Cheap But Should Do Well as Virus Test Debuts,InvestorPlace,/news/stocks/abt-stock-should-do-well-with-its-new-covid-19-test-1029635842,positive,0.6211468577384949
9/30/2020 2:51:51 PM,Is Norwegian Cruise Stock Finally a Buy? ,InvestorPlace,/news/stocks/is-norwegian-cruise-line-stock-finally-a-buy-cseo-1029636595,neutral,0.8548449277877808
10/1/2020 6:43:07 PM,Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO,InvestorPlace,/news/stocks/best-etfs-for-2020-the-advisorshares-vice-etf-sam-1029642036,neutral,0.6936799883842468
10/6/2020 5:27:20 PM,Canada to buy up to 20.5M Abbott rapid coronavirus antigen tests,Seeking Alpha,https://seekingalpha.com/news/3620219-canada-to-buy-up-to-20_5m-abbott-rapid-coronavirus-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5087339878082275
10/7/2020 2:18:57 PM,Abbott: ID NOW COVID-19 Interim Results Confirm Previous Data Submitted To FDA ,RTTNews,/news/stocks/abbott-id-now-covid-19-interim-results-confirm-previous-data-submitted-to-fda-1029656908,neutral,0.8771108984947205
10/8/2020 11:55:08 AM,The Risk-to-Reward Proposition for Sorrento Has Gone Bad,InvestorPlace,/news/stocks/the-risk-to-reward-proposition-for-sorrento-therapeutics-srne-stock-has-gone-negative-1029661288,positive,0.5604221224784851
10/9/2020 6:09:50 PM,Sorrento Stock Investors Should Play Powerball Instead,InvestorPlace,/news/stocks/srne-stock-how-to-get-rich-off-shareholders-1029666739,neutral,0.9250040054321289
10/11/2020 11:24:33 AM,30-second coronavirus test could help out the travel sector and more,Seeking Alpha,https://seekingalpha.com/news/3621273-30-second-coronavirus-test-help-out-travel-sector-and?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6863268613815308
10/12/2020 1:07:34 PM,Abbott gets FDA emergency use OK for COVID antibody test,Seeking Alpha,https://seekingalpha.com/news/3621356-abbott-gets-fda-emergency-use-ok-for-covid-antibody-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6162715554237366
10/12/2020 3:12:10 PM,Abbott Gets Emergency Use Authorization For COVID-19 IgM Antibody Test - Quick Facts ,RTTNews,/news/stocks/abbott-gets-emergency-use-authorization-for-covid-19-igm-antibody-test-quick-facts-1029670053,positive,0.706359326839447
10/15/2020 12:10:15 PM,Germany ramps up capacity of rapid COVID tests,Seeking Alpha,https://seekingalpha.com/news/3622402-germany-ramps-up-capacity-of-rapid-covid-tests?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9057559370994568
10/16/2020 9:16:53 AM,5 High-Yield Stocks for 5%-Plus Dividend Payouts,InvestorPlace,/news/stocks/5-high-yield-stocks-abbv-enb-pm-unm-ibm-for-5-plus-dividend-payouts-1029687693,neutral,0.9269536733627319
10/20/2020 3:01:35 PM,Abbott Laboratories is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1029698639,neutral,0.9339648485183716
10/20/2020 4:11:53 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3623754-notable-earnings-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.855887770652771
10/20/2020 8:48:55 PM,"5 Top Stock Trades for Wednesday: LOGI, PM, VZ, IRBT, ABT",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-logi-pm-vz-irbt-abt-1029701059,neutral,0.9361504316329956
10/20/2020 9:35:12 PM,Abbott Laboratories Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3623808-abbott-laboratories-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7809802889823914
10/21/2020 11:32:31 AM,"Abbott Laboratories EPS beats by $0.07, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3624125-abbott-laboratories-eps-beats-0_07-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5431235432624817
10/21/2020 11:43:53 AM,"Abbott Q3 top line up 10%, diagnostics up 38% on COVID-19 demand",Seeking Alpha,https://seekingalpha.com/news/3624134-abbott-q3-top-line-up-10-diagnostics-up-38-on-covidminus-19-demand?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9365359544754028
10/21/2020 1:38:48 PM,Abbott Laboratories Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-beat-estimates-1029704055,positive,0.8631237149238586
10/21/2020 2:15:38 PM,ASTC Stock News: Why Astrotech Stock Is Soaring 160% Today,InvestorPlace,/news/stocks/astc-stock-news-why-astrotech-stock-is-soaring-160-today-1029706122,positive,0.6332952976226807
10/29/2020 12:33:25 PM,9 Companies to Invest In Before We Hit 2021,InvestorPlace,/news/stocks/9-companies-to-invest-in-before-2021-1029741057,neutral,0.9193782210350037
11/2/2020 11:05:35 AM,3 Biotech Stocks With Eye-Catching Pipelines,InvestorPlace,/news/stocks/3-biotech-stocks-with-eye-catching-pipelines-1029752447,neutral,0.5421434044837952
11/2/2020 1:18:09 PM,"With the Pandemic Peaking, Hold Off on United Airlines Stock",InvestorPlace,/news/stocks/with-the-pandemic-peaking-hold-off-on-united-airlines-stock-1029754094,neutral,0.564302921295166
11/3/2020 1:42:00 PM,Your First Instinct About Sorrento Therapeutics Is Probably Right,InvestorPlace,/news/stocks/srne-stock-day-late-dollar-short-1029759222,neutral,0.9101305603981018
11/4/2020 5:12:44 PM,Healthcare rallies as Presidential vote count continues,Seeking Alpha,https://seekingalpha.com/news/3631239-healthcare-rallies-presidential-vote-count-continues?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5205023288726807
11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301,neutral,0.8556708097457886
11/9/2020 2:42:48 PM,Positive data on Pfizer/BioNTech COVID-19 vaccine pressures test makers,Seeking Alpha,https://seekingalpha.com/news/3633699-positive-data-on-pfizer-biontech-covidminus-19-vaccine-pressures-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8232104182243347
11/10/2020 2:18:40 PM,Abbott launches new device for chronic pain,Seeking Alpha,https://seekingalpha.com/news/3634370-abbott-launches-new-device-for-chronic-pain?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6861943006515503
11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408,neutral,0.7889739274978638
11/13/2020 8:12:37 AM,Musk questions accuracy of rapid coronavirus antigen tests,Seeking Alpha,https://seekingalpha.com/news/3635981-musk-questions-accuracy-of-rapid-coronavirus-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8394519686698914
11/18/2020 5:20:53 AM,FDA authorizes first at-home rapid COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3637350-fda-authorizes-first-home-rapid-covidminus-19-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8152946829795837
11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075,neutral,0.9004662036895752
12/2/2020 2:45:06 PM,Abbott: Health Canada Approves FreeStyle Libre 2 For Adults And Children With Diabetes ,RTTNews,/news/stocks/abbott-health-canada-approves-freestyle-libre-2-for-adults-and-children-with-diabetes-1029857677,positive,0.7562074661254883
12/3/2020 6:53:40 PM,3 Dividend Stocks for Big Total Returns in 2021,InvestorPlace,/news/stocks/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt-1029863076,positive,0.7688310742378235
12/7/2020 2:03:50 PM,9 Stocks to Buy Despite the Rocky Transition,InvestorPlace,/news/stocks/9-stocks-to-buy-during-rocky-transition-1029869814,neutral,0.48994529247283936
12/10/2020 7:17:05 PM,9 Stocks to Buy for a Divided Government,InvestorPlace,/news/stocks/9-stocks-to-buy-for-a-divided-government-1029883312,neutral,0.8210727572441101
12/11/2020 4:19:44 PM,Abbott Laboratories increases dividend by 25% to $0.45,Seeking Alpha,https://seekingalpha.com/news/3643742-abbott-laboratories-increases-dividend-25-to-0_45?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.941403865814209
12/15/2020 3:20:32 PM,Abbott Obtains CE Mark For COVID-19 IgG Quantitative Antibody Blood Test ,RTTNews,/news/stocks/abbott-obtains-ce-mark-for-covid-19-igg-quantitative-antibody-blood-test-1029894287,neutral,0.6478196978569031
12/16/2020 10:47:45 AM,Micro-cap oncology biotech Scopus Biopharma prices downsized $2.75M IPO,Seeking Alpha,https://seekingalpha.com/news/3644762-micro-cap-oncology-biotech-scopus-biopharma-prices-downsized-2_75m-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4526408910751343
12/16/2020 6:44:13 PM,Abbott scores an EUA win with COVID-19 rapid antigen test,Seeking Alpha,https://seekingalpha.com/news/3645019-abbott-scores-eua-win-covidminus-19-rapid-antigen-test?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9237339496612549
12/17/2020 10:43:26 AM,FDA Nod For Abbott's At-home Covid-19 Test ,RTTNews,/news/stocks/fda-nod-for-abbott-s-at-home-covid-19-test-1029901352,neutral,0.5740795135498047
12/17/2020 7:43:14 PM,"9 Stocks to Buy With $5,000 in Starter Money",InvestorPlace,/news/stocks/9-stocks-to-buy-with-5000-in-starter-money-1029904303,neutral,0.9186460375785828
1/11/2021 2:30:36 PM,Abbott gets FDA nod for handheld concussion blood test,Seeking Alpha,https://seekingalpha.com/news/3650295-abbott-gets-fda-nod-for-handheld-concussion-blood-test?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7726023197174072
1/11/2021 3:30:06 PM,Abbott Gets FDA Clearance For Rapid Handheld Blood Test For Mild Traumatic Brain Injury ,RTTNews,/news/stocks/abbott-gets-fda-clearance-for-rapid-handheld-blood-test-for-mild-traumatic-brain-injury-1029955794,positive,0.8899834156036377
1/12/2021 3:40:01 PM,Abbott To Complete U.S. Govt Order For 150 Mln BinaxNOW COVID-19 Rapid Tests ,RTTNews,/news/stocks/abbott-to-complete-u-s-govt-order-for-150-mln-binaxnow-covid-19-rapid-tests-1029960328,positive,0.9375120997428894
1/12/2021 4:52:55 PM,Abbott to supply additional 30M COVID-19 tests to U.S. Government,Seeking Alpha,https://seekingalpha.com/news/3650773-abbott-to-supply-additional-30m-covidminus-19-tests-to-u-s-government?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5163325667381287
1/13/2021 2:10:07 PM,Quanterix guides FY20 revenue below consensus,Seeking Alpha,https://seekingalpha.com/news/3651078-quanterix-guides-fy20-revenue-below-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5011759400367737
1/14/2021 3:26:56 PM,Abbott To Launch NeuroSphere MyPath Digital Health App - Quick Facts ,RTTNews,/news/stocks/abbott-to-launch-neurosphere-mypath-digital-health-app-quick-facts-1029969060,neutral,0.858898937702179
1/20/2021 1:20:33 PM,Abbott secures expanded medicare reimbursement for MitraClip,Seeking Alpha,https://seekingalpha.com/news/3652620-abbott-secures-expanded-medicare-reimbursement-for-mitraclip?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9425864815711975
1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247,neutral,0.817572295665741
1/21/2021 4:25:23 PM,Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost,InvestorPlace,/news/stocks/biden-stocks-16-stocks-to-watch-for-a-defense-production-act-boost-1029991455,neutral,0.895939290523529
1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,positive,0.6939177513122559
1/25/2021 11:58:38 AM,3 Reasons To Invest in Pfizer Stock Despite Its Dismal Performance,InvestorPlace,/news/stocks/3-reasons-to-invest-in-pfizer-stock-despite-its-dismal-performance-1029999021,neutral,0.5312947630882263
1/25/2021 3:01:29 PM,Here's what Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-quarterly-earnings-preview-stock-1029999373,neutral,0.9277660250663757
1/26/2021 12:59:46 PM,Abbott's Panbio rapid antigen test scores CE mark for two new uses,Seeking Alpha,https://seekingalpha.com/news/3654285-abbotts-panbio-rapid-antigen-test-receives-ce-mark-for-two-new-uses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.632722020149231
1/26/2021 2:07:40 PM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-misses-j-j-beats-in-big-pharma-earnings-vaccine-developer-curevac-taps-equity-market-1030004007,positive,0.7611163854598999
1/26/2021 3:38:25 PM,Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device ,RTTNews,/news/stocks/abbott-receives-ce-mark-for-two-new-uses-of-panbio-covid-19-ag-rapid-test-device-1030004976,positive,0.8921246528625488
1/26/2021 4:29:52 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3654433-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.855887770652771
1/26/2021 6:12:25 PM,Abbott Laboratories Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654454-abbott-laboratories-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8149189949035645
1/27/2021 12:33:31 PM,"Abbott Laboratories EPS beats by $0.10, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3654827-abbott-laboratories-eps-beats-0_10-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.561865508556366
1/27/2021 1:04:00 PM,"Abbott tops Q4 consensus, COVID-19 testing-related sales of $2.4B",Seeking Alpha,https://seekingalpha.com/news/3654858-abbott-tops-q4-consensus-covid-19-testing-related-sales-of-24b?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8933160901069641
1/27/2021 1:21:28 PM,"The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF",InvestorPlace,/news/stocks/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf-1029891558,neutral,0.8699871301651001
1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241,neutral,0.8347625136375427
1/27/2021 1:38:56 PM,Abbott Laboratories Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q4-adjusted-earnings-beat-estimates-1030009238,positive,0.8854728937149048
1/27/2021 1:41:45 PM,Abbott Projects 2021 EPS Growth Of More Than 35% - Quick Facts ,RTTNews,/news/stocks/abbott-projects-2021-eps-growth-of-more-than-35-quick-facts-1030009249,positive,0.8512700796127319
1/27/2021 10:30:36 PM,"4 Top Stock Trades for Thursday: BB, MSFT, ABT, TXN",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-bb-msft-abt-txn-1030012231,neutral,0.9209056496620178
1/28/2021 1:53:40 PM,Abbott upgraded to Buy at BTIG following strong Q4 results,Seeking Alpha,https://seekingalpha.com/news/3655508-abbott-upgraded-to-buy-at-btig-following-strong-q4-results?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9275579452514648
1/28/2021 2:03:49 PM,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-decision-day-for-amgen-zymeworks-sinks-on-data-ortho-clinical-diagnostics-ipo-1030014922,neutral,0.9371458292007446
1/28/2021 2:07:10 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1030014923,neutral,0.7969076037406921
1/28/2021 4:04:02 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-28-2021-1030015872,negative,0.6627025604248047
1/28/2021 7:29:12 PM,BioThera BLA for Roche Avastin biosimilar accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/3655629-biothera-bla-for-roche-avastin-biosimilar-accepted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8186587691307068
1/29/2021 1:45:44 PM,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-vaccine-readout-clinical-hold-on-bellicum-study-lifted-lilly-earnings-nls-pharma-ipo-1030019600,neutral,0.9045888781547546
2/1/2021 1:55:19 PM,COVID-19 test kit developer Lucira Health to price IPO between $15-$17,Seeking Alpha,https://seekingalpha.com/news/3656589-covid-19-test-kit-developer-lucira-health-to-price-ipo-between-15-17?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8657827377319336
2/2/2021 2:05:48 PM,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-pfizer-earnings-tiziana-covid-19-vaccine-data-decision-day-for-mallinckrodt-s-burn-treatment-1030032611,neutral,0.9199008345603943
2/9/2021 2:10:28 PM,"The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-dynavax-poaches-gsk-vaccine-exec-kalvista-jumps-on-data-readout-corcept-issues-negative-preannouncement-1030060223,negative,0.8829746842384338
2/11/2021 1:26:22 PM,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-dermtech-soars-on-contract-fluidigm-plunges-on-earnings-decision-day-for-regeneron-bioventus-debuts-1030072237,negative,0.9134436845779419
2/19/2021 6:48:45 PM,Abbott Laboratories declares $0.45 dividend,Seeking Alpha,https://seekingalpha.com/news/3664033-abbott-laboratories-declares-0_45-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.910200297832489
2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9283661842346191
2/28/2021 2:36:40 PM,"The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More",Benzinga,/news/stocks/the-past-week-s-notable-insider-buys-agree-realty-avis-budget-zoetis-and-more-1030132210,neutral,0.8334846496582031
3/3/2021 2:31:53 PM,7 Blue-Chip Stocks That May Be Perfect For Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-may-be-perfect-for-retirement-1030146050,neutral,0.8465081453323364
3/3/2021 4:03:43 PM,Health Canada OKs expanded use of Abbott's FreeStyle Libre system,Seeking Alpha,https://seekingalpha.com/news/3668802-health-canada-oks-expanded-use-of-abbott-freestyle-libre-system?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8035731911659241
3/4/2021 1:50:49 PM,Big Tech and non-tech valuations may be closer than they appear: At the Open,Seeking Alpha,https://seekingalpha.com/news/3669326-big-tech-and-non-tech-valuations?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7399551868438721
3/5/2021 2:10:36 PM,Abbott wins FDA emergency use nod for PCR assay differentiating Sars-Cov-2 from other respiratory infections,Seeking Alpha,https://seekingalpha.com/news/3669915-abbott-secures-fda-eua-for-alinity-m-resp-4-plex-molecular-assay?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9232509136199951
3/5/2021 3:26:29 PM,Abbott Gets EUA For Laboratory PCR Assay That Detects Four Viruses In One Test ,RTTNews,/news/stocks/abbott-gets-eua-for-laboratory-pcr-assay-that-detects-four-viruses-in-one-test-1030155154,positive,0.7491645216941833
3/8/2021 2:25:32 PM,Abbott launches NeuroSphere Virtual Clinic in U.S.,Seeking Alpha,https://seekingalpha.com/news/3670253-abbott-launches-neurosphere-virtual-clinic-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8563659191131592
3/9/2021 12:02:32 AM,Abbott Announces U.S. Launch Of NeuroSphere Virtual Clinic ,RTTNews,/news/stocks/abbott-announces-u-s-launch-of-neurosphere-virtual-clinic-1030161312,neutral,0.8178986310958862
3/9/2021 8:38:33 AM,"Corporate vaccination drives get underway, as well as mask policies",Seeking Alpha,https://seekingalpha.com/news/3670551-corporate-vaccination-drives-get-underway-as-well-as-mask-policies?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6693150997161865
3/11/2021 3:53:46 PM,Abbott Pandemic Defense Coalition Formed For Early Detection Of Future Pandemic Threats ,RTTNews,/news/stocks/abbott-pandemic-defense-coalition-formed-for-early-detection-of-future-pandemic-threats-1030173982,neutral,0.8732801675796509
3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599,positive,0.6150591373443604
3/16/2021 3:39:23 PM,Abbott suspends study comparing HeartMate PHP against Abiomed's Impella,Seeking Alpha,https://seekingalpha.com/news/3673196-abbott-suspends-study-for-heartmate-php-against-abiomeds-impella?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9279478788375854
3/16/2021 8:17:29 PM,FDA streamlines path for emergency use authorization of COVID-19 tests,Seeking Alpha,https://seekingalpha.com/news/3673294-fda-streamlines-path-for-emergency-use-authorization-of-covid-19-tests?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9069279432296753
3/17/2021 10:01:32 PM,Abbott secures $255M defense logistics agency contract for BinaxNOW COVID-19 test,Seeking Alpha,https://seekingalpha.com/news/3673849-abbott-secures-255m-defense-logistics-agency-contract-for-binaxnow-covid-19-test?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9422999620437622
3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8964442610740662
3/26/2021 4:12:59 PM,Covid Fatigue Threatens to Derail Once Relevant Quidel,InvestorPlace,/news/stocks/covid-fatigue-threatens-to-derail-qdel-stock-1030250781,negative,0.7714329957962036
4/1/2021 5:53:16 AM,Abbott's BinaxNOW COVID-19 Ag Self Test Receives FDA EUA To Detect COVID-19 Infection ,RTTNews,/news/stocks/abbott-s-binaxnow-covid-19-ag-self-test-receives-fda-eua-to-detect-covid-19-infection-1030267000,neutral,0.6255862712860107
4/1/2021 6:28:47 AM,FDA OKs emergency use of Abbott's rapid COVID-19 self test,Seeking Alpha,https://seekingalpha.com/news/3678407-fda-oks-emergency-use-of-abbotts-rapid-covid-19-self-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7684237957000732
4/1/2021 1:46:30 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-preps-for-bla-filing-sonoma-surges-bioxcel-readout-ortho-clinical-lands-contract-1030268533,neutral,0.9482611417770386
4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707,neutral,0.9073498249053955
4/1/2021 9:18:58 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-acy-stock-clean-energy-stocks-1030270991,neutral,0.9254742860794067
4/6/2021 1:21:08 PM,Abbott's XIENCE stent indication gets European approval,Seeking Alpha,https://seekingalpha.com/news/3679499-abbotts-xience-stent-indication-gets-european-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9396718740463257
4/6/2021 3:10:45 PM,Abbott: XIENCE Stent Gets CE Mark In Europe For Shorter Duration Of Dual Anti-platelet Therapy ,RTTNews,/news/stocks/abbott-xience-stent-gets-ce-mark-in-europe-for-shorter-duration-of-dual-anti-platelet-therapy-1030277191,positive,0.9479992985725403
4/8/2021 1:29:28 PM,Abbott gets CE mark approval for next-generation TriClip device,Seeking Alpha,https://seekingalpha.com/news/3680341-abbott-gets-ce-mark-approval-for-next-generation-triclip-device?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7389501333236694
4/8/2021 3:21:09 PM,Abbott Gets CE Mark Approval For Next-Generation TriClip Device - Quick Facts ,RTTNews,/news/stocks/abbott-gets-ce-mark-approval-for-next-generation-triclip-device-quick-facts-1030285907,positive,0.6555267572402954
4/9/2021 6:35:31 PM,3 Stocks Near 52-Week Lows That Could Bounce Back,Benzinga,/news/stocks/3-stocks-near-52-week-lows-that-could-bounce-back-1030289942,negative,0.9153965711593628
4/9/2021 10:05:00 PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-abbott-laboratories-1030290304,neutral,0.7941276431083679
4/15/2021 4:03:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-15-2021-1030308913,negative,0.5670151710510254
4/17/2021 3:25:15 PM,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-johnson-johnson-biogen-earnings-neurology-conference-and-ipos-1030314413,neutral,0.9472424983978271
4/18/2021 3:01:24 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-q1-earnings-preview-1030315034,neutral,0.9230455160140991
4/19/2021 1:13:52 PM,Abbott to sell rapid COVID-19 self test at Walgreens stores,Seeking Alpha,https://seekingalpha.com/news/3682931-abbott-to-sell-rapid-covid-19-self-test-at-walgreens-stores?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8160873055458069
4/19/2021 2:57:46 PM,Abbott Begins Shipping BinaxNOW COVID-19 Ag Self Test To Retailers Today - Quick Facts ,RTTNews,/news/stocks/abbott-begins-shipping-binaxnow-covid-19-ag-self-test-to-retailers-today-quick-facts-1030317913,neutral,0.8690094351768494
4/19/2021 3:38:36 PM,"Walgreens, Abbott Agree To Sell BinaxNOW Antigen Self Test Through Walgreens Stores ",RTTNews,/news/stocks/walgreens-abbott-agree-to-sell-binaxnow-antigen-self-test-through-walgreens-stores-1030318196,neutral,0.5040148496627808
4/19/2021 4:21:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3683044-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660826683044434
4/19/2021 5:57:54 PM,Abbott Laboratories Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683080-abbott-laboratories-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7050294280052185
4/20/2021 11:31:09 AM,"Abbott Laboratories EPS beats by $0.05, misses on revenue",Seeking Alpha,https://seekingalpha.com/news/3683304-abbott-laboratories-eps-beats-0_05-misses-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4413624107837677
4/20/2021 12:13:41 PM,Abbott stock falls as 2021 guidance misses estimates,Seeking Alpha,https://seekingalpha.com/news/3683338-abbott-falls-as-2021-2021-guidance-misses-estimates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9630182981491089
4/20/2021 1:41:45 PM,Abbott Laboratories Backs FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-backs-fy21-outlook-quick-facts-1030322386,neutral,0.49494096636772156
4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640,neutral,0.7906168103218079
4/20/2021 3:29:30 PM,Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology,Benzinga,/news/stocks/remote-monitoring-telemedicine-company-sees-spiked-growth-of-products-and-technology-1030323571,positive,0.8027835488319397
4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9643991589546204
4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6614382266998291
4/26/2021 5:30:41 PM,3 Top Blue-Chip Healthcare Stocks With Healthy Dividends,InvestorPlace,/news/stocks/3-top-blue-chip-healthcare-stocks-with-healthy-dividends-1030347105,positive,0.7900867462158203
4/28/2021 2:29:03 PM,7 Pharmaceutical Stocks With Dividends in Hand,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-dividends-in-hand-1030359387,neutral,0.926287829875946
5/7/2021 7:30:30 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3693377-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
5/12/2021 3:14:32 PM,7 Great Growth Stocks to Consider for Your Short List,InvestorPlace,/news/stocks/7-great-growth-stocks-to-consider-for-your-short-list-1030422219,neutral,0.901633620262146
5/13/2021 6:06:24 PM,Abbott recalls certain pacemakers over potential electrical short,Seeking Alpha,https://seekingalpha.com/news/3696084-abbott-recalls-certain-pacemakers-over-potential-electrical-short?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9507547616958618
5/14/2021 5:19:53 PM,"If You Do the Math, Senseonics Makes No Sense",InvestorPlace,/news/stocks/sens-stock-math-makes-no-sense-1030431757,neutral,0.8822470903396606
5/17/2021 1:18:58 PM,Abbott receives CE mark for Navitor,Seeking Alpha,https://seekingalpha.com/news/3697125-abbott-receives-ce-mark-for-navitor?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8456611037254333
5/19/2021 5:37:15 PM,FDA says public shouldn't use antibody tests to determine COVID-19 immunity,Seeking Alpha,https://seekingalpha.com/news/3698328-fda-says-public-shouldnt-use-antibody-tests-to-determine-covid-19-immunity?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7633371949195862
5/20/2021 8:47:00 PM,Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories to A2,Moodys,/news/bonds/abbott-ireland-financing-dac-moody-s-upgrades-abbott-laboratories-to-a2-1030452702,positive,0.8304269909858704
5/24/2021 11:01:37 AM,Dogs who sniff Covid could be coming to an airport near you,Seeking Alpha,https://seekingalpha.com/news/3699351-dogs-who-sniff-covid-could-be-coming-to-an-airport-near-you?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5938941240310669
5/25/2021 4:02:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-25-2021-1030463045,negative,0.5758828520774841
5/25/2021 6:07:34 PM,"Barclays sees ""renaissance"" in medical device industry",Seeking Alpha,https://seekingalpha.com/news/3699979-barclays-sees-renaissance-in-medical-device-industry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7192384600639343
6/1/2021 10:00:45 AM,This Significant New Partnership Makes Senseonics Stock Worth Another Look,InvestorPlace,/news/stocks/sens-stock-worth-another-look-1030480773,positive,0.600441038608551
6/1/2021 2:21:19 PM,Abbott Laboratories Slashes FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-slashes-fy21-outlook-quick-facts-1030481662,negative,0.9596457481384277
6/1/2021 2:22:27 PM,Abbott sinks after slashing 2021 guidance,Seeking Alpha,https://seekingalpha.com/news/3701731-abbott-sinks-after-slashing-2021-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9516929388046265
6/1/2021 7:39:01 PM,Abbott highlights base business as waning COVID-19 test sales prompt cut to guidance,Seeking Alpha,https://seekingalpha.com/news/3702015-abbott-highlights-base-business-as-waning-covid-19-test-sales-prompt-cut-to-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5771766901016235
6/2/2021 11:00:33 AM,68 Biggest Movers From Yesterday,Benzinga,/news/stocks/68-biggest-movers-from-yesterday-1030486020,neutral,0.7365332245826721
6/2/2021 12:50:04 PM,"iRhythm downgraded on CEO exit, UBS bullish on aducanumab approval; in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3702278-irhythm-downgraded-on-ceo-exit-ubs-bullish-on-aducanumab-approval-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6011046171188354
6/2/2021 1:41:41 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030486666,neutral,0.8142690658569336
6/2/2021 2:51:35 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-amc-stock-bb-stock-dogecoin-prices-1030488344,neutral,0.9298974871635437
6/2/2021 3:58:01 PM,Abbott’s revised guidance prompts model update for COVID-19 test makers at UBS,Seeking Alpha,https://seekingalpha.com/news/3702385-abbotts-revised-guidance-prompts-model-update-for-covid-19-test-makers-at-ubs?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7727414965629578
6/3/2021 4:48:19 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030492081,neutral,0.9183946847915649
6/3/2021 10:58:34 PM,Why Senseonics Shares Are Rocketing Higher After Hours Thursday,Benzinga,/news/stocks/why-senseonics-shares-are-rocketing-higher-after-hours-thursday-1030493163,positive,0.5865007638931274
6/4/2021 5:07:04 PM,Senseonics rallies as CGM data shows promise against rivals,Seeking Alpha,https://seekingalpha.com/news/3703405-senseonics-rallies-as-cgm-data-shows-promise-against-rivals?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.510136604309082
6/6/2021 1:52:43 AM,Thermo Fisher Scientific targets M&A as COVID-19-related impact wanes,Seeking Alpha,https://seekingalpha.com/news/3703520-thermo-fisher-scientific-targets-ma-as-covid-19-related-impact-wanes?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5306828022003174
6/11/2021 5:19:00 PM,Abbott Declares 390th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-390th-consecutive-quarterly-dividend-1030516275,negative,0.49190571904182434
6/18/2021 1:46:55 PM,"Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic",Benzinga,/news/stocks/cramer-weighs-in-on-senseonics-holdings-celsius-and-contextlogic-1030535178,neutral,0.8721359968185425
6/22/2021 1:00:00 PM,Abbott Earns First-of-its-Kind Recommendation for High School STEM Interns to Receive College Credit,PR Newswire,/news/stocks/abbott-earns-first-of-its-kind-recommendation-for-high-school-stem-interns-to-receive-college-credit-1030542303,positive,0.881915271282196
6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404,positive,0.9269535541534424
6/24/2021 3:00:00 PM,People Who Exercise Intensely Could Improve Recovery by Adjusting Their Hydration Habits,PR Newswire,/news/stocks/people-who-exercise-intensely-could-improve-recovery-by-adjusting-their-hydration-habits-1030551377,positive,0.7103398442268372
6/25/2021 11:50:45 AM,3 High-Yield Stocks With Secure Payouts,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-with-secure-payouts-1030554651,neutral,0.7198594212532043
6/25/2021 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1030554985,neutral,0.9235584139823914
6/25/2021 5:30:00 PM,Late-Breaking Data Demonstrate Abbott's FreeStyle® Libre System Supports Health Equity for Millions of Americans Living with Diabetes,PR Newswire,/news/stocks/late-breaking-data-demonstrate-abbott-s-freestyle-libre-system-supports-health-equity-for-millions-of-americans-living-with-diabetes-1030555435,positive,0.9065446257591248
6/30/2021 2:10:33 PM,Abbott Xient stents receive FDA approval for shorter blood thinning indication,Seeking Alpha,https://seekingalpha.com/news/3711393-abbott-xient-stents-receive-fda-approval-for-shorter-blood-thinning-indication?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9228141903877258
6/30/2021 3:00:00 PM,Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients,PR Newswire,/news/stocks/abbott-s-xience-stent-receives-fda-approval-for-shortest-blood-thinner-course-for-high-bleeding-risk-patients-1030567382,positive,0.9432345032691956
6/30/2021 3:22:19 PM,Abbott's XIENCE Stent Receives FDA Approval For High Bleeding Risk Patients ,RTTNews,/news/stocks/abbott-s-xience-stent-receives-fda-approval-for-high-bleeding-risk-patients-1030567226,positive,0.942254364490509
6/30/2021 3:41:40 PM,NIH study suggests antigen tests and PCR tests are equally effective in detecting COVID-19,Seeking Alpha,https://seekingalpha.com/news/3711452-nih-study-suggests-antigen-tests-and-pcr-tests-are-equally-effective-in-detecting-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6477051973342896
7/1/2021 4:04:10 PM,3 Pros and 3 Cons to Consider Before Joining the Senseonics Frenzy,InvestorPlace,/news/stocks/3-pros-3-cons-sens-stock-consider-1030572638,neutral,0.9434351325035095
7/2/2021 5:40:11 PM,The 7 Best Dividend Stocks to Buy for Income Investors In July 2021 ,InvestorPlace,/news/stocks/the-7-best-dividend-stocks-to-buy-for-income-investors-in-july-2021-1030576310,neutral,0.7900514006614685
7/3/2021 3:26:32 AM,Intellia and gene editors lead weekly healthcare gainers; CEL-SCI and Citius trail,Seeking Alpha,https://seekingalpha.com/news/3712730-intellia-and-gene-editors-lead-weekly-healthcare-gainers-cel-sci-and-citius-trail?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8811821937561035
7/6/2021 3:11:44 PM,Wait For a Pullback Before Taking a Position In Senseonics,InvestorPlace,/news/stocks/wait-for-a-pullback-before-taking-position-in-sens-stock-1030582593,neutral,0.9350326657295227
7/7/2021 3:39:05 PM,Abbott selling STARLIMS informatics suite to Francisco Partners for undisclosed amount,Seeking Alpha,https://seekingalpha.com/news/3713355-abbott-selling-starlims-informatics-suite-to-francisco-partners-for-undisclosed-amount?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9367415904998779
7/9/2021 5:25:23 AM,Abbott's St. Jude Medical To Pay $27 Mln To Settle Allegations Over Heart Devices ,RTTNews,/news/stocks/abbott-s-st-jude-medical-to-pay-27-mln-to-settle-allegations-over-heart-devices-1030591765,negative,0.8110788464546204
7/9/2021 8:02:53 PM,7 Super-Safe Dividend Stock Performers to Buy,InvestorPlace,/news/stocks/7-super-safe-dividend-stocks-to-buy-1030594111,neutral,0.8698828220367432
7/12/2021 8:18:56 PM,QIAGEN guidance cut pressures rival COVID-19 test makers,Seeking Alpha,https://seekingalpha.com/news/3714475-qiagen-guidance-cut-pressures-rival-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7807005643844604
7/15/2021 4:13:26 PM,FDA devices head says progress being made on diabetes devices backlog,Seeking Alpha,https://seekingalpha.com/news/3715640-fda-devices-head-says-progress-being-made-on-diabetes-devices-backlog?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8434410095214844
7/16/2021 4:10:20 PM,7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-to-juice-your-portfolio-yield-1030615780,neutral,0.8995172381401062
7/18/2021 1:04:02 AM,Moderna headlines weekly healthcare gainers; FibroGen and Biogen trail,Seeking Alpha,https://seekingalpha.com/news/3716141-moderna-headlines-weekly-healthcare-gainers-fibrogen-and-biogen-trail?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9005433320999146
7/18/2021 4:25:56 PM,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-earnings-kickstart-with-j-j-and-biogen-albireo-awaits-fda-decisions-more-ipos-1030617574,positive,0.5948063731193542
7/19/2021 3:39:32 PM,Moderna leads COVID-19 vaccine developers; Test makers trade higher amid pandemic concerns,Seeking Alpha,https://seekingalpha.com/news/3716375-moderna-leads-covid-19-vaccine-developers-test-makers-trade-higher-amid-pandemic-concerns?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9418497085571289
7/19/2021 4:40:06 PM,3 High-Yield Dividend Aristocrats To Buy Now,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-aristocrats-to-buy-now-1030621331,neutral,0.9055553078651428
7/20/2021 3:01:32 PM,Here's what Wall Street expects from Abbott Laboratories's earnings report,Markets Insider Automation,/news/stocks/abbott_laboratories-quarter-earnings-preview-q2-1030625198,neutral,0.9050445556640625
7/21/2021 1:41:50 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3717408-notable-earnings-before-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8825733065605164
7/21/2021 9:47:26 PM,7 Vice Stocks To Buy To Be Cynically Defensive,InvestorPlace,/news/stocks/7-vice-stocks-to-buy-for-cynical-defensiveness-1030632441,neutral,0.904120683670044
7/22/2021 11:16:54 AM,"Abbott Laboratories EPS beats by $0.15, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3717920-abbott-laboratories-eps-beats-0_15-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5997918248176575
7/22/2021 12:14:24 PM,Abbott accelerates quarterly growth as medical devices outperform diagnostics,Seeking Alpha,https://seekingalpha.com/news/3717979-abbott-accelerates-quarterly-growth-as-medical-devices-outperform-diagnostics?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.947837769985199
7/22/2021 1:15:00 PM,Abbott Reports Second-Quarter 2021 Results,PR Newswire,/news/stocks/abbott-reports-second-quarter-2021-results-1030634453,neutral,0.5767498016357422
7/22/2021 1:34:54 PM,Abbott Laboratories Q2 Income Advances,RTTNews,/news/stocks/abbott-laboratories-q2-income-advances-1030634534,positive,0.5223132371902466
7/22/2021 1:44:20 PM,Abbott Laboratories Maintains FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-maintains-fy21-outlook-quick-facts-1030634603,neutral,0.9290735721588135
7/22/2021 2:18:49 PM,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-merck-eisai-seres-ulcerative-colitis-drug-flunks-midstage-study-pfizer-to-invest-in-arvinas-absci-ipo-1030634923,neutral,0.8168380260467529
7/22/2021 8:40:28 PM,The 10 Best Dividend Income Growers in the S&P 500,InvestorPlace,/news/stocks/the-10-best-dividend-income-growers-in-the-sp-500-1030636942,positive,0.7578825354576111
7/29/2021 3:00:00 PM,"New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations",PR Newswire,/news/stocks/new-study-half-of-americans-living-with-diabetes-may-be-consuming-less-than-the-recommended-amount-of-protein-which-is-associated-with-greater-physical-limitations-1030662793,neutral,0.5179531574249268
8/2/2021 3:00:00 PM,"Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management",PR Newswire,/news/stocks/abbott-s-freestyle-libre-2-ios-app-cleared-in-u-s-providing-a-seamless-digital-experience-to-simplify-diabetes-management-1030676704,positive,0.8078081607818604
8/2/2021 3:22:04 PM,FDA Clears Abbott's FreeStyle Libre 2 IOS App For Diabetes Management ,RTTNews,/news/stocks/fda-clears-abbott-s-freestyle-libre-2-ios-app-for-diabetes-management-1030676772,positive,0.49642255902290344
8/2/2021 6:12:23 PM,Abbott to pay $160M to Feds to resolve Medicare diabetes false claims allegations,Seeking Alpha,https://seekingalpha.com/news/3723310-abbott-to-pay-160m-to-feds-to-resolve-medicare-diabetes-false-claims-allegations?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7411043047904968
8/3/2021 7:29:47 AM,Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap,InvestorPlace,/news/stocks/senseonics-financials-doesnt-support-its-high-market-cap-1030681657,negative,0.9352030754089355
8/3/2021 1:32:47 PM,Abbott gets FDA clearance for Ultreon powered OCT imaging platform,Seeking Alpha,https://seekingalpha.com/news/3723887-abbott-gets-fda-clearance-for-ultreon-powered-oct-imaging-platform?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8168668150901794
8/3/2021 3:00:00 PM,Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-its-imaging-technology-using-artificial-intelligence-for-vessels-in-the-heart-1030684117,positive,0.9280005693435669
8/3/2021 3:47:13 PM,FDA OKs Abbott's OCT Imaging Platform With Artificial Intelligence - Quick Facts ,RTTNews,/news/stocks/fda-oks-abbott-s-oct-imaging-platform-with-artificial-intelligence-quick-facts-1030684158,neutral,0.774268627166748
8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.935555636882782
8/16/2021 2:00:00 PM,Abbott's Amplatzer™ Amulet™ Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke,PR Newswire,/news/stocks/abbott-s-amplatzer-amulet-device-approved-by-fda-to-treat-people-with-atrial-fibrillation-at-risk-of-stroke-1030734059,positive,0.8080539107322693
8/16/2021 2:27:22 PM,FDA OKs Abbott's Amplatzer Amulet Device To Treat Atrial Fibrillation - Quick Facts ,RTTNews,/news/stocks/fda-oks-abbott-s-amplatzer-amulet-device-to-treat-atrial-fibrillation-quick-facts-1030734169,neutral,0.5494714975357056
8/20/2021 2:14:06 AM,Acting FDA head Woodcock ruled out as permanent nominee - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3732564-acting-fda-head-woodcock-ruled-out-as-permanent-nominee-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7850372195243835
8/21/2021 5:22:50 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030750231,neutral,0.9183946847915649
8/25/2021 10:00:32 AM,"Senseonics Can Move Higher, but Competitive Concerns Abound",InvestorPlace,/news/stocks/sens-stock-can-move-higher-but-competition-is-tight-1030757136,negative,0.5930012464523315
8/27/2021 2:46:00 PM,GUIDE-HF Study Data Show Abbott's CardioMEMS™ Device Can Improve Care for More Patients with Heart Failure,PR Newswire,/news/stocks/guide-hf-study-data-show-abbott-s-cardiomems-device-can-improve-care-for-more-patients-with-heart-failure-1030763613,positive,0.9476441740989685
8/27/2021 3:07:56 PM,Abbott: CardioMEMS Device Shows Potential Benefits In New Groups Of Patients ,RTTNews,/news/stocks/abbott-cardiomems-device-shows-potential-benefits-in-new-groups-of-patients-1030763676,positive,0.9246754050254822
8/30/2021 5:55:00 PM,Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke,PR Newswire,/news/stocks/late-breaking-data-shows-abbott-s-amplatzer-amulet-occluder-offers-superior-left-atrial-appendage-closure-compared-to-watchman-device-for-people-with-atrial-fibrillation-at-risk-of-stroke-1030767458,positive,0.9517533183097839
9/2/2021 3:30:00 PM,"Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC",PR Newswire,/news/stocks/abbott-expands-peripheral-vascular-offerings-with-acquisition-of-walk-vascular-llc-1030776806,positive,0.8591693043708801
9/2/2021 3:58:10 PM,Abbott Announces Acquisition Of Walk Vascular - Quick Facts ,RTTNews,/news/stocks/abbott-announces-acquisition-of-walk-vascular-quick-facts-1030776916,neutral,0.9201468229293823
9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655,neutral,0.8197962045669556
9/3/2021 1:31:13 PM,"The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself",Benzinga,/news/stocks/the-daily-biotech-pulse-cellect-jumps-on-first-apograft-transplantation-astrazeneca-european-commission-bury-legal-hatchet-cassava-defends-itself-1030779479,neutral,0.7601718902587891
9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942,neutral,0.9088907241821289
9/10/2021 5:56:12 PM,Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks,Benzinga,/news/stocks/why-biden-s-action-plan-is-bullish-for-covid-19-testing-stocks-1030793082,neutral,0.872940182685852
9/13/2021 10:00:07 AM,7 S&P 500 Dividend Stocks To Buy Yielding 4%  ,InvestorPlace,/news/stocks/7-sp-500-dividend-stocks-to-buy-yielding-4-1030795279,neutral,0.8440023064613342
9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122,positive,0.8988337516784668
9/15/2021 6:46:00 PM,Abbott Declares 391st Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-391st-consecutive-quarterly-dividend-1030802564,neutral,0.6397631764411926
9/15/2021 8:23:34 PM,Narrower drug pricing bill introduced in House by centrist Democrats,Seeking Alpha,https://seekingalpha.com/news/3740127-narrower-drug-pricing-bill-introduced-in-house-by-centrist-democrats?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6811553239822388
9/15/2021 9:20:09 PM,House committee approves portion of spending package that includes drug price negotiation,Seeking Alpha,https://seekingalpha.com/news/3740192-house-committee-approves-portion-of-spending-package-that-includes-drug-price-negotiation?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5973886251449585
9/17/2021 9:27:41 PM,Abbott bags ~$119.5M contract for antigen test kikts,Seeking Alpha,https://seekingalpha.com/news/3740991-abbott-bags-1195m-contract-for-antigen-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5151508450508118
9/20/2021 3:00:00 PM,Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-minimally-invasive-portico-with-flexnav-tavr-system-to-treat-patients-with-aortic-valve-disease-1030809994,positive,0.927403450012207
9/20/2021 3:12:40 PM,Abbott Reports FDA Approval For Portico With FlexNav TAVR System - Quick Facts ,RTTNews,/news/stocks/abbott-reports-fda-approval-for-portico-with-flexnav-tavr-system-quick-facts-1030810073,positive,0.6839020252227783
9/22/2021 2:40:41 PM,7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-now-as-the-pandemic-forces-a-rethink-1030816434,neutral,0.5023189783096313
9/23/2021 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1030818999,neutral,0.9299495220184326
9/24/2021 6:19:15 AM,COVID-19 test maker Cue Health prices 12.5M-share IPO at $16,Seeking Alpha,https://seekingalpha.com/news/3743862-covid-19-test-maker-cue-health-prices-125m-share-ipo-at-16?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8757523894309998
9/24/2021 7:21:46 PM,FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations,Benzinga,/news/stocks/fda-establishes-additional-conditions-of-emergency-use-nod-for-covid-19-tests-for-viral-mutations-1030822366,neutral,0.9161942005157471
9/30/2021 11:17:26 AM,Meet members of the 2021 IPO class: Healthcare - 2,Seeking Alpha,https://seekingalpha.com/news/3746475-meet-members-of-the-2021-ipo-class-healthcare-2?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.944514811038971
9/30/2021 3:48:00 PM,Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center for Malnutrition Solutions,PR Newswire,/news/stocks/abbott-commits-to-reducing-malnutrition-globally-with-launch-of-abbott-center-for-malnutrition-solutions-1030834363,positive,0.8123182058334351
10/11/2021 12:43:40 PM,ChemoCentryx appoints rheumatologist Rita I. Jain as chief medical officer,Seeking Alpha,https://seekingalpha.com/news/3751206-chemocentryx-appoints-rheumatologist-rita-i-jain-as-chief-medical-officer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9209420680999756
10/14/2021 5:18:23 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-14-2021-1030867192,negative,0.5822784900665283
10/14/2021 6:41:30 PM,Expert Ratings For Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1030867408,neutral,0.8545588850975037
10/18/2021 1:00:00 PM,Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally,PR Newswire,/news/stocks/abbott-and-real-madrid-team-up-to-support-the-health-and-nutrition-of-children-globally-1030873217,positive,0.6678293347358704
10/18/2021 1:34:17 PM,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-18-23-j-j-biogen-kickstart-big-pharma-earnings-regeneron-sanofi-roche-await-fda-decisions-and-ipos-1030873336,neutral,0.7243751883506775
10/18/2021 3:01:24 PM,Here's what Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q3-quarterly-earnings-preview-1030873640,neutral,0.9277660250663757
10/18/2021 3:22:00 PM,"Jason Sudeikis Joins Abbott, Real Madrid at New York Stock Exchange to Support Children's Health",PR Newswire,/news/stocks/jason-sudeikis-joins-abbott-real-madrid-at-new-york-stock-exchange-to-support-children-s-health-1030873917,neutral,0.8996554613113403
10/19/2021 3:06:57 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3755050-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.855887770652771
10/20/2021 1:30:00 PM,Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance,PR Newswire,/news/stocks/abbott-reports-third-quarter-2021-results-achieves-strong-double-digit-earnings-growth-and-raises-guidance-1030881349,positive,0.953553318977356
10/20/2021 1:33:59 PM,Abbott Laboratories Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-adjusted-earnings-beat-estimates-1030881346,positive,0.8631237149238586
10/20/2021 1:41:19 PM,Abbott Laboratories Boosts FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy21-outlook-quick-facts-1030881374,positive,0.903106153011322
10/20/2021 2:16:25 PM,"The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-retreats-amid-vaccine-issues-lumiradx-covid-test-approved-in-india-sesen-shines-on-positive-bladder-cancer-review-1030881679,positive,0.555168092250824
10/20/2021 4:34:30 PM,Abbot Labs and Biogen Outshine Novavax in the Health Care Sector,Benzinga,/news/stocks/abbot-labs-and-biogen-outshine-novavax-in-the-health-care-sector-1030882395,neutral,0.6113497614860535
10/21/2021 1:46:38 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1030885393,neutral,0.7969076037406921
10/21/2021 6:58:26 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1030886780,neutral,0.9183946847915649
10/26/2021 2:07:45 PM,"Becton, Dickinson launches new rapid antigen test for COVID-19",Seeking Alpha,https://seekingalpha.com/news/3758130-becton-dickinson-launches-new-rapid-antigen-test-for-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7903124690055847
10/27/2021 4:08:17 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-27-2021-1030905856,negative,0.601506233215332
11/3/2021 2:00:00 PM,Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations,PR Newswire,/news/stocks/abbott-launches-new-initiative-to-drive-diversity-in-medical-research-and-improve-care-among-under-represented-populations-1030932063,positive,0.8963579535484314
11/3/2021 2:38:24 PM,7 Dividend Aristocrat Stocks That Should Grace Your Portfolio,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-that-should-grace-your-portfolio-1030933089,neutral,0.9271454215049744
11/5/2021 5:55:56 PM,10 S&P 500 Stocks to Buy After Winning in Q3,InvestorPlace,/news/stocks/10-sp-500-stocks-to-buy-after-winning-in-the-third-quarter-1030943473,positive,0.8830471634864807
11/9/2021 3:00:00 PM,"Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology",PR Newswire,/news/stocks/abbott-and-the-american-diabetes-association-launch-first-of-its-kind-community-initiative-in-columbus-ohio-to-advance-access-to-diabetes-care-and-technology-1030954266,neutral,0.5716991424560547
11/12/2021 3:00:00 PM,Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial,PR Newswire,/news/stocks/abbott-s-new-leadless-pacemaker-system-meets-primary-endpoints-in-pivotal-trial-1030970204,positive,0.640161395072937
11/12/2021 3:23:03 PM,Abbott's New Leadless Pacemaker System Meets Main Goal In Pivotal Trial ,RTTNews,/news/stocks/abbott-s-new-leadless-pacemaker-system-meets-main-goal-in-pivotal-trial-1030970266,positive,0.5959834456443787
11/15/2021 4:48:00 PM,Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI),PR Newswire,/news/stocks/abbott-achieves-highest-score-in-its-industry-for-the-ninth-consecutive-year-on-the-dow-jones-sustainability-index-djsi-1030977044,positive,0.9480909109115601
11/15/2021 9:59:15 PM,Talis Biomedical appoints former Abbott executive as CEO,Seeking Alpha,https://seekingalpha.com/news/3771019-talis-biomedical-appoints-former-abbott-executive-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8403695225715637
11/16/2021 2:30:12 PM,"The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment",Benzinga,/news/stocks/the-daily-biotech-pulse-kezar-jumps-on-data-biogen-r-d-chief-to-retire-molecular-partners-wilts-on-covid-trial-disappointment-1030980303,neutral,0.6811907291412354
11/16/2021 7:00:00 PM,"Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development",PR Newswire,/news/stocks/abbott-launches-similac-360-total-care-with-exclusive-blend-of-five-hmo-prebiotics-and-designed-to-support-the-immune-system-digestive-health-and-brain-development-1030981619,positive,0.739890456199646
11/29/2021 7:10:31 PM,3 Top Stock Trades for the Week,InvestorPlace,/news/stocks/3-top-stock-trades-for-the-week-1029510280,neutral,0.8792451620101929
12/2/2021 4:01:44 PM,"At-home COVID tests to be covered by private insurance, Biden to announce - Reuters",Seeking Alpha,https://seekingalpha.com/news/3776489-at-home-covid-tests-to-be-covered-by-private-insurance-biden-to-announce-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9309754967689514
12/3/2021 9:32:33 PM,Even Good Penny Stocks Like Senseonics Aren’t Always Profitable,InvestorPlace,/news/stocks/even-good-penny-stocks-like-senseonics-arent-always-profitable-1031024049,neutral,0.9106321930885315
12/6/2021 11:00:09 AM,7 Stocks to Buy to Give Your Portfolio a Booster Shot,InvestorPlace,/news/stocks/7-stocks-to-buy-to-give-portfolio-booster-shot-1031025563,neutral,0.8892467617988586
12/10/2021 6:40:47 PM,"Abbott Laboratories raises quarterly dividend by ~4%, $5B authorized in share repurchase",Seeking Alpha,https://seekingalpha.com/news/3779238-abbott-laboratories-raises-quarterly-dividend-by-4-5b-authorized-in-share-repurchase?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9393631815910339
12/10/2021 6:41:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-10-2021-1031039422,negative,0.6048893332481384
12/10/2021 7:00:00 PM,Abbott Increases Quarterly Dividend for 50th Consecutive Year,PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-for-50th-consecutive-year-1031039455,negative,0.6778942346572876
12/10/2021 7:00:53 PM,Expert Ratings For Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031039450,neutral,0.8545588850975037
12/10/2021 7:08:46 PM,3 Healthcare Stocks for Long-Term Dividend Growth,InvestorPlace,/news/stocks/3-healthcare-stocks-for-long-term-dividend-growth-1031039566,neutral,0.9333980679512024
12/10/2021 7:19:25 PM,"Abbott says White to retire as Executive Chair, names CEO Ford as Chairman",Seeking Alpha,https://seekingalpha.com/news/3779257-abbott-says-white-to-retire-as-executive-chair-names-ceo-ford-as-chairman?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8327579498291016
12/10/2021 8:00:00 PM,Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman,PR Newswire,/news/stocks/abbott-names-robert-b-ford-chairman-of-the-board-miles-d-white-to-retire-as-executive-chairman-1031039555,neutral,0.8778679966926575
12/15/2021 2:35:00 PM,"Diabetes tech market still has a clear favorite, Baird says",Seeking Alpha,https://seekingalpha.com/news/3780179-diabetes-tech-market-still-has-a-clear-favorite-baird-says?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5169559717178345
12/16/2021 7:33:48 PM,"NYC to distribute 500K at-home COVID tests, 1M face masks to fight Omicron",Seeking Alpha,https://seekingalpha.com/news/3781020-nyc-to-distribute-500k-at-home-covid-tests-1m-kn95-masks-to-fight-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5914677381515503
12/21/2021 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1031059248,neutral,0.9324039220809937
12/21/2021 4:26:35 PM,"As COVID cases and testing rises, test makers are mixed",Seeking Alpha,https://seekingalpha.com/news/3782381-as-covid-cases-and-testing-rises-test-makers-are-mixed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8225782513618469
12/22/2021 9:08:01 AM,"COVID roundup: More mandates, halving quarantine, FDA pill approval?",Seeking Alpha,https://seekingalpha.com/news/3782556-covid-roundup-israels-fourth-dose-halving-quarantine-fda-pill-approval?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7903928756713867
12/24/2021 9:37:35 PM,COVID uptick to hurt MedTech firms and healthcare providers in early 2022 - Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/3783326-covid-uptick-to-hurt-medtech-firms-and-healthcare-providers-in-early-2022-goldman-sachs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7903519868850708
12/27/2021 2:09:56 PM,Abbott price target raised at Raymond James on benefiting from COVID wave,Seeking Alpha,https://seekingalpha.com/news/3783417-abbott-price-target-raised-at-raymond-james-on-benefiting-from-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6861585974693298
12/27/2021 4:21:53 PM,"As demand surges, at-home COVID test makers rise led by Cue Health and Lucira Health",Seeking Alpha,https://seekingalpha.com/news/3783460-as-demand-surges-at-home-covid-test-makers-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9186003804206848
12/27/2021 7:33:40 PM,"As demand surges, at-home COVID test makers rise led by Cue Health and Lucira Health",Seeking Alpha,https://seekingalpha.com/news/3783460-as-demand-surges-at-home-covid-test-makers-continue-to-rise-led-by-cue-health-and-lucira-health?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9186003804206848
12/28/2021 8:50:51 PM,"FDA: COVID antigen tests can detect Omicron, but there may be some false negatives",Seeking Alpha,https://seekingalpha.com/news/3783764-fda-covid-antigen-tests-can-detect-omicron-but-there-may-be-some-false-negatives?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6898133158683777
12/30/2021 7:42:41 PM,Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock,InvestorPlace,/news/stocks/best-stocks-for-2022-why-abbvie-abbv-stock-looks-like-high-dividend-growth-stock-1031071815,neutral,0.5186933279037476
1/3/2022 4:28:09 PM,"Abbott, Baxter among MedTech favorites at Raymond James for early 2022",Seeking Alpha,https://seekingalpha.com/news/3784631-abbott-baxter-among-medtech-favorites-at-raymond-james-for-early-2022?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.817206859588623
1/3/2022 11:09:10 PM,"6 Stocks Taking Center Stage At CES 2022, Including For The First Time A Healthcare Company",Benzinga,/news/stocks/6-stocks-taking-center-stage-at-ces-2022-including-for-the-first-time-a-healthcare-company-1031074929,positive,0.6020779609680176
1/4/2022 3:00:00 PM,Abbott's Proclaim™ XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.,PR Newswire,/news/stocks/abbott-s-proclaim-xr-spinal-cord-stimulation-system-now-offers-expanded-mri-compatibility-in-u-s-1031076199,positive,0.7863820791244507
1/4/2022 3:08:07 PM,FDA expands MRI compatibility for Abbott's Proclaim XR Spinal Cord Stimulation System,Seeking Alpha,https://seekingalpha.com/news/3785008-fda-expands-mri-compatibility-for-abbotts-proclaim-xr-spinal-cord-stimulation-system?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8823874592781067
1/4/2022 5:44:53 PM,US FDA approves expanded MRI compatibility for Abbott's Proclaim XR system,Seeking Alpha,https://seekingalpha.com/news/3785149-us-fda-approves-expanded-mri-compatibility-for-abbotts-proclaim-xr-system?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8911523818969727
1/4/2022 7:08:56 PM,"Walmart, Kroger increase prices for Abbott rapid COVID-19 antigen tests",Seeking Alpha,https://seekingalpha.com/news/3785169-walmart-kroger-increase-prices-for-abbott-rapid-covid-19-antigen-tests?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.789467990398407
1/4/2022 11:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1031077864,neutral,0.9284790754318237
1/5/2022 9:26:40 AM,CES 2022: What to expect at the Consumer Electronics Show,Seeking Alpha,https://seekingalpha.com/news/3785276-ces-2022-what-to-expect-at-the-consumer-electronics-show?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9415290951728821
1/5/2022 6:17:57 PM,Rapid antigen tests lag PCR tests in early detection of COVID-19 - study,Seeking Alpha,https://seekingalpha.com/news/3785522-rapid-antigen-tests-lag-pcr-tests-in-early-detection-of-covid-19-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8127948045730591
1/6/2022 7:15:00 PM,Abbott Announces Future of Biowearables at Consumer Electronics Show,PR Newswire,/news/stocks/abbott-announces-future-of-biowearables-at-consumer-electronics-show-1031082311,neutral,0.8324560523033142
1/6/2022 9:24:33 PM,Abbott aims to increase production of home COVID tests to 100M per month - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3786007-abbott-aims-to-increase-production-of-home-covid-tests-to-100m-per-month-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9022958278656006
1/10/2022 8:01:06 PM,"3 Top Stock Trades for the Week of Jan. 10, 2022",InvestorPlace,/news/stocks/3-top-stock-trades-for-the-week-of-jan-10-2022-1031091902,neutral,0.9109970331192017
1/10/2022 10:57:12 PM,Private health insurers must cover up to 8 at-home COVID tests per month per person,Seeking Alpha,https://seekingalpha.com/news/3786901-private-health-insurers-must-cover-up-to-8-at-home-covid-tests-per-month-per-person?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9370114207267761
1/11/2022 1:45:00 PM,ACELYRIN Appoints Melanie Gloria as Chief Operating Officer,PR Newswire,/news/stocks/acelyrin-appoints-melanie-gloria-as-chief-operating-officer-1031093657,neutral,0.9282802939414978
1/12/2022 2:29:44 PM,Abbott gets FDA clearance for cardiac mapping system to treat abnormal heart rhythms,Seeking Alpha,https://seekingalpha.com/news/3787505-abbott-gets-fda-clearance-for-cardiac-mapping-system-to-treat-abnormal-heart-rhythms?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8196480870246887
1/12/2022 3:00:00 PM,Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms,PR Newswire,/news/stocks/abbott-receives-u-s-fda-clearance-for-new-cardiac-mapping-system-to-improve-how-doctors-treat-abnormal-heart-rhythms-1031097079,positive,0.7779353260993958
1/12/2022 3:31:01 PM,Abbott Receives FDA Clearance For Cardiac Mapping System ,RTTNews,/news/stocks/abbott-receives-fda-clearance-for-cardiac-mapping-system-1031097244,positive,0.8679478168487549
1/17/2022 4:32:10 PM,Abbott Labs awarded $310M army contract,Seeking Alpha,https://seekingalpha.com/news/3788516-abbott-labs-awarded-310m-army-contract?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8839145302772522
1/19/2022 11:00:09 AM,3 Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-and-hold-forever-abbv-kr-cvx-1031111966,neutral,0.9479490518569946
1/19/2022 5:51:57 PM,DexCom raised to Overweight at Wells Fargo on upcoming catalyst and sales potential,Seeking Alpha,https://seekingalpha.com/news/3789296-dexcom-raised-to-overweight-at-wells-fargo-on-upcoming-catalyst-and-sales-potential?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6178609132766724
1/20/2022 7:29:04 PM,3 Dividend Aristocrats Yielding Over 4%,InvestorPlace,/news/stocks/3-dividend-aristocrats-yielding-over-4-1031117369,neutral,0.8441977500915527
1/21/2022 8:21:49 PM,USPS begins shipping free at-home COVID-19 rapid tests,Seeking Alpha,https://seekingalpha.com/news/3790428-usps-begins-shipping-free-at-home-covid-19-rapid-tests?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7598156332969666
1/25/2022 3:01:13 PM,Abbott Laboratories is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q4-1031126422,neutral,0.9352886080741882
1/25/2022 3:30:55 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3791285-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.855887770652771
1/25/2022 4:02:13 PM,Will Abbott Laboratories maintain EPS beat run in Q4 amid COVID challenges?,Seeking Alpha,https://seekingalpha.com/news/3791300-will-abbott-laboratories-maintain-eps-beat-run-in-q4-amid-covid-challenges?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6408485770225525
1/26/2022 12:31:14 PM,"Abbott Laboratories Non-GAAP EPS of $1.32 beats by $0.11, revenue of $11.5B beats by $790M",Seeking Alpha,https://seekingalpha.com/news/3791701-abbott-laboratories-non-gaap-eps-of-1_32-beats-0_11-revenue-of-11_5b-beats-790m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7765228748321533
1/26/2022 1:17:31 PM,Abbott beats Street estimates on top and bottom lines; COVID-19 testing sales reached $2.3B,Seeking Alpha,https://seekingalpha.com/news/3791736-abbott-beats-street-estimates-on-top-and-bottom-lines-covid-19-testing-sales-reached-23b?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7894521355628967
1/26/2022 1:30:00 PM,Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast,PR Newswire,/news/stocks/abbott-reports-strong-fourth-quarter-2021-results-issues-2022-forecast-1031130382,positive,0.9384156465530396
1/26/2022 1:52:02 PM,Abbott Q4 Profit Tops Estimates; Net Sales Up 7.7% On Organic Basis ,RTTNews,/news/stocks/abbott-q4-profit-tops-estimates-net-sales-up-7-7-on-organic-basis-1031130558,positive,0.9511792659759521
1/26/2022 2:29:25 PM,"The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data",Benzinga,/news/stocks/the-daily-biotech-pulse-gilead-s-blood-cancer-studies-placed-on-partial-clinical-hold-immunocore-gets-fda-nod-nrx-touts-positive-covid-19-data-1031130804,neutral,0.8202436566352844
1/27/2022 6:02:35 PM,What 5 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-abbott-laboratories-1031136557,neutral,0.9314632415771484
1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625,neutral,0.5936208367347717
1/31/2022 4:09:17 PM,Abbott on a roll since reporting Q4 earnings last week; shares up 6% since then,Seeking Alpha,https://seekingalpha.com/news/3793580-abbott-on-a-roll-since-reporting-q4-earnings-last-week-shares-up-6-since-then?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9456838369369507
2/7/2022 3:00:00 PM,Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial,PR Newswire,/news/stocks/abbott-announces-world-s-first-implant-of-dual-chamber-leadless-pacemaker-in-pivotal-trial-1031167297,positive,0.5382736921310425
2/17/2022 11:11:00 PM,Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant,PR Newswire,/news/stocks/abbott-voluntarily-recalls-powder-formulas-manufactured-at-one-plant-1031206683,negative,0.913927435874939
2/18/2022 12:08:14 PM,Abbott issues voluntary recall of certain infant formulas,Seeking Alpha,https://seekingalpha.com/news/3801866-abt-stock-lower-after-voluntary-recall-of-certain-infant-formulas?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7511181831359863
2/18/2022 4:36:24 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3801995-abbott-laboratories-declares-0_47-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9249960780143738
2/18/2022 5:26:00 PM,Abbott Declares 393rd Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-393rd-consecutive-quarterly-dividend-1031209210,neutral,0.5496838092803955
2/18/2022 10:16:33 PM,Abbott infant formula recall could mean $325M revenue hit - Cowen,Seeking Alpha,https://seekingalpha.com/news/3802189-abbott-infant-formula-recall-could-mean-325m-revenue-hit-cowen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.952254056930542
2/21/2022 1:42:42 PM,China warns against use of certain Abbott formula products after U.S. recall,Seeking Alpha,https://seekingalpha.com/news/3802225-abt-stock-in-focus-as-china-warns-against-products-after-us-recall?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6828964948654175
2/21/2022 3:00:00 PM,Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure,PR Newswire,/news/stocks/abbott-s-cardiomems-hf-system-receives-fda-approval-to-support-patients-battling-earlier-stage-heart-failure-1031212652,positive,0.9459757208824158
2/21/2022 3:18:02 PM,FDA Approves Expanded Indication For Abbott's CardioMEMS HF System ,RTTNews,/news/stocks/fda-approves-expanded-indication-for-abbott-s-cardiomems-hf-system-1031212728,positive,0.7923353910446167
2/23/2022 5:32:21 PM,Abbott CardioMEMS HF System gains expanded heart failure indication,Seeking Alpha,https://seekingalpha.com/news/3804354-abbott-cardiomems-hf-system-gains-expanded-heart-failure-indication?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7145962715148926
3/1/2022 9:36:49 PM,Abbott Recalls Another Lot Of Simila After A Second Infant-fatality ,RTTNews,/news/stocks/abbott-recalls-another-lot-of-simila-after-a-second-infant-fatality-1031244546,negative,0.8513670563697815
3/2/2022 11:22:37 AM,Abbott expands voluntary recall of infant formula after FDA informs of 2nd infant death,Seeking Alpha,https://seekingalpha.com/news/3808301-abbott-expands-voluntary-recall-of-infant-formula-after-fda-informs-of-2nd-infant-death?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5210843086242676
3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946,neutral,0.8909978270530701
3/3/2022 11:00:45 AM,7 Long-Term Stocks to Buy Now and Hold Forever,InvestorPlace,/news/stocks/7-long-term-stocks-to-buy-now-and-hold-forever-1031250895,neutral,0.9340663552284241
3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9586585164070129
3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9664651155471802
3/22/2022 9:45:34 PM,FDA inspection found violations at Abbott infant formula plant months before recall,Seeking Alpha,https://seekingalpha.com/news/3816229-fda-inspection-found-violations-at-abbott-infant-formula-plant-months-before-recall?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9427162408828735
3/23/2022 7:50:36 PM,Cue Health plunges to a post-IPO low as COVID-19 test makers drop,Seeking Alpha,https://seekingalpha.com/news/3816623-hlth-stock-plunges-to-post-ipo-low-as-covid-19-test-makers-drop?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9639391303062439
3/24/2022 2:00:00 PM,Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin,PR Newswire,/news/stocks/abbott-s-freestyle-libre-is-first-and-only-cgm-system-to-gain-expanded-reimbursement-in-japan-to-include-all-people-with-diabetes-who-use-insulin-1031304977,positive,0.8611099720001221
3/24/2022 3:42:17 PM,Abbott's glucose monitoring system FreeStyle gets expanded reimbursement in Japan,Seeking Alpha,https://seekingalpha.com/news/3817014-abbotts-glucose-monitoring-system-freestyle-gets-expanded-reimbursement-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9470187425613403
3/24/2022 9:45:45 PM,Abbott granted $1B U.S. Army contract for COVID-19 test kits,Seeking Alpha,https://seekingalpha.com/news/3817288-abbott-granted-1b-us-army-contract-for-covid-19-test-kits?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9285584092140198
3/28/2022 3:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1031312031,neutral,0.9381691813468933
3/30/2022 1:30:00 PM,Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain,PR Newswire,/news/stocks/abbott-and-lisc-team-up-to-address-diversity-and-equity-gaps-in-the-healthcare-industry-supply-chain-1031318457,positive,0.8324437141418457
4/4/2022 2:10:57 PM,Baxter cut to Sell as Goldman Sachs flags macro risks in MedTech space,Seeking Alpha,https://seekingalpha.com/news/3820395-baxter-cut-to-sell-as-goldman-sachs-flags-macro-concerns-on-medtech-space?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8837200999259949
4/4/2022 3:00:00 PM,Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-aveir-vr-leadless-pacemaker-system-to-treat-patients-with-slow-heart-rhythms-1031330035,positive,0.9340997338294983
4/4/2022 3:40:17 PM,Abbott: FDA Approves Aveir Pacemaker For Treatment Of Patients With Slow Heart Rhythms ,RTTNews,/news/stocks/abbott-fda-approves-aveir-pacemaker-for-treatment-of-patients-with-slow-heart-rhythms-1031330258,positive,0.9143253564834595
4/8/2022 11:35:39 AM,"Best Stocks for 2022: Up 20% This Year, AbbVie Is Doing Great",InvestorPlace,/news/stocks/best-stocks-for-2022-up-20-this-year-abbv-stock-is-doing-great-1031342773,positive,0.9464345574378967
4/12/2022 1:31:27 PM,Retailers Ration Baby Formula Sales Amid Widespread Shortage ,RTTNews,/news/stocks/retailers-ration-baby-formula-sales-amid-widespread-shortage-1031349330,negative,0.5877463817596436
4/14/2022 9:27:57 PM,Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings,Benzinga,/news/stocks/raymond-james-thinks-med-tech-investors-are-somewhat-paralyzed-ahead-of-q1-earnings-1031357902,negative,0.9467341303825378
4/17/2022 8:31:32 PM,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-17-april-23-j-j-abbott-earnings-adcom-test-for-tg-therapeutics-and-more-1031359853,neutral,0.9330936670303345
4/19/2022 12:02:36 PM,Abbott contaminated-baby-formula probe faces uncertainty - WSJ,Seeking Alpha,https://seekingalpha.com/news/3824225-abbott-contaminated-baby-formula-probe-faces-uncertainty-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6685810089111328
4/19/2022 2:53:30 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3824327-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.855887770652771
4/19/2022 3:01:13 PM,Abbott Laboratories earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q1-1031364014,neutral,0.9074124693870544
4/19/2022 3:47:20 PM,Abbott's Q1 result to be a litmus test for COVID-19 test demand,Seeking Alpha,https://seekingalpha.com/news/3824353-abbotts-q1-result-to-be-a-litmus-test-for-covid-19-test-demand?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7752286195755005
4/19/2022 8:19:41 PM,"This Week's Earnings Spotlight: Tesla, Netflix, IBM, American Express, Snap And More",Benzinga,/news/stocks/this-week-s-earnings-spotlight-tesla-netflix-ibm-american-express-snap-and-more-1031365103,neutral,0.9261942505836487
4/20/2022 11:31:04 AM,"Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M",Seeking Alpha,https://seekingalpha.com/news/3824658-abbott-laboratories-non-gaap-eps-of-1_73-beats-0_27-revenue-of-11_9b-beats-900m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5859308838844299
4/20/2022 12:03:17 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3824672-abbott-laboratories-declares-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9249960780143738
4/20/2022 12:29:44 PM,"Abbott beats revenue, profit estimates on strong COVID test demand; 2022 forecast unchanged",Seeking Alpha,https://seekingalpha.com/news/3824690-abbott-beats-street-revenue-profit-estimates-on-strong-covid-test-demand-2022-forecast-unchanged?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8799716830253601
4/20/2022 1:30:00 PM,Abbott Reports First-Quarter 2022 Results,PR Newswire,/news/stocks/abbott-reports-first-quarter-2022-results-1031367614,neutral,0.9231804013252258
4/20/2022 1:34:52 PM,"Abbott Laboratories Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/abbott-laboratories-q1-profit-increases-beats-estimates-1031367654,positive,0.9386962056159973
4/20/2022 2:13:16 PM,Abbott: FY22 Adj. EPS Guidance Remains Unchanged ,RTTNews,/news/stocks/abbott-fy22-adj-eps-guidance-remains-unchanged-1031367856,neutral,0.9132503271102905
4/20/2022 3:28:06 PM,"Benzinga's Daily Brief On Trending Tickers For April 20, 2022: Procter & Gamble, Lululemon, Netflix, And More",Benzinga,/news/stocks/benzinga-s-daily-brief-on-trending-tickers-for-april-20-2022-procter-gamble-lululemon-netflix-and-more-1031368314,neutral,0.945219099521637
4/21/2022 10:20:16 AM,"Abbott Q1 EPS, Sales Rise, ANTM Hits All-time High, Healthcare Services' Q1 Results Trump Estimates ",RTTNews,/news/stocks/abbott-q1-eps-sales-rise-antm-hits-all-time-high-healthcare-services-q1-results-trump-estimates-1031370869,positive,0.9463129043579102
4/21/2022 3:28:58 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031372164,neutral,0.8545588850975037
4/21/2022 9:43:38 PM,"What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings",Benzinga,/news/stocks/what-does-raymond-james-wells-fargo-have-to-say-on-abbott-s-q1-earnings-1031373178,neutral,0.9351181387901306
4/22/2022 10:15:59 AM,7 Stocks to Buy If You Think Inflation Is Topping Out,InvestorPlace,/news/stocks/7-stocks-to-buy-if-you-think-inflation-topping-out-1031374796,neutral,0.8500613570213318
4/25/2022 3:00:00 PM,Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health App,PR Newswire,/news/stocks/abbott-strengthens-its-connected-care-technologies-with-latest-neurosphere-mypath-digital-health-app-1031380293,positive,0.9024441242218018
4/26/2022 10:16:16 AM,3 Dividend Stocks for Value Investors Seeking Regular Income,InvestorPlace,/news/stocks/dividend-stocks-investors-seeking-income-1031384022,neutral,0.9316470623016357
4/26/2022 3:00:00 PM,Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation,PR Newswire,/news/stocks/abbott-recommends-rejection-of-below-market-mini-tender-offer-by-trc-capital-investment-corporation-1031385148,neutral,0.7960801124572754
4/26/2022 5:12:05 PM,EXCLUSIVE: Verano CIO Aaron Miles Says Company Is 'Strategically Building' As Crucial Markets Come Online,Benzinga,/news/stocks/exclusive-verano-cio-aaron-miles-says-company-is-strategically-building-as-crucial-markets-come-online-1031385748,positive,0.9019123911857605
4/27/2022 1:14:16 PM,"Abbott, CamDiab, Ypsomed partner to develop automated insulin delivery system",Seeking Alpha,https://seekingalpha.com/news/3827588-abbott-camdiab-ypsomed-partner-to-develop-automated-insulin-delivery-system?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.509587287902832
4/27/2022 2:00:00 PM,"Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes",PR Newswire,/news/stocks/abbott-camdiab-and-ypsomed-unveil-new-automated-insulin-delivery-partnership-for-people-with-diabetes-1031390668,positive,0.6989327073097229
4/28/2022 1:00:00 PM,New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes,PR Newswire,/news/stocks/new-analysis-shows-that-abbott-s-freestyle-libre-system-provides-similar-and-sustained-reductions-in-glucose-levels-for-people-with-both-type-1-and-type-2-diabetes-1031396577,positive,0.9393938779830933
4/28/2022 3:00:00 PM,Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company's Amulet™ Device,PR Newswire,/news/stocks/abbott-strengthens-left-atrial-appendage-closure-leadership-with-u-s-availability-of-amplatzer-steerable-delivery-sheath-for-the-company-s-amulet-device-1031397579,positive,0.9538249373435974
4/29/2022 3:00:00 PM,Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months,PR Newswire,/news/stocks/study-finds-89-of-patients-treated-for-persistent-atrial-fibrillation-using-abbott-s-ablation-device-remain-symptom-free-for-at-least-15-months-1031402573,positive,0.38674965500831604
4/29/2022 10:35:00 PM,Abbott to Release Metabolic Nutrition Formulas,PR Newswire,/news/stocks/abbott-to-release-metabolic-nutrition-formulas-1031403702,neutral,0.8718746900558472
5/2/2022 10:15:00 AM,Morgan Stanley issues list of 45 highest conviction stock picks,Seeking Alpha,https://seekingalpha.com/news/3829447-morgan-stanley-issues-list-of-45-highest-conviction-stock-picks?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8834772706031799
5/2/2022 12:23:58 PM,Abbott to release certain batches of baby formulas,Seeking Alpha,https://seekingalpha.com/news/3829938-abbott-to-release-certain-batches-of-baby-formulas?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9339041113853455
5/4/2022 1:26:34 PM,Abbott gets FDA clearance for test detecting 4 sexually transmitted infections,Seeking Alpha,https://seekingalpha.com/news/3832016-abbott-gets-fda-clearance-for-test-detecting-4-sexually-transmitted-infections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660982251167297
5/4/2022 3:00:00 PM,Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise,PR Newswire,/news/stocks/abbott-obtains-fda-clearance-for-first-test-that-simultaneously-detects-four-common-sexually-transmitted-infections-stis-as-cases-are-on-the-rise-1031419833,positive,0.8675051331520081
5/4/2022 3:20:45 PM,Abbott Gets FDA Clearance For Alinity M STI Assay Test - Quick Facts ,RTTNews,/news/stocks/abbott-gets-fda-clearance-for-alinity-m-sti-assay-test-quick-facts-1031420473,positive,0.6447444558143616
5/10/2022 1:27:46 PM,"CVS, Walgreens and Target limit baby formula purchases amid supply constraints",Seeking Alpha,https://seekingalpha.com/news/3835946-cvs-walgreens-and-target-limit-baby-formula-purchases-amid-supply-constraints?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8882865905761719
5/11/2022 3:00:00 PM,Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials,PR Newswire,/news/stocks/abbott-and-women-as-one-partner-to-help-more-underrepresented-physicians-lead-clinical-trials-1031448593,neutral,0.5796269178390503
5/11/2022 6:45:47 PM,FDA allows Abbott to release baby formula from plant amid nationwide shortage,Seeking Alpha,https://seekingalpha.com/news/3837096-fda-allows-abbott-to-release-baby-formula-from-plant-amid-nationwide-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8802862167358398
5/13/2022 2:49:33 AM,White House announces actions to address baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3837883-biden-to-meet-retailers-manufacturers-to-address-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8637828230857849
5/13/2022 3:17:51 PM,U.S. lawmakers launch probe into baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3838682-us-lawmakers-launch-probe-on-baby-formula-shortage-abc-news?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7784526944160461
5/13/2022 5:44:27 PM,Perrigo CEO Kessler says to expect baby formula shortage through rest of year - Reuters,Seeking Alpha,https://seekingalpha.com/news/3838771-perrigo-ceo-kessler-says-to-expect-baby-formula-shortage-through-rest-of-year-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9177316427230835
5/13/2022 6:18:42 PM,CDC completes Abbott baby formula probe,Seeking Alpha,https://seekingalpha.com/news/3838794-abt-stock-on-watch-as-cdc-completes-baby-formula-probe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8439351916313171
5/16/2022 1:26:24 PM,FDA to investigate why inspection of Abbott baby formula plant took so long - NBC News,Seeking Alpha,https://seekingalpha.com/news/3839178-fda-to-investigate-why-inspection-of-abbott-baby-formula-similac-plant-took-so-long-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8024479746818542
5/16/2022 5:04:30 PM,"U.S. to offer transport, logistics support to baby formula makers to overcome shortage",Seeking Alpha,https://seekingalpha.com/news/3839347-us-to-offer-transport-logistics-support-to-address-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7190572023391724
5/16/2022 8:39:54 PM,Abbott and FDA agree on steps to reopen baby formula production plant,Seeking Alpha,https://seekingalpha.com/news/3839529-abbott-and-fda-agree-on-steps-to-reopen-baby-formula-production-plant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8536458015441895
5/16/2022 10:22:00 PM,"Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility",PR Newswire,/news/stocks/abbott-enters-into-consent-decree-with-u-s-food-and-drug-administration-for-its-sturgis-mich-plant-agreement-creates-pathway-to-reopen-facility-1031465888,positive,0.9263589382171631
5/16/2022 11:21:57 PM,Baby formula imports allowed under FDA guidance to address nationwide shortage,Seeking Alpha,https://seekingalpha.com/news/3839683-baby-formula-imports-allowed-under-fda-guidance-to-address-nationwide-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8493423461914062
5/17/2022 4:03:45 AM,Abbott Reaches Agreement With FDA To Restart Baby Formula Production Amid U.S. Shortage ,RTTNews,/news/stocks/abbott-reaches-agreement-with-fda-to-restart-baby-formula-production-amid-u-s-shortage-1031466360,positive,0.9345834255218506
5/17/2022 1:52:20 PM,"Abbott price target cut at Citi on higher inflation, slowing growth",Seeking Alpha,https://seekingalpha.com/news/3839997-abbott-price-target-cut-at-citi-on-higher-inflation-slowing-growth?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7758093476295471
5/17/2022 2:07:56 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, May 17",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-may-17-1031468262,neutral,0.9063923954963684
5/17/2022 3:32:23 PM,ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With the FDA,InvestorPlace,/news/stocks/abt-stock-climbs-as-abbott-reaches-a-baby-formula-deal-with-the-fda-1031469387,positive,0.8194882869720459
5/17/2022 4:09:37 PM,Nano Dimension (NNDM) Stock Gains 10% on Share Buyback News,InvestorPlace,/news/stocks/nano-dimension-nndm-stock-gains-10-on-share-buyback-news-1031469456,positive,0.946994960308075
5/17/2022 4:56:22 PM,Nestlé exporting baby formula from Europe to alleviate shortage - WSJ,Seeking Alpha,https://seekingalpha.com/news/3840100-nestle-exporting-baby-formula-from-europe-to-alleviate-shortage-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6532036066055298
5/17/2022 7:04:14 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1031469588,neutral,0.9183946847915649
5/17/2022 7:18:54 PM,Abbott shares spike after deal with FDA to reopen baby formula plant,Seeking Alpha,https://seekingalpha.com/news/3840146-abt-stock-spikes-after-deal-with-fda-to-reopen-formula-plan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.579771101474762
5/18/2022 5:05:37 PM,"Abbott tax, stock buyback practices focus of new probe by Sen. Wyden",Seeking Alpha,https://seekingalpha.com/news/3840558-abbott-tax-stock-buyback-practices-focus-of-new-probe-by-sen-wyden?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8849424123764038
5/18/2022 9:24:54 PM,FDA Commissioner Califf to testify on baby formula shortage at House hearing Thursday,Seeking Alpha,https://seekingalpha.com/news/3840698-fda-commissioner-califf-to-testify-on-baby-formula-shortage-at-house-hearing-thursday?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8126957416534424
5/18/2022 10:16:18 PM,7 Best Value Stocks to Buy if You Need Some Market Stability in Your Life ,InvestorPlace,/news/stocks/7-best-value-stocks-to-buy-if-you-need-some-market-stability-in-your-life-1031473820,neutral,0.9113149642944336
5/18/2022 11:15:34 PM,Biden invokes Defense Production Act to alleviate baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3840720-biden-invokes-defense-production-act-to-alleviate-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6882817149162292
5/19/2022 3:15:00 PM,New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies,PR Newswire,/news/stocks/new-late-breaking-data-highlight-abbott-structural-heart-transcatheter-valve-therapies-1031475958,neutral,0.7659264206886292
5/19/2022 3:35:00 PM,Abbott Presents Data Reinforcing Impact Of Its Minimally Invasive Heart Devices ,RTTNews,/news/stocks/abbott-presents-data-reinforcing-impact-of-its-minimally-invasive-heart-devices-1031476036,positive,0.8994463086128235
5/19/2022 7:00:21 PM,Abbott in focus as U.S. lawmakers question FDA chief over baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3841101-abbott-in-focus-as-us-lawmakers-question-fda-chief-over-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7394297122955322
5/20/2022 1:06:56 PM,Does Abbott become a buy following a deal to bring its baby formula plant back online?,Seeking Alpha,https://seekingalpha.com/news/3841206-abbotts-stock-hit-a-52-week-low-last-week-is-now-the-time-to-buy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8166223764419556
5/20/2022 1:09:55 PM,Danone ramps up baby formula shipments to U.S. after Abbott recall - Reuters,Seeking Alpha,https://seekingalpha.com/news/3841347-danone-boosts-baby-formula-shipments-to-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6708142757415771
5/23/2022 12:57:14 PM,Morgan Stanley names 15 stocks that can weather a bear market,Seeking Alpha,https://seekingalpha.com/news/3841671-morgan-stanley-15-stocks-that-can-weather-a-bear-market?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8845469355583191
5/23/2022 8:43:11 PM,Abbott should continue baby formula rebates throughout 2022 - Senators,Seeking Alpha,https://seekingalpha.com/news/3841976-abbott-should-continue-baby-formula-rebates-throughout-2022-senators?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5897440910339355
5/24/2022 1:03:16 AM,Insulet jumps on report Dexcom in talks to acquire,Seeking Alpha,https://seekingalpha.com/news/3842032-insulet-jumps-on-report-dexcom-in-talks-to-acquire?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5540674328804016
5/24/2022 7:37:12 PM,Federal Trade Commission launches probe on baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3842378-abt-stock-lower-as-ftc-launches-probe-on-baby-formula-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8375776410102844
5/24/2022 9:28:17 PM,Abbott to release 300K cans of baby formula produced at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3842444-abbott-to-release-300k-cans-of-baby-formula-produced-at-michigan-plant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8568978309631348
5/24/2022 11:11:00 PM,Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need,PR Newswire,/news/stocks/abbott-to-release-elecare-amino-acid-based-formulas-to-help-meet-critical-patient-need-1031486423,positive,0.6522821187973022
5/25/2022 2:02:01 PM,US To Get About 2 Mln Infant Formula Cans From UK's Kendal Nutricare: FDA ,RTTNews,/news/stocks/us-to-get-about-2-mln-infant-formula-cans-from-uk-s-kendal-nutricare-fda-1031488037,neutral,0.5038869380950928
5/25/2022 2:53:14 PM,Report on Abbott baby formula plant took months to reach top FDA official - WaPo,Seeking Alpha,https://seekingalpha.com/news/3842676-report-on-abbott-baby-formula-plant-took-months-to-reach-top-fda-official-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8883728384971619
5/25/2022 6:30:58 PM,"Despite 'lost confidence' in Abbott, FDA OKd baby formula plant reopening",Seeking Alpha,https://seekingalpha.com/news/3842780-despite-lost-confidence-in-abbott-fda-okd-baby-formula-plant-reopening?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6123470067977905
5/26/2022 6:13:45 PM,Abbott says monkeypox test is currently under development,Seeking Alpha,https://seekingalpha.com/news/3843224-abbott-says-monkeypox-test-is-currently-under-development?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.917594850063324
5/26/2022 9:31:16 PM,Quant Ratings Updated on 75 Stocks,InvestorPlace,/news/stocks/quant-ratings-updated-on-75-stocks-1031494096,neutral,0.9200773239135742
5/27/2022 1:02:35 PM,Reckitt Benckiser said to get first round bids for infant formula unit,Seeking Alpha,https://seekingalpha.com/news/3843452-reckitt-benckiser-said-to-get-first-round-bids-for-infant-formula-unit?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6418617367744446
5/27/2022 8:07:17 PM,Baby formula being sent from Danone and Bubs Australia to address shortage,Seeking Alpha,https://seekingalpha.com/news/3843593-baby-formula-being-sent-from-danone-and-bubs-australia-to-address-shortage?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8566755652427673
5/31/2022 1:07:38 PM,Abbott announces FDA clearance for FreeStyle Libre 3 glucose monitor,Seeking Alpha,https://seekingalpha.com/news/3843925-abbott-announces-fda-clearance-for-freestyle-libre-3-glucose-monitor?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6341802477836609
5/31/2022 2:00:00 PM,"Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor",PR Newswire,/news/stocks/abbott-s-freestyle-libre-3-receives-u-s-fda-clearance-features-world-s-smallest-thinnest-and-most-accurate-14-day-glucose-sensor-1031498062,positive,0.7998412847518921
5/31/2022 2:19:14 PM,Abbott Says FDA Oks FreeStyle Libre 3 System As Glucose Monitor For Diabetic Patients ,RTTNews,/news/stocks/abbott-says-fda-oks-freestyle-libre-3-system-as-glucose-monitor-for-diabetic-patients-1031498199,neutral,0.6578083038330078
6/2/2022 3:28:43 PM,FDA response to Abbott baby formula recall to undergo HHS review,Seeking Alpha,https://seekingalpha.com/news/3845065-abbott-baby-formula-fda-inspection-to-undergo-hhs-review?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7710351347923279
6/3/2022 1:26:41 PM,Abbott says developing new continuous glucose-ketone monitoring system,Seeking Alpha,https://seekingalpha.com/news/3845489-abbott-says-developing-new-continuous-glucose-ketone-monitoring-system?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5393500924110413
6/3/2022 3:00:00 PM,Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System,PR Newswire,/news/stocks/abbott-announces-development-of-novel-continuous-glucose-ketone-monitoring-system-1031508432,positive,0.5695568919181824
6/4/2022 3:56:32 PM,Abbott has restarted baby formula production at Michigan facility,Seeking Alpha,https://seekingalpha.com/news/3845723-abbott-has-restarted-baby-formula-production-at-michigan-facility?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8623588681221008
6/5/2022 3:00:00 PM,Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor,PR Newswire,/news/stocks/late-breaking-data-demonstrate-abbott-s-freestyle-libre-3-system-is-most-accurate-14-day-continuous-glucose-monitor-1031509811,positive,0.8738741278648376
6/6/2022 4:59:43 AM,Abbott Says Data Show FreeStyle Libre 3 System Most Accurate 14-Day Continuous Glucose Monitor ,RTTNews,/news/stocks/abbott-says-data-show-freestyle-libre-3-system-most-accurate-14-day-continuous-glucose-monitor-1031509995,positive,0.7962623834609985
6/6/2022 1:40:31 PM,Abbott Restarts Baby Formula Production At Michigan Plant ,RTTNews,/news/stocks/abbott-restarts-baby-formula-production-at-michigan-plant-1031510640,negative,0.5253151655197144
6/7/2022 6:52:04 PM,5 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/5-analysts-have-this-to-say-about-abbott-laboratories-1031514293,neutral,0.9230043888092041
6/8/2022 11:10:53 AM,"Becton, Dickinson partners with CerTest Biotec for monkeypox test",Seeking Alpha,https://seekingalpha.com/news/3846602-becton-dickinson-partners-with-certest-biotec-for-monkeypox-test?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7132588028907776
6/8/2022 8:04:49 PM,Abbott alerted to baby formula allegations months earlier - WSJ,Seeking Alpha,https://seekingalpha.com/news/3846855-abbott-alerted-to-baby-formula-allegations-months-earlier-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7430927157402039
6/9/2022 10:28:31 AM,7 Monkeypox Stocks That May Take Off in Q2,InvestorPlace,/news/stocks/7-monkeypox-stocks-that-may-take-off-in-q2-1031518690,negative,0.5036308765411377
6/9/2022 11:47:37 AM,7 Undervalued Penny Stocks to Buy for Massive Gains,InvestorPlace,/news/stocks/7-undervalued-penny-stocks-to-buy-for-massive-gains-1031519069,positive,0.6069763898849487
6/10/2022 10:11:09 AM,3 Dividend Stocks to Buy Now for 20 Years of Income Growth,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-20-years-of-income-growth-1031521688,neutral,0.870885968208313
6/10/2022 3:28:42 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3847734-abbott-laboratories-declares-0_47-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.9249960780143738
6/10/2022 5:26:00 PM,Abbott Declares 394th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-394th-consecutive-quarterly-dividend-1031522522,neutral,0.486250102519989
6/16/2022 10:48:03 AM,Abbott stops baby formula production after flooding at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3849136-abt-stock-falls-as-company-stops-baby-formula-production-after-flooding?utm_source=businessinsider&utm_medium=referral,negative,0.9433165192604065
6/16/2022 2:31:48 PM,"Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16",Benzinga,/news/stocks/benzinga-before-the-bell-tesla-raises-prices-revlon-goes-bankrupt-and-other-top-financial-stories-thursday-june-16-1031533079,neutral,0.732093870639801
6/17/2022 5:27:47 PM,U.S. COVID test makers anticipate layoffs as federal funding dries up – Stat,Seeking Alpha,https://seekingalpha.com/news/3849680-us-covid-test-makers-anticipate-layoffs-as-federal-funding-dries-up-stat?utm_source=businessinsider&utm_medium=referral,negative,0.9688188433647156
6/22/2022 7:42:58 PM,Abbott pares gains as FDA reports another death linked to baby formula,Seeking Alpha,https://seekingalpha.com/news/3850942-abbott-pares-gains-as-fda-reports-another-death-linked-to-baby-formula?utm_source=businessinsider&utm_medium=referral,negative,0.9343262314796448
6/23/2022 8:45:17 AM,FDA Probes Death Of Infant Who Consumed Abbott Infant Formula ,RTTNews,/news/stocks/fda-probes-death-of-infant-who-consumed-abbott-infant-formula-1031545044,negative,0.8299989104270935
6/24/2022 5:26:37 PM,What 6 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-abbott-laboratories-1031549198,neutral,0.9357114434242249
6/24/2022 9:22:54 PM,Amazon.com To $180? Here's The Biggest Price Target Changes For Friday,Benzinga,/news/stocks/amazon-com-to-180-here-s-the-biggest-price-target-changes-for-friday-1031549647,neutral,0.9326549172401428
6/26/2022 12:18:50 AM,Monkeypox is not an international health emergency yet – WHO,Seeking Alpha,https://seekingalpha.com/news/3851872-monkeypox-is-not-an-international-health-emergency-yet-who?utm_source=businessinsider&utm_medium=referral,neutral,0.8119661808013916
6/28/2022 7:37:36 PM,Cue Health hits new post-IPO low amid selloff in COVID-19 test makers,Seeking Alpha,https://seekingalpha.com/news/3852604-hlth-stock-hits-new-post-ipo-low-amid-selloff-in-covid-19-test-makers?utm_source=businessinsider&utm_medium=referral,negative,0.9588428139686584
6/28/2022 8:18:40 PM,CDC announces emergency operations center for monkeypox,Seeking Alpha,https://seekingalpha.com/news/3852623-cdc-announces-emergency-operations-center-for-monkeypox?utm_source=businessinsider&utm_medium=referral,negative,0.551201343536377
6/29/2022 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1031557601,neutral,0.9235584139823914
7/1/2022 9:19:29 AM,"US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland ",RTTNews,/news/stocks/us-to-import-17-mln-bottles-of-infant-formula-from-new-zealand-ireland-1031562261,positive,0.5079754590988159
7/6/2022 4:06:52 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-6-2022-1031570726,neutral,0.5229201316833496
7/6/2022 7:42:34 PM,FDA to help foreign baby formula makers to access U.S. market for long-term,Seeking Alpha,https://seekingalpha.com/news/3854763-fda-to-help-foreign-baby-formula-makers-to-access-us-market-for-long-term?utm_source=businessinsider&utm_medium=referral,positive,0.8716979026794434
7/7/2022 10:39:16 AM,Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King,InvestorPlace,/news/stocks/best-stocks-for-2022-abbv-stock-1031572601,neutral,0.6148743629455566
7/8/2022 12:03:34 PM,Siga Technologies receives approval from UK for tecovirimat,Seeking Alpha,https://seekingalpha.com/news/3855320-siga-technologies-receives-approval-from-uk-for-tecovirimat?utm_source=businessinsider&utm_medium=referral,positive,0.8077393174171448
7/10/2022 1:11:02 AM,Abbott baby formula plant resumes operations after flooding,Seeking Alpha,https://seekingalpha.com/news/3855509-abbott-baby-formula-plant-resumes-operations-after-flooding?utm_source=businessinsider&utm_medium=referral,neutral,0.6411958932876587
7/11/2022 9:43:40 AM,US To Import 4.9 Mln Cans Of Baby Formula From Australia ,RTTNews,/news/stocks/us-to-import-4-9-mln-cans-of-baby-formula-from-australia-1031577611,neutral,0.5213204622268677
7/12/2022 1:58:20 PM,Abbott's deep brain stimulation device gains Breakthrough Therapy status for depression,Seeking Alpha,https://seekingalpha.com/news/3856070-abbott-deep-brain-stimulation-device-gains-breakthrough-therapy-status-for-depression?utm_source=businessinsider&utm_medium=referral,positive,0.9397528767585754
7/12/2022 3:00:00 PM,Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression,PR Newswire,/news/stocks/abbott-receives-fda-s-breakthrough-device-designation-to-explore-use-of-deep-brain-stimulation-to-manage-severe-depression-1031581263,positive,0.7932584285736084
7/12/2022 3:16:52 PM,Abbott: FDA Grants Breakthrough Device Designation To Investigate DBS System In TRD ,RTTNews,/news/stocks/abbott-fda-grants-breakthrough-device-designation-to-investigate-dbs-system-in-trd-1031581397,positive,0.8826384544372559
7/15/2022 4:27:23 PM,"Earnings week ahead: Tesla, Twitter, Netflix, Snap, and more",Seeking Alpha,https://seekingalpha.com/news/3857250-earnings-week-ahead-tesla-twitter-netflix-snap-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9304302334785461
7/15/2022 8:02:26 PM,7 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-abbott-laboratories-1031591016,neutral,0.9152542352676392
7/19/2022 2:35:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3858105-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.855887770652771
7/19/2022 3:01:13 PM,Abbott Laboratories earnings: here's what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q2-1031597199,neutral,0.9398906826972961
7/19/2022 3:59:17 PM,All eyes on Abbott Q2 results amid potential impact due to baby formula woes,Seeking Alpha,https://seekingalpha.com/news/3858155-all-eyes-on-abbott-q2-results-amid-potential-impact-due-to-baby-formula-woes?utm_source=businessinsider&utm_medium=referral,negative,0.7657757997512817
7/20/2022 11:32:41 AM,"Abbott Laboratories Non-GAAP EPS of $1.43 beats by $0.29, revenue of $11.3B beats by $930M, raises full-year EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3858429-abbott-laboratories-non-gaap-eps-of-143-beats-by-029-revenue-of-113b-beats-by-930m-raises-full-year-eps-guidance?utm_source=businessinsider&utm_medium=referral,positive,0.9311678409576416
7/20/2022 12:01:51 PM,Abbott raises guidance as COVID-19 testing sales drive 2Q beat,Seeking Alpha,https://seekingalpha.com/news/3858450-abt-stock-in-focus-as-company-raises-guidance-on-covid-19-testing-sales?utm_source=businessinsider&utm_medium=referral,positive,0.6868993043899536
7/20/2022 1:30:00 PM,Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance,PR Newswire,/news/stocks/abbott-reports-second-quarter-2022-results-and-raises-full-year-eps-guidance-1031600587,positive,0.7840874195098877
7/20/2022 1:37:11 PM,"Abbott Laboratories Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/abbott-laboratories-q2-profit-increases-beats-estimates-1031600625,positive,0.9405601620674133
7/20/2022 2:06:56 PM,Abbott Q2 Profit Tops Estimates; Raises 2022 Earnings Guidance ,RTTNews,/news/stocks/abbott-q2-profit-tops-estimates-raises-2022-earnings-guidance-1031600839,positive,0.9293842315673828
7/20/2022 2:22:38 PM,Abbott Laboratories (ABT) Stock Slides Despite Q2 Earnings Beat,InvestorPlace,/news/stocks/abbott-laboratories-abt-stock-slides-despite-q2-earnings-beat-1031601542,negative,0.9672896862030029
7/20/2022 2:46:22 PM,Cathie Wood’s Ark Invest Is Closing Its Transparency ETF. 12 Things to Know.,InvestorPlace,/news/stocks/cathie-woods-ark-invest-is-closing-its-transparency-etf-12-things-to-know-1031601593,neutral,0.861939549446106
7/20/2022 6:02:24 PM,"Tech Shares Move Higher, Nasdaq Jumps 200 Points",Benzinga,/news/stocks/tech-shares-move-higher-nasdaq-jumps-200-points-1031601821,positive,0.6636475920677185
7/21/2022 8:33:24 AM,"ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% ",RTTNews,/news/stocks/abt-raises-earnings-forecast-biib-provides-rosy-revenue-outlook-elv-q2-revenue-up-15-6-1031603549,positive,0.9477339386940002
7/23/2022 2:37:15 PM,WHO declares monkeypox outbreak a global health emergency,Seeking Alpha,https://seekingalpha.com/news/3859824-who-declares-monkeypox-outbreak-a-global-health-emergency?utm_source=businessinsider&utm_medium=referral,negative,0.857020378112793
7/26/2022 2:49:53 PM,Abbott Unveils NeuroSphere Virtual Clinic In Canada ,RTTNews,/news/stocks/abbott-unveils-neurosphere-virtual-clinic-in-canada-1031615301,neutral,0.8572051525115967
7/27/2022 11:10:39 AM,7 Large-Cap Stocks to Buy on the Dip,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-on-the-dip-1031619962,neutral,0.7422232031822205
7/27/2022 5:48:54 PM,"Abbott, Merck under Wyden scrutiny for not providing offshore taxable income info",Seeking Alpha,https://seekingalpha.com/news/3861579-abbott-merck-under-wyden-scrutiny-for-not-providing-offshore-taxable-income-info?utm_source=businessinsider&utm_medium=referral,negative,0.9057963490486145
7/27/2022 6:52:02 PM,Medtronic Stock Keeps Ticking Forward,Benzinga,/news/stocks/medtronic-stock-keeps-ticking-forward-1031621716,neutral,0.5848955512046814
7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral,positive,0.6786968111991882
8/4/2022 1:58:56 PM,Why Is Senseonics (SENS) Stock Heating Up Today?,InvestorPlace,/news/stocks/why-is-senseonics-sens-stock-heating-up-today-1031651580,neutral,0.8316879868507385
8/4/2022 10:10:00 PM,Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals,PR Newswire,/news/stocks/abbott-and-weightwatchers-partner-to-support-people-living-with-diabetes-in-attaining-their-health-goals-1031652452,neutral,0.6495490670204163
8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161,neutral,0.8945893049240112
8/11/2022 3:00:00 PM,New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions,PR Newswire,/news/stocks/new-study-shows-abbott-s-blood-test-for-concussion-could-predict-outcomes-from-brain-injury-and-inform-treatment-interventions-1031675961,positive,0.6042281985282898
8/11/2022 4:00:06 PM,Abbott: Research Shows TBI Blood Test Helpful In Predicting Recovery From Traumatic Brain Injury ,RTTNews,/news/stocks/abbott-research-shows-tbi-blood-test-helpful-in-predicting-recovery-from-traumatic-brain-injury-1031676310,positive,0.9210914969444275
8/12/2022 12:46:48 PM,Abbott to build new manufacturing plant in Ireland as part of €440M investment,Seeking Alpha,https://seekingalpha.com/news/3872336-abbott-to-build-new-manufacturing-plant-in-ireland-as-part-of-440m-investment?utm_source=businessinsider&utm_medium=referral,positive,0.6099467873573303
8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall – Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral,neutral,0.7759352922439575
8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral,positive,0.785580039024353
8/23/2022 1:20:48 PM,Abbott's spinal cord stimulation device for pain gets FDA approval,Seeking Alpha,https://seekingalpha.com/news/3875792-abbotts-spinal-cord-stimulation-device-for-pain-gets-fda-approval?utm_source=businessinsider&utm_medium=referral,positive,0.9068102836608887
8/23/2022 3:00:00 PM,FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions,PR Newswire,/news/stocks/fda-approves-abbott-s-new-spinal-cord-stimulation-device-provides-tailored-relief-to-multiple-pain-areas-and-adds-more-treatment-options-for-evolving-pain-conditions-1031700567,positive,0.9267091155052185
8/23/2022 3:15:17 PM,Abbott Announces FDA Approval For Its Proclaim Plus Spinal Cord Stimulation System ,RTTNews,/news/stocks/abbott-announces-fda-approval-for-its-proclaim-plus-spinal-cord-stimulation-system-1031700707,positive,0.5449576377868652
8/23/2022 6:32:34 PM,Abbott to extend baby formula rebates for another month – Politico,Seeking Alpha,https://seekingalpha.com/news/3875926-abbott-to-extend-baby-formula-rebates-for-another-month?utm_source=businessinsider&utm_medium=referral,neutral,0.788470447063446
8/29/2022 8:28:00 AM,Abbott resumes Similac baby formula production at Michigan plant,Seeking Alpha,https://seekingalpha.com/news/3877249-abbott-resumes-similac-baby-formula-production-at-michigan-plant?utm_source=businessinsider&utm_medium=referral,neutral,0.8694591522216797
8/29/2022 2:52:32 PM,Biden administration ending free at-home COVID tests due to lack of funding,Seeking Alpha,https://seekingalpha.com/news/3877465-biden-administration-ending-free-at-home-covid-tests-due-to-lack-of-funding?utm_source=businessinsider&utm_medium=referral,negative,0.9594377279281616
8/29/2022 3:00:00 PM,New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients,PR Newswire,/news/stocks/new-data-show-abbott-s-heartmate-3-heart-pump-extends-life-beyond-five-years-for-advanced-heart-failure-patients-1031710814,positive,0.8018595576286316
8/29/2022 3:19:22 PM,Abbott: Study Shows HeartMate 3 Pump Extends Life Expectancy Of Advanced Heart Failure Patients ,RTTNews,/news/stocks/abbott-study-shows-heartmate-3-pump-extends-life-expectancy-of-advanced-heart-failure-patients-1031710938,positive,0.7794992923736572
8/29/2022 6:58:22 PM,Abbott Laboratories hits 52-week low; stock down 26% YTD,Seeking Alpha,https://seekingalpha.com/news/3877556-abbott-laboratories-hits-52-week-low-stock-down-26-ytd?utm_source=businessinsider&utm_medium=referral,negative,0.9679475426673889
9/4/2022 12:38:00 PM,"ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-leading-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031723224,neutral,0.7875134348869324
9/6/2022 9:00:07 PM,3 Dividend Kings for Income Investors to Count On,InvestorPlace,/news/stocks/dividend-kings-that-income-investors-can-count-on-1031584429,neutral,0.8128063082695007
9/8/2022 3:00:00 PM,Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery,PR Newswire,/news/stocks/three-year-data-on-world-s-smallest-heart-device-show-benefits-of-fixing-holes-in-newborn-hearts-without-surgery-1031732072,positive,0.7992433309555054
9/8/2022 8:15:20 PM,FDA alerts on potential clip lock malfunctions in Abbott's MitraClip heart implant device,Seeking Alpha,https://seekingalpha.com/news/3881393-fda-alerts-on-potential-clip-lock-malfunctions-in-abbotts-mitraclip-heart-implant-device?utm_source=businessinsider&utm_medium=referral,negative,0.9355024099349976
9/9/2022 10:43:42 AM,Biden administration to procure over 100M at-home COVID tests,Seeking Alpha,https://seekingalpha.com/news/3881564-biden-administration-to-procure-over-100m-at-home-covid-tests?utm_source=businessinsider&utm_medium=referral,positive,0.793345034122467
9/9/2022 2:43:49 PM,"Top Financial Stories Friday, September 09: Elon Musk Hints At Potential Apple-SpaceX Partnership, GM's EV For Cost Conscious Buyers, Google Under DOJ Scanner For Search-Engine Dominance And More...",Benzinga,/news/stocks/top-financial-stories-friday-september-09-elon-musk-hints-at-potential-apple-spacex-partnership-gm-s-ev-for-cost-conscious-buyers-google-under-doj-scanner-for-search-engine-dominance-and-more-1031734640,neutral,0.5125482082366943
9/11/2022 11:03:19 PM,7 Blue-Chip Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-before-bull-market-returns-1031630381,neutral,0.882673442363739
9/12/2022 8:25:00 PM,"ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/abt-investor-notice-rosen-nationally-regarded-investor-counsel-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031738128,neutral,0.8218675255775452
9/13/2022 4:56:03 PM,Inari initiated Hold at Truist; notes competition overshadows market potential,Seeking Alpha,https://seekingalpha.com/news/3882433-inari-initiated-hold-at-truist-notes-competition-overshadows-market-growth?utm_source=businessinsider&utm_medium=referral,negative,0.954951822757721
9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral,neutral,0.8521955013275146
9/15/2022 4:58:31 PM,Abbott Laboratories declares $0.47 dividend,Seeking Alpha,https://seekingalpha.com/news/3883171-abbott-laboratories-declares-0_47-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.9249960780143738
9/15/2022 6:56:00 PM,Abbott Declares 395th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-395th-consecutive-quarterly-dividend-1031746500,neutral,0.6126108765602112
9/15/2022 7:00:16 PM,7 Top-Rated Biotech Stocks to Buy for Q4,InvestorPlace,/news/stocks/7-top-rated-biotech-stocks-to-buy-for-q4-1031746729,neutral,0.8415942192077637
9/17/2022 8:45:00 PM,Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies,PR Newswire,/news/stocks/late-breaking-data-show-breadth-of-abbott-s-minimally-invasive-structural-heart-technologies-1031749148,positive,0.8248679637908936
9/17/2022 9:15:00 PM,"ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-leading-and-longstanding-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031749152,neutral,0.7307000756263733
9/20/2022 8:05:48 PM,FDA finds 'confluence of systemic vulnerabilities' led to Abbott baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3884566-abbott-baby-formula-shortage-due-to-confluence-of-systemic-vulnerabilities-fda-finds?utm_source=businessinsider&utm_medium=referral,negative,0.954406201839447
9/22/2022 5:52:24 PM,Abbott stock falls below $100 for first time in two years as it hits fresh 52-week low,Seeking Alpha,https://seekingalpha.com/news/3885376-abbott-stock-falls-below-100-for-first-time-in-two-years-as-it-hits-fresh-52-week-low?utm_source=businessinsider&utm_medium=referral,negative,0.956089198589325
9/27/2022 10:00:07 AM,7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’,InvestorPlace,/news/stocks/7-vaccine-stocks-to-sell-asap-now-that-the-pandemics-over-1031766411,neutral,0.6584042310714722
9/27/2022 3:47:00 PM,FDA updates COVID-19 test policy to cut emergency use requests,Seeking Alpha,https://seekingalpha.com/news/3886420-fda-updates-covid-19-test-policy-to-cut-emergency-use-requests?utm_source=businessinsider&utm_medium=referral,negative,0.5927170515060425
9/28/2022 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1031770099,neutral,0.9299495220184326
9/28/2022 9:15:00 PM,"ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-a-longstanding-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031771127,neutral,0.8135055899620056
10/3/2022 10:14:22 AM,"Svante Pääbo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral,neutral,0.7340630292892456
10/5/2022 6:15:52 PM,Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?,InvestorPlace,/news/stocks/best-stocks-2022-whats-not-to-like-about-abbvie-abbv-stock-1031785559,neutral,0.88181471824646
10/6/2022 3:00:00 PM,New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life,PR Newswire,/news/stocks/new-study-published-in-the-new-england-journal-of-medicine-demonstrates-abbott-s-freestyle-libre-2-system-has-positive-impacts-on-glucose-levels-and-quality-of-life-1031787402,positive,0.9201245307922363
10/7/2022 1:07:23 PM,DexCom adds 10% as Medicare updates coverage for glucose monitoring,Seeking Alpha,https://seekingalpha.com/news/3889667-dxcm-stock-gains-as-medicare-updates-coverage-for-glucose-monitoring?utm_source=businessinsider&utm_medium=referral,positive,0.8601243495941162
10/7/2022 9:33:16 PM,Abbott monkeypox test wins Emergency Use Authorization from FDA,Seeking Alpha,https://seekingalpha.com/news/3889813-abbott-monkeypox-test-wins-emergency-use-authorization-from-fda?utm_source=businessinsider&utm_medium=referral,positive,0.9431344866752625
10/8/2022 4:10:00 AM,"ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-top-ranked-investor-counsel-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-abt-1031790974,neutral,0.8088554739952087
10/10/2022 7:01:25 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1031793852,neutral,0.9183946847915649
10/10/2022 9:22:47 PM,Analyst Ratings for Abbott Laboratories,Benzinga,/news/stocks/analyst-ratings-for-abbott-laboratories-1031794005,neutral,0.9048534035682678
10/12/2022 3:42:00 PM,Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season,PR Newswire,/news/stocks/abbott-and-the-home-edit-redesign-the-medicine-cabinet-to-help-people-prepare-for-the-upcoming-virus-season-1031799886,neutral,0.8456060290336609
10/12/2022 4:02:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-12-2022-1031799955,neutral,0.5273875594139099
10/12/2022 9:13:54 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031800764,neutral,0.8545588850975037
10/13/2022 1:50:23 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Humana (HUM),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-humana-hum-1031801105,neutral,0.9022407531738281
10/14/2022 5:10:04 PM,"Earnings week ahead: Tesla, Netflix, Johnson & Johnson, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3891460-earnings-week-ahead-tesla-netflix-johnson-johnson-att-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9371859431266785
10/14/2022 6:30:00 PM,"Catalyst Watch: Tesla, Netflix, Fisker, TechCrunch Disrupt and Paris Motor Show headline big week",Seeking Alpha,https://seekingalpha.com/news/3891159-catalyst-watch-tesla-netflix-techcrunch-disrupt-and-paris-motor-show-headline-big-week?utm_source=businessinsider&utm_medium=referral,neutral,0.8451207876205444
10/15/2022 12:18:00 PM,"ROSEN, SKILLED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/rosen-skilled-investor-counsel-encourages-abbott-laboratories-investors-with-losses-to-secure-counsel-before-important-october-31-deadline-in-securities-class-action-abt-1031807311,neutral,0.8480948805809021
10/17/2022 7:38:04 AM,Abbott Recalls Certain Ready-to-Feed Liquid Products ,RTTNews,/news/stocks/abbott-recalls-certain-ready-to-feed-liquid-products-1031808927,negative,0.9283695220947266
10/17/2022 2:34:50 PM,Morgan Stanley says large cap healthcare remains attractive amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3891861-morgan-stanely-says-large-cap-healthcare-remains-attractive-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral,positive,0.9349676966667175
10/17/2022 6:11:51 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031810704,neutral,0.8545588850975037
10/18/2022 2:32:23 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3892262-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.855887770652771
10/18/2022 3:01:13 PM,Abbott Laboratories earnings preview: what to expect,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1031813407,neutral,0.9070191979408264
10/18/2022 4:09:22 PM,Johnson & Johnson weighs job cuts ahead of consumer health spinoff,Seeking Alpha,https://seekingalpha.com/news/3892300-johnson-johnson-weighs-job-cuts-ahead-of-consumer-health-spinoff?utm_source=businessinsider&utm_medium=referral,negative,0.9445424675941467
10/18/2022 4:17:24 PM,Can Abbott maintain EPS beat run in Q3 as industry faces slowdown in COVID products demand?,Seeking Alpha,https://seekingalpha.com/news/3892303-can-abbott-q3-results-maintain-eps-beat-run-as-industry-faces-slowdown-in-covid-products?utm_source=businessinsider&utm_medium=referral,negative,0.7564548850059509
10/18/2022 4:21:58 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-18-2022-1031813984,neutral,0.4930572509765625
10/19/2022 11:33:00 AM,"Abbott Laboratories raises full-year profit guidance, Non-GAAP EPS of $1.15 beats by $0.21, revenue of $10.4B beats by $750M",Seeking Alpha,https://seekingalpha.com/news/3892575-abbott-laboratories-raises-full-year-profit-guidance-non-gaap-eps-of-115-beats-by-021-revenue-of-104b-beats-by-750m?utm_source=businessinsider&utm_medium=referral,positive,0.9157806038856506
10/19/2022 12:15:38 PM,Abbott Q3 topline contracts amid falling COVID-19 testing and baby formula issue,Seeking Alpha,https://seekingalpha.com/news/3892592-abbott-q3-topline-weighed-down-by-falling-covid-19-testing-baby-formula-issue?utm_source=businessinsider&utm_medium=referral,negative,0.9195976257324219
10/19/2022 1:30:00 PM,Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance,PR Newswire,/news/stocks/abbott-reports-third-quarter-2022-results-and-raises-full-year-eps-guidance-1031816923,positive,0.7879471182823181
10/19/2022 1:35:58 PM,"Abbott Laboratories Q3 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q3-profit-decreases-but-beats-estimates-1031816962,negative,0.9700227379798889
10/19/2022 2:00:31 PM,Abbott Laboratories Boosts FY22 Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy22-outlook-update-1031817091,positive,0.6155235171318054
10/19/2022 2:17:52 PM,"SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19",Benzinga,/news/stocks/spacex-starlink-s-new-in-flight-connectivity-service-amazon-s-ny-workers-reject-union-celsius-network-faces-several-federal-investigations-top-stories-wednesday-oct-19-1031817194,negative,0.6755456328392029
10/19/2022 4:30:06 PM,Abbott falls 8% to hit 52-week low despite Q3 beat,Seeking Alpha,https://seekingalpha.com/news/3892731-abt-stock-falls-most-in-over-a-year-despite-q3-beat?utm_source=businessinsider&utm_medium=referral,negative,0.9651945233345032
10/19/2022 4:36:11 PM,"Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday",Benzinga,/news/stocks/abbott-laboratories-m-t-bank-and-some-other-big-stocks-moving-lower-on-wednesday-1031817999,negative,0.966247022151947
10/19/2022 6:30:03 PM,Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-united-airlines-shares-are-trading-higher-here-are-43-stocks-moving-in-wednesday-s-mid-day-session-1031818321,neutral,0.9014329314231873
10/19/2022 8:39:37 PM,3 Stocks Set to Soar From 52-Week Lows,InvestorPlace,/news/stocks/3-stocks-set-to-soar-from-52-week-lows-1031818896,negative,0.7520971298217773
10/20/2022 7:52:51 AM,Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday,Benzinga,/news/stocks/why-olaplex-shares-dipped-around-57-here-are-75-biggest-movers-from-yesterday-1031819854,negative,0.5553937554359436
10/20/2022 12:36:11 PM,Morgan Stanley Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/morgan-stanley-keeps-their-buy-rating-on-abbott-labs-abt-1031821123,neutral,0.9171220064163208
10/21/2022 12:36:31 PM,Abbott Labs (ABT) Gets a Buy from Raymond James,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-raymond-james-1031824303,positive,0.6176379323005676
10/21/2022 7:53:36 PM,Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms,Benzinga,/news/stocks/amazon-to-175-plus-jp-morgan-cuts-price-target-on-meta-platforms-1031825185,positive,0.4481063485145569
10/23/2022 12:22:00 PM,"ABT APPROACHING DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Cl...",PR Newswire,/news/stocks/abt-approaching-deadline-rosen-respected-investor-counsel-encourages-abbott-laboratories-investors-with-losses-over-100k-to-secure-counsel-before-important-october-31-deadline-in-securities-cl-1031825986,neutral,0.807856023311615
10/26/2022 4:07:48 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-26-2022-1031838805,neutral,0.4896213412284851
10/26/2022 6:38:29 PM,Abbott draws Neutral rating at Mizuho on COVID headwinds and baby formula recall,Seeking Alpha,https://seekingalpha.com/news/3895804-abbott-draws-neutral-rating-at-mizuho-on-covid-headwinds-infant-formula-issue?utm_source=businessinsider&utm_medium=referral,negative,0.906148374080658
10/28/2022 3:00:00 PM,Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation,PR Newswire,/news/stocks/abbott-s-freestyle-libre-is-named-best-medical-technology-in-last-50-years-by-the-galien-foundation-1031848415,positive,0.8466652631759644
10/29/2022 8:00:00 PM,"With medical devices market expected to soar, here are companies set to benefit the most",Seeking Alpha,https://seekingalpha.com/news/3897411-with-medical-devices-market-expected-to-soar-here-are-companies-set-to-benefit-the-most?utm_source=businessinsider&utm_medium=referral,neutral,0.7235878705978394
10/31/2022 8:11:00 PM,"ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT",PR Newswire,/news/stocks/abt-final-deadline-today-rosen-a-top-ranked-law-firm-encourages-abbott-laboratories-investors-to-secure-counsel-before-important-october-31-deadline-in-securities-class-action-abt-1031854965,neutral,0.5480005145072937
11/1/2022 3:02:58 PM,Monkeypox remains a global health emergency – WHO,Seeking Alpha,https://seekingalpha.com/news/3898590-monkeypox-remains-a-global-health-emergency-who?utm_source=businessinsider&utm_medium=referral,negative,0.9023171663284302
11/5/2022 1:45:57 AM,RBC Capital Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-abbott-labs-abt-1031877340,neutral,0.8339378833770752
11/6/2022 11:53:00 AM,"Politician’s Picks: Senior Delaware Senator Favors CVS, ABT, TSM Stocks",TipRanks,/news/stocks/politician-s-picks-senior-delaware-senator-favors-cvs-abt-tsm-stocks-1031875664,neutral,0.9354084134101868
11/9/2022 6:51:44 PM,3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War,Benzinga,/news/stocks/3-food-processing-dividend-stocks-that-could-benefit-from-food-shortages-driven-by-russia-ukraine-war-1031893358,neutral,0.7988489866256714
11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral,negative,0.8541243672370911
11/12/2022 5:05:09 PM,7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond,InvestorPlace,/news/stocks/7-no-brainer-blue-chip-stocks-to-buy-for-2023-and-beyond-1031906025,neutral,0.8862760066986084
11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral,negative,0.6932174563407898
11/13/2022 1:18:00 PM,"T, ABT, or PG: Which Value Stock Could Fetch Higher Returns?",TipRanks,/news/stocks/t-abt-or-pg-which-value-stock-could-fetch-higher-returns-1031905396,neutral,0.9156758189201355
11/16/2022 9:54:37 PM,Shortages a Boon for These 2 Medical Device Stocks,TipRanks,/news/stocks/shortages-a-boon-for-these-2-medical-device-stocks-1031920308,neutral,0.6144965887069702
11/17/2022 3:00:00 PM,Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology,PR Newswire,/news/stocks/abbott-receives-three-ces-2023-innovation-awards-for-advancements-in-health-technology-1031922396,positive,0.8915176391601562
12/6/2022 9:32:15 PM,Quant Ratings Updated on 92 Stocks,InvestorPlace,/news/stocks/20221206-quant-ratings-1031956530,neutral,0.9286938905715942
12/8/2022 7:28:42 PM,EU wants to delay medical device law amid supply challenges - Reuters,Seeking Alpha,https://seekingalpha.com/news/3915442-eu-wants-to-delay-medical-device-law-amid-supply-challenges-reuters?utm_source=businessinsider&utm_medium=referral,negative,0.830899715423584
12/9/2022 3:52:14 PM,Abbott Laboratories raises quarterly dividend by 8.5% to $0.51/share,Seeking Alpha,https://seekingalpha.com/news/3915744-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.9024595618247986
12/9/2022 4:48:00 PM,"Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth",PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-marking-51-consecutive-years-of-dividend-growth-1031963083,positive,0.8495567440986633
12/12/2022 3:02:20 PM,11 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/11-analysts-have-this-to-say-about-abbott-laboratories-1031965384,neutral,0.9286305904388428
12/12/2022 7:02:12 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1031967429,neutral,0.8545588850975037
12/13/2022 2:30:00 PM,Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions,PR Newswire,/news/stocks/abbott-and-the-brain-injury-association-of-america-launch-concussion-awareness-now-coalition-team-up-with-rebel-wilson-to-raise-awareness-on-seriousness-of-concussions-1031969106,positive,0.60829758644104
12/13/2022 11:39:28 PM,"A Career Politician Who Regularly Trades The SPY, Picked Up These 3 High Yielding ETFs Instead",Benzinga,/news/etf/a-career-politician-who-regularly-trades-the-spy-picked-up-these-3-high-yielding-etfs-instead-1031970409,neutral,0.9289416670799255
12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral,neutral,0.8428406715393066
12/15/2022 12:33:20 PM,White House restarts program to ship free at-home COVID tests,Seeking Alpha,https://seekingalpha.com/news/3917481-white-house-restarts-program-to-ship-free-at-home-covid-tests?utm_source=businessinsider&utm_medium=referral,positive,0.7587370276451111
12/19/2022 3:00:00 PM,"Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain",PR Newswire,/news/stocks/abbott-launches-the-world-s-smallest-implantable-rechargeable-spinal-cord-stimulation-system-for-chronic-pain-1031980099,positive,0.5521309971809387
12/19/2022 4:56:10 PM,Abbott wins FDA approval of Eterna spinal cord stimulation system,Seeking Alpha,https://seekingalpha.com/news/3918462-abbott-wins-fda-approval-of-eterna-spinal-cord-stimulation-system?utm_source=businessinsider&utm_medium=referral,positive,0.900209903717041
12/20/2022 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1031982443,neutral,0.9324039220809937
12/21/2022 3:00:00 PM,Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany,PR Newswire,/news/stocks/abbott-s-freestyle-libre-3-integrated-with-automated-insulin-delivery-system-mylife-loop-in-germany-1031984918,neutral,0.761584997177124
12/21/2022 3:56:35 PM,Abbott : FreeStyle Libre 3 Integrated With Automated Insulin Delivery System Mylife Loop In Germany ,RTTNews,/news/stocks/abbott-freestyle-libre-3-integrated-with-automated-insulin-delivery-system-mylife-loop-in-germany-1031985097,neutral,0.7822043299674988
12/25/2022 5:00:44 PM,Goldman Sachs highlights key healthcare themes for 2023,Seeking Alpha,https://seekingalpha.com/news/3920634-goldman-sachs-micro-over-macro-healthcare-themes-2023?utm_source=businessinsider&utm_medium=referral,neutral,0.7464402914047241
12/28/2022 4:45:41 PM,Imported baby formula to face US tariffs again in 2023 - WSJ,Seeking Alpha,https://seekingalpha.com/news/3920955-imported-baby-formula-to-face-us-tariffs-again-in-2023-wsj?utm_source=businessinsider&utm_medium=referral,neutral,0.6578342914581299
12/30/2022 5:11:21 PM,Diabetes rates in children set to skyrocket by 2060 - study,Seeking Alpha,https://seekingalpha.com/news/3921303-diabetes-rates-in-children-set-to-skyrocket-by-2060-study?utm_source=businessinsider&utm_medium=referral,neutral,0.8470563888549805
1/4/2023 3:00:00 PM,Abbott Hosts Conference Call for Fourth-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-fourth-quarter-earnings-1031999915,neutral,0.9284790754318237
1/6/2023 4:26:21 PM,Abbott Labs (ABT) Gets a Buy from Morgan Stanley,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-morgan-stanley-1032004652,positive,0.5357733964920044
1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182,neutral,0.8010979890823364
1/7/2023 3:00:00 AM,"Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation",PR Newswire,/news/stocks/abbott-blood-centers-of-america-launch-first-of-its-kind-mixed-reality-experience-for-use-during-blood-donation-1032005233,neutral,0.779870331287384
1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.9474840760231018
1/11/2023 3:41:27 PM,"COVID-19 public health emergency extended by HHS, possibly for final time",Seeking Alpha,https://seekingalpha.com/news/3923735-covid-19-public-health-emergency-extended-by-hhs-possibly-for-final-time?utm_source=businessinsider&utm_medium=referral,negative,0.764000654220581
1/13/2023 1:56:59 AM,RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-labs-abt-1032016258,positive,0.6241188049316406
1/17/2023 1:45:29 AM,Abbott Labs (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-rbc-capital-1032021130,neutral,0.763346254825592
1/17/2023 2:47:29 PM,Abbott receives FDA approval for transcatheter  aortic valve implantation system,Seeking Alpha,https://seekingalpha.com/news/3925017-abbott-receives-fda-approval-for-transcatheter-aortic-valve-implantation-system?utm_source=businessinsider&utm_medium=referral,positive,0.9115230441093445
1/17/2023 3:00:00 PM,"Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis",PR Newswire,/news/stocks/abbott-receives-fda-approval-for-navitor-a-next-generation-tavi-system-designed-to-treat-aortic-stenosis-1032022647,positive,0.9318044781684875
1/17/2023 3:19:04 PM,Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis ,RTTNews,/news/stocks/abbott-says-fda-oks-navitor-tavi-system-to-treat-severe-aortic-stenosis-1032022759,positive,0.6261970400810242
1/19/2023 4:36:36 PM,Surmodics sinks as FDA declines to approve drug-coated balloon,Seeking Alpha,https://seekingalpha.com/news/3925969-srdx-stock-sinks-fda-declines-drug-coated-balloon?utm_source=businessinsider&utm_medium=referral,negative,0.955564022064209
1/20/2023 5:16:36 PM,"Earnings week ahead: Tesla, Microsoft, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3926380-earnings-week-ahead-tesla-microsoft-att-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9216915369033813
1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral,neutral,0.8929739594459534
1/21/2023 1:06:50 AM,Abbott under DOJ criminal probe over behavior at Michigan baby formula plant - WSJ,Seeking Alpha,https://seekingalpha.com/news/3926538-abbott-under-doj-criminal-probe-over-behavior-at-michigan-baby-formula-plant-wsj?utm_source=businessinsider&utm_medium=referral,negative,0.9450469613075256
1/21/2023 5:29:01 PM,Abbott Reportedly Under Criminal Probe Over Baby Formula ,RTTNews,/news/stocks/abbott-reportedly-under-criminal-probe-over-baby-formula-1032031946,negative,0.8709281086921692
1/24/2023 3:01:13 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-q4-earnings-preview-1032036909,neutral,0.9230455160140991
1/24/2023 3:12:43 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3927200-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.855887770652771
1/24/2023 4:03:50 PM,Abbott Q4 results in focus as DOJ probe on baby formula plant looms,Seeking Alpha,https://seekingalpha.com/news/3927227-abbott-q4-results-in-focus-as-doj-probe-on-baby-formula-plant-looms?utm_source=businessinsider&utm_medium=referral,negative,0.49189043045043945
1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral,positive,0.5872244238853455
1/25/2023 12:30:40 PM,"Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M",Seeking Alpha,https://seekingalpha.com/news/3927653-abbott-laboratories-non-gaap-eps-of-1_30-beats-0_37-revenue-of-10_1b-beats-410m?utm_source=businessinsider&utm_medium=referral,neutral,0.640045166015625
1/25/2023 1:30:00 PM,Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook,PR Newswire,/news/stocks/abbott-reports-fourth-quarter-and-full-year-2022-results-issues-2023-financial-outlook-1032040053,neutral,0.8177111148834229
1/25/2023 1:37:16 PM,"Abbott posts 12% revenue drop amid baby formula disruption, waning COVID impact",Seeking Alpha,https://seekingalpha.com/news/3927717-abt-stock-falls-topline-drops-baby-formula-disruption?utm_source=businessinsider&utm_medium=referral,negative,0.9739528298377991
1/25/2023 1:37:18 PM,"Abbott Laboratories Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q4-profit-decreases-but-beats-estimates-1032040072,negative,0.9697469472885132
1/25/2023 2:01:20 PM,"Abbott Issues FY23 Earnings, Sales Growth View - Update ",RTTNews,/news/stocks/abbott-issues-fy23-earnings-sales-growth-view-update-1032040194,neutral,0.9326155185699463
1/25/2023 7:45:10 PM,BTIG Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/btig-sticks-to-their-buy-rating-for-abbott-labs-abt-1032041537,neutral,0.8102794289588928
1/26/2023 1:48:11 PM,NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/nike-to-rally-over-23-here-are-10-other-analyst-forecasts-for-thursday-1032043576,neutral,0.8975791931152344
1/26/2023 2:00:32 PM,What 5 Analyst Ratings Have To Say About Abbott Laboratories,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-abbott-laboratories-1032043633,neutral,0.9314632415771484
1/26/2023 2:26:52 PM,Abbott wins FDA approval of Proclaim XR for diabetic peripheral neuropathy,Seeking Alpha,https://seekingalpha.com/news/3928423-abbott-wins-fda-approval-of-proclaim-xr-for-diabetic-peripheral-neuropathy?utm_source=businessinsider&utm_medium=referral,positive,0.9168708324432373
1/26/2023 3:00:00 PM,FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy,PR Newswire,/news/stocks/fda-approves-abbott-s-spinal-cord-stimulation-for-people-living-with-painful-diabetic-peripheral-neuropathy-1032043917,positive,0.5993849635124207
1/26/2023 3:25:06 PM,Abbott Says FDA Oks Proclaim XR Spinal Cord Stimulation System To Treat DPN ,RTTNews,/news/stocks/abbott-says-fda-oks-proclaim-xr-spinal-cord-stimulation-system-to-treat-dpn-1032044061,positive,0.6113629341125488
1/28/2023 1:45:29 AM,Abbott Labs (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-rbc-capital-1032047806,neutral,0.763346254825592
1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral,neutral,0.743737518787384
1/31/2023 5:28:03 PM,FDA to overhaul food safety division in wake of baby formula issues,Seeking Alpha,https://seekingalpha.com/news/3929983-fda-to-overhaul-food-safety-division-in-wake-of-baby-formula-issues?utm_source=businessinsider&utm_medium=referral,negative,0.9238804578781128
1/31/2023 9:30:04 PM,Quant Ratings Updated on 105 Stocks,InvestorPlace,/news/stocks/20230131-quant-ratings-1032055811,neutral,0.9263681173324585
2/2/2023 4:45:39 PM,"Abbott receives FDA, European authorizations for cardiac catheters",Seeking Alpha,https://seekingalpha.com/news/3931361-abbott-receives-fda-european-authorizations-for-cardiac-catheters?utm_source=businessinsider&utm_medium=referral,positive,0.8263409733772278
2/9/2023 12:05:00 AM,"Abbott to Acquire Cardiovascular Systems, Inc.",PR Newswire,/news/stocks/abbott-to-acquire-cardiovascular-systems-inc-1032080428,neutral,0.9411662220954895
2/9/2023 1:49:06 AM,Abbott To Acquire Cardiovascular Systems In $890 Mln Deal ,RTTNews,/news/stocks/abbott-to-acquire-cardiovascular-systems-in-890-mln-deal-1032080477,neutral,0.879942774772644
2/9/2023 3:33:35 AM,Abbott to acquire heart device maker Cardiovascular Systems for $20/share,Seeking Alpha,https://seekingalpha.com/news/3933976-csii-stock-jumps-as-abbott-agrees-to-acquire?utm_source=businessinsider&utm_medium=referral,neutral,0.8908029198646545
2/9/2023 10:10:24 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT) and Phibro Animal Health (PAHC),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbott-labs-abt-and-phibro-animal-health-pahc-1032082205,negative,0.9202778935432434
2/9/2023 11:10:09 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Teva Pharmaceutical (TEVA) and Galapagos (GLPG)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-teva-pharmaceutical-teva-and-galapagos-glpg-1032082361,neutral,0.9165567755699158
2/9/2023 11:15:08 AM,Abbott Labs (ABT) Gets a Buy from BTIG,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-btig-1032082410,neutral,0.6713735461235046
2/9/2023 12:57:55 PM,Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M,Benzinga,/news/stocks/abbott-adds-complementary-technologies-to-its-vascular-offering-via-cardiovascular-systems-deal-for-890m-1032082584,neutral,0.5640031099319458
2/9/2023 1:15:59 PM,Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?,InvestorPlace,/news/stocks/why-is-cardiovascular-systems-csii-stock-up-48-today-1032082955,positive,0.7256490588188171
2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral,neutral,0.5336910486221313
2/13/2023 5:29:22 PM,Surmodics downgraded at Needham on uncertainty over drug-coated balloon,Seeking Alpha,https://seekingalpha.com/news/3935282-srdx-stock-downgraded-needham-uncertainty-drug-coated-balloon?utm_source=businessinsider&utm_medium=referral,negative,0.9035682082176208
2/13/2023 6:57:52 PM,Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock,Benzinga,/news/stocks/abbott-cardiovascular-systems-acquisition-could-further-add-uncertainty-over-surmodics-product-analyst-downgrades-stock-1032092007,negative,0.9592587947845459
2/13/2023 10:42:16 PM,The 7 Most Undervalued Dividend Aristocrats to Buy,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-aristocrats-to-buy-1032092498,positive,0.5109917521476746
2/14/2023 9:05:22 PM,Which Healthcare Stock Is a Better Pick in 2023?,InvestorPlace,/news/stocks/which-healthcare-stock-is-a-better-pick-in-2023-1032095959,neutral,0.9094558358192444
2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral,neutral,0.4218192398548126
2/15/2023 7:11:38 PM,7 Hot Healthcare Stocks With the Potential to Outperform,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-with-the-potential-to-outperform-1032103825,positive,0.9004144668579102
2/17/2023 5:28:31 PM,Abbott Laboratories declares $0.51 dividend,Seeking Alpha,https://seekingalpha.com/news/3937785-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.9251407384872437
2/17/2023 6:26:00 PM,Abbott Declares 397th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-397th-consecutive-quarterly-dividend-1032106758,negative,0.5318531394004822
2/17/2023 6:35:08 PM,I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.,InvestorPlace,/news/stocks/i-tricked-chatgpt-into-picking-stocks-to-buy-heres-what-it-said-1032106844,neutral,0.9173052310943604
2/21/2023 8:01:54 PM,Abbott slips as govt. scrutiny over baby formula shortage tightens,Seeking Alpha,https://seekingalpha.com/news/3938655-abt-stock-slips-govt-scrutiny-over-baby-formula-shortage-tightens?utm_source=businessinsider&utm_medium=referral,negative,0.9441646933555603
2/22/2023 6:04:18 PM,Apple nears bid to shake up glucose monitoring market – Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3939276-apple-nears-bid-to-shake-up-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral,neutral,0.5583457946777344
2/27/2023 12:52:03 PM,Top 5 Health Care Stocks That May Rocket Higher In Q1 2023,Benzinga,/news/stocks/top-5-health-care-stocks-that-may-rocket-higher-in-q1-2023-1032127321,positive,0.9267569184303284
2/28/2023 3:00:00 PM,Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices,PR Newswire,/news/stocks/late-breaking-data-reinforce-benefits-of-abbott-s-minimally-invasive-heart-devices-1032131783,positive,0.9138531684875488
2/28/2023 3:16:47 PM,Abbott touts new data on Navitor transcatheter aortic valve implant,Seeking Alpha,https://seekingalpha.com/news/3941872-abbott-touts-new-data-on-navitor-transcatheter-aortic-valve-implant?utm_source=businessinsider&utm_medium=referral,neutral,0.8000856041908264
3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral,neutral,0.9219886064529419
3/2/2023 7:00:10 PM,DexCom rises as Medicare updates coverage for continuous glucose monitors,Seeking Alpha,https://seekingalpha.com/news/3943517-dexcom-rises-as-medicare-updates-coverage-for-continuous-glucose-monitors?utm_source=businessinsider&utm_medium=referral,positive,0.9243982434272766
3/4/2023 1:45:13 AM,RBC Capital Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-labs-abt-1032145073,neutral,0.9134108424186707
3/4/2023 4:41:00 PM,New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation,PR Newswire,/news/stocks/new-data-show-superiority-of-abbott-s-triclip-device-compared-to-medical-therapy-for-tricuspid-regurgitation-1032145266,positive,0.9473688006401062
3/5/2023 3:07:00 PM,Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device,PR Newswire,/news/stocks/late-breaking-data-from-landmark-coapt-trial-show-long-term-benefits-of-abbott-s-mitraclip-device-1032145646,positive,0.9353907108306885
3/6/2023 3:16:19 AM,Abbott: Data Show Long-Term Benefits Of MitraClip Device For Treating Secondary Mitral Regurgitation ,RTTNews,/news/stocks/abbott-data-show-long-term-benefits-of-mitraclip-device-for-treating-secondary-mitral-regurgitation-1032145839,positive,0.9140604734420776
3/6/2023 11:50:15 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-eli-lilly-co-lly-1032146876,positive,0.505389392375946
3/6/2023 1:00:00 PM,U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems,PR Newswire,/news/stocks/u-s-fda-clears-abbott-s-freestyle-libre-2-and-freestyle-libre-3-sensors-for-integration-with-automated-insulin-delivery-systems-1032146895,positive,0.8915063738822937
3/6/2023 1:01:07 PM,FDA clears Abbott's FreeStyle Libre 2 and 3 sensors for integration with AID systems,Seeking Alpha,https://seekingalpha.com/news/3944374-fda-clears-abbotts-freestyle-libre-2-and-3-sensors-for-integration-with-aid-systems?utm_source=businessinsider&utm_medium=referral,positive,0.8797801733016968
3/6/2023 1:30:40 PM,"Abbott: FDA Clears FreeStyle Libre 2, 3 Sensors For Integration With AID Systems ",RTTNews,/news/stocks/abbott-fda-clears-freestyle-libre-2-3-sensors-for-integration-with-aid-systems-1032147034,positive,0.9085178375244141
3/6/2023 1:35:06 PM,Abbott Labs (ABT) Gets a Buy from BTIG,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-btig-1032147287,neutral,0.6713735461235046
3/6/2023 4:32:32 PM,DexCom slips as Abbott wins FDA nod for CGM integration,Seeking Alpha,https://seekingalpha.com/news/3944516-dexcom-slips-abbott-wins-fda-nod-for-cgm-integration?utm_source=businessinsider&utm_medium=referral,negative,0.838771641254425
3/6/2023 8:13:57 PM,"Nasdaq, S&P, Dow come off session highs ahead of Powell testimony, jobs data this week",Seeking Alpha,https://seekingalpha.com/news/3944519-nasdaq-sp-dow-rise-as-investors-eye-powell-testimony-jobs-data-this-week?utm_source=businessinsider&utm_medium=referral,neutral,0.5360780358314514
3/6/2023 9:51:35 PM,7 Dividend Kings to Buy for an Uncertain Market Environment,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-an-uncertain-market-environment-1032148499,neutral,0.6553321480751038
3/7/2023 12:20:17 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-tenax-therapeutics-tenx-and-day-one-biopharmaceuticals-dawn-1032150096,neutral,0.9147000312805176
3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral,positive,0.533659815788269
3/7/2023 2:41:03 PM,Abbott wins FDA nod for blood-based concussion test,Seeking Alpha,https://seekingalpha.com/news/3944908-abbott-wins-fda-nod-for-blood-based-concussion-test?utm_source=businessinsider&utm_medium=referral,positive,0.7476749420166016
3/7/2023 3:00:00 PM,Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-first-commercially-available-lab-based-blood-test-to-help-evaluate-concussion-1032150562,positive,0.6541779637336731
3/8/2023 1:34:07 AM,Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason,Benzinga,/news/stocks/health-care-etfs-have-lost-in-the-last-month---these-top-pharma-stocks-are-the-reason-1032151775,negative,0.9652082920074463
3/9/2023 4:10:32 AM,"Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), BioMarin Pharmaceutical (BMRN) and Marinus (MRNS)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-abbott-labs-abt-biomarin-pharmaceutical-bmrn-and-marinus-mrns-1032155138,negative,0.6811610460281372
3/23/2023 2:00:00 PM,"Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement",PR Newswire,/news/stocks/don-t-mess-with-your-melon-abbott-and-the-brain-injury-association-of-america-urge-if-you-hit-your-head-get-it-checked-in-new-public-service-announcement-1032187849,neutral,0.8935118913650513
3/26/2023 4:00:27 PM,Global continuous glucose monitoring market to hit $32B by 2031 – report,Seeking Alpha,https://seekingalpha.com/news/3951266-global-cgm-market-to-hit-32b-by-2031?utm_source=businessinsider&utm_medium=referral,positive,0.7806898951530457
3/28/2023 6:35:20 PM,FDA strategy aims to avoid another baby formula shortage,Seeking Alpha,https://seekingalpha.com/news/3951979-fda-strategy-aims-to-avoid-another-baby-formula-shortage-abbott?utm_source=businessinsider&utm_medium=referral,neutral,0.9227812886238098
3/29/2023 3:00:00 PM,Abbott Hosts Conference Call for First-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-first-quarter-earnings-1032200423,neutral,0.9381691813468933
3/29/2023 8:31:59 PM,Why did Tandem Diabetes Care stock go down today?,Seeking Alpha,https://seekingalpha.com/news/3952467-why-did-tandem-diabetes-care-stock-go-down-today?utm_source=businessinsider&utm_medium=referral,negative,0.920922577381134
3/30/2023 10:25:38 AM,Bank of America Securities Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-buy-rating-for-abbott-labs-abt-1032202978,neutral,0.8659629225730896
3/31/2023 2:37:20 PM,3 Healthcare Stocks to Watch As the Industry Evolves,InvestorPlace,/news/stocks/3-healthcare-stocks-to-watch-as-the-industry-evolves-zts-cvs-abt-1032207411,neutral,0.9028501510620117
4/5/2023 11:07:35 AM,Democratic senators urge U.S. to maintain free COVID tests under Medicare,Seeking Alpha,https://seekingalpha.com/news/3954602-democratic-senators-urge-medicare-maintain-free-covid-tests?utm_source=businessinsider&utm_medium=referral,neutral,0.8428521156311035
4/5/2023 9:01:24 PM,10 Analysts Have This to Say About Abbott Laboratories,Benzinga,/news/stocks/10-analysts-have-this-to-say-about-abbott-laboratories-1032217622,neutral,0.9251134991645813
4/6/2023 1:50:42 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Verastem (VSTM) and Pliant Therapeutics (PLRX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-verastem-vstm-and-pliant-therapeutics-plrx-1032217896,neutral,0.8984230160713196
4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral,neutral,0.9115643501281738
4/6/2023 9:02:12 PM,Abbott recalls millions of FreeStyle Libre glucose monitoring devices,Seeking Alpha,https://seekingalpha.com/news/3955151-abbott-stock-recalls-freestyle-libre-cgm-devices?utm_source=businessinsider&utm_medium=referral,neutral,0.7092098593711853
4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral,negative,0.536685049533844
4/14/2023 1:59:01 PM,Abbott reader for FreeStyle Libre CGM system granted FDA nod,Seeking Alpha,https://seekingalpha.com/news/3956614-abbott-stock-reader-freestyle-libre-fda-nod?utm_source=businessinsider&utm_medium=referral,neutral,0.6459108591079712
4/14/2023 3:00:00 PM,FDA Clears Reader for Abbott's FreeStyle Libre® 3 System,PR Newswire,/news/stocks/fda-clears-reader-for-abbott-s-freestyle-libre-3-system-1032232842,neutral,0.5807796120643616
4/14/2023 3:23:49 PM,Abbott: FDA Clears Reader For FreeStyle Libre 3 Integrated Continuous Glucose Monitoring System ,RTTNews,/news/stocks/abbott-fda-clears-reader-for-freestyle-libre-3-integrated-continuous-glucose-monitoring-system-1032232925,positive,0.6684578657150269
4/14/2023 6:30:56 PM,"Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more",Seeking Alpha,https://seekingalpha.com/news/3956682-earnings-week-ahead-tesla-att-charles-schwab-netflix-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9345334768295288
4/17/2023 12:50:30 PM,"Medicare continuous glucose monitor coverage changes help Abbott, DexCom",Seeking Alpha,https://seekingalpha.com/news/3956897-medicare-continuous-glucose-monitor-coverage-changes-help-abbott-dexcom?utm_source=businessinsider&utm_medium=referral,neutral,0.8907845616340637
4/17/2023 2:00:00 PM,Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries,PR Newswire,/news/stocks/abbott-s-freestyle-libre-continuous-glucose-monitoring-systems-obtain-significantly-expanded-coverage-for-medicare-beneficiaries-1032236135,positive,0.9471355080604553
4/17/2023 4:37:25 PM,Profit from the Artificial Intelligence Boom with These 7 AI ETFs,InvestorPlace,/news/stocks/profit-from-the-artificial-intelligence-boom-with-these-7-ai-etfs-1032237146,neutral,0.5204213857650757
4/18/2023 9:05:12 AM,Bank of America Securities Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-abbott-labs-abt-1032238930,neutral,0.8622652888298035
4/18/2023 2:44:20 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3957371-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.855887770652771
4/18/2023 3:01:13 PM,Abbott Laboratories is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q1-quarterly-earnings-preview-stock-1032239737,neutral,0.9326412081718445
4/18/2023 3:49:45 PM,All eyes on Abbott Q1 results amid baby formula woes and device recall,Seeking Alpha,https://seekingalpha.com/news/3957394-all-eyes-on-abbott-q1-results-amid-baby-formula-woes-device-recall?utm_source=businessinsider&utm_medium=referral,neutral,0.5463623404502869
4/19/2023 11:18:28 AM,"Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/3957631-abbott-laboratories-non-gaap-eps-of-1_03-beats-0_05-revenue-of-9_7b-beats-60m?utm_source=businessinsider&utm_medium=referral,neutral,0.6092519760131836
4/19/2023 12:07:24 PM,Abbott stock pops as sales grow on medical devices amid COVID test slowdown,Seeking Alpha,https://seekingalpha.com/news/3957654-abbott-stock-pops-sales-grow-medical-devices-amid-covid-test-slowdown?utm_source=businessinsider&utm_medium=referral,positive,0.8428386449813843
4/19/2023 1:15:00 PM,Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business,PR Newswire,/news/stocks/abbott-reports-first-quarter-2023-results-increases-outlook-for-underlying-base-business-1032243109,positive,0.9360458254814148
4/19/2023 1:38:45 PM,"Abbott Laboratories Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q1-profit-decreases-but-beats-estimates-1032243165,negative,0.9695577621459961
4/19/2023 3:34:38 PM,"Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories",Benzinga,/news/stocks/meta-prepares-for-further-job-cuts-google-to-allow-developers-to-use-alternative-payment-options-intel-ditches-production-of-bitcoin-mining-chip-today-s-top-stories-1032243704,negative,0.5472509264945984
4/19/2023 4:57:22 PM,"Hot Stocks: ABT, TRV rise on earnings; crypto, EV stocks slide; BBBY surges",Seeking Alpha,https://seekingalpha.com/news/3957812-hot-stocks-abt-trv-rise-on-earnings-crypto-ev-stocks-slide-bbby-surges?utm_source=businessinsider&utm_medium=referral,negative,0.530299186706543
4/19/2023 7:04:49 PM,Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-travelers-companies-shares-are-trading-higher-by-over-5-here-are-other-stocks-moving-in-wednesday-s-mid-day-session-1032244301,neutral,0.8831062912940979
4/19/2023 8:33:38 PM,Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results,Benzinga,/news/stocks/nasdaq-edges-higher-abbott-laboratories-reports-upbeat-results-1032244485,positive,0.9000365734100342
4/20/2023 7:20:07 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Elanco Animal Health (ELAN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-elanco-animal-health-elan-1032245849,neutral,0.9202766418457031
4/20/2023 8:35:07 AM,Bernstein Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/bernstein-sticks-to-their-buy-rating-for-abbott-labs-abt-1032246011,neutral,0.8644355535507202
4/20/2023 10:20:49 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Revance Therapeutics (RVNC) and Actinium Pharmaceuticals (ATNM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-revance-therapeutics-rvnc-and-actinium-pharmaceuticals-atnm-1032246271,neutral,0.9060968160629272
4/20/2023 12:30:20 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Alphatec Holdings (ATEC) and Inogen (INGN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-alphatec-holdings-atec-and-inogen-ingn-1032246890,neutral,0.907609224319458
4/20/2023 3:00:00 PM,Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change,PR Newswire,/news/stocks/abbott-and-new-global-consortium-partnership-address-viral-outbreaks-caused-by-climate-change-1032247007,neutral,0.7797219753265381
4/20/2023 3:56:30 PM,Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/abbott-laboratories-to-rally-17-here-are-10-other-analyst-forecasts-for-thursday-1032247303,neutral,0.8821839690208435
4/21/2023 1:00:27 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Arcutis Biotherapeutics (ARQT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-arcutis-biotherapeutics-arqt-1032250002,neutral,0.9040801525115967
4/25/2023 1:35:17 PM,Abbott's life support system receives new FDA clearances,Seeking Alpha,https://seekingalpha.com/news/3959712-abbotts-life-support-system-receives-new-fda-clearances?utm_source=businessinsider&utm_medium=referral,positive,0.9386566281318665
4/25/2023 3:00:00 PM,Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients,PR Newswire,/news/stocks/abbott-s-life-support-system-receives-new-fda-clearances-to-help-doctors-treat-more-critically-ill-patients-1032258591,positive,0.9337091445922852
4/25/2023 3:29:46 PM,Abbott Announces Two New FDA Clearances For Life Support System ,RTTNews,/news/stocks/abbott-announces-two-new-fda-clearances-for-life-support-system-1032258728,positive,0.6799670457839966
4/25/2023 11:54:00 PM,Cytek Biosciences Set to Join S&P SmallCap 600,PR Newswire,/news/stocks/cytek-biosciences-set-to-join-s-p-smallcap-600-1032260191,neutral,0.9178665280342102
4/27/2023 10:45:09 AM,7 Healthcare Stocks With Huge Return Potential for Long-Term Investors,InvestorPlace,/news/stocks/7-healthcare-stocks-with-huge-return-potential-for-long-term-investors-1032267993,positive,0.7780923843383789
4/27/2023 10:10:00 PM,"Abbott Completes Acquisition of Cardiovascular Systems, Inc.",PR Newswire,/news/stocks/abbott-completes-acquisition-of-cardiovascular-systems-inc-1032270277,neutral,0.8218526244163513
5/1/2023 3:29:42 PM,3 Stocks to Buy Before They Soar to New Heights in 2023,InvestorPlace,/news/stocks/3-stocks-to-buy-before-they-soar-to-new-heights-in-2023-1032278717,neutral,0.808144748210907
5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral,positive,0.9210435748100281
5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.8873199820518494
5/11/2023 11:20:32 AM,Program for free COVID tests is ending as U.S. pandemic emergency winds down,Seeking Alpha,https://seekingalpha.com/news/3969917-program-free-covid-tests-ending-pandemic-emergency-winds-down?utm_source=businessinsider&utm_medium=referral,negative,0.9544445872306824
5/11/2023 2:16:37 PM,Abbott wins FDA expanded indication for Eterna neuromodulation device,Seeking Alpha,https://seekingalpha.com/news/3970111-abbott-wins-fda-expanded-nod--eterna-neuromodulation-device?utm_source=businessinsider&utm_medium=referral,positive,0.833604097366333
5/11/2023 3:00:00 PM,Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative,PR Newswire,/news/stocks/abbott-announces-new-partnerships-and-programs-to-advance-its-diversity-in-clinical-trials-initiative-1032318053,positive,0.8716667890548706
5/11/2023 6:12:03 PM,Monkeypox is no longer a global health emergency – WHO,Seeking Alpha,https://seekingalpha.com/news/3970268-monkeypox-is-no-longer-a-global-health-emergency-who?utm_source=businessinsider&utm_medium=referral,neutral,0.8971009254455566
5/14/2023 7:30:40 PM,Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks,InvestorPlace,/news/stocks/investing-for-the-long-term-here-are-7-must-have-dividend-stocks-1032324961,neutral,0.943790078163147
5/15/2023 10:17:32 PM,"Shell Asset boosts stake in AT&T, reduces Huntington Bancshares, Arch Capital",Seeking Alpha,https://seekingalpha.com/news/3971818-shell-asset-boosts-stake-in-att-reduces-huntington-bancshares-arch-capital?utm_source=businessinsider&utm_medium=referral,neutral,0.6880554556846619
5/16/2023 2:46:42 PM,Abbott spinal cord devices gain indication for back pain,Seeking Alpha,https://seekingalpha.com/news/3972152-abbott-spinal-cord-devices-gain-indication-for-back-pain?utm_source=businessinsider&utm_medium=referral,positive,0.6411091685295105
5/16/2023 3:00:00 PM,Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-its-spinal-cord-stimulation-systems-to-treat-chronic-back-pain-in-people-who-have-limited-surgical-options-1032331347,positive,0.9426031112670898
5/16/2023 3:19:01 PM,Abbott Says FDA Approves Spinal Cord Stimulation Devices To Treat Chronic Back Pain ,RTTNews,/news/stocks/abbott-says-fda-approves-spinal-cord-stimulation-devices-to-treat-chronic-back-pain-1032331503,positive,0.6418827176094055
5/17/2023 4:55:50 PM,Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears,TipRanks,/news/stocks/billionaire-paul-tudor-jones-pours-millions-into-these-2-stocks-amid-recession-fears-1032335705,neutral,0.8901801109313965
5/18/2023 1:37:27 PM,Abbott wins FDA nod for insertable cardiac monitor Assert-IQ,Seeking Alpha,https://seekingalpha.com/news/3973034-abbott-stock-wins-fda-nod-cardiac-monitor-assert-iq?utm_source=businessinsider&utm_medium=referral,positive,0.8928763270378113
5/18/2023 3:00:00 PM,Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term,PR Newswire,/news/stocks/abbott-receives-fda-clearance-for-assert-iq-insertable-cardiac-monitor-to-help-doctors-monitor-people-s-heart-rhythms-long-term-1032337503,positive,0.9018507599830627
5/18/2023 3:14:21 PM,Abbott Laboratories Says FDA Approves Assert-IQ Insertable Cardiac Monitor ,RTTNews,/news/stocks/abbott-laboratories-says-fda-approves-assert-iq-insertable-cardiac-monitor-1032337598,positive,0.7598147392272949
5/19/2023 1:20:40 PM,Stereotaxis stock rises after pact with Abbott to improve abnormal heart beat treatment,Seeking Alpha,https://seekingalpha.com/news/3973466-stereotaxis-stock-rises-abbott-pact-abnormal-heart-beat-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.6508517265319824
5/19/2023 1:31:40 PM,Abbott gains approval of TactiFlex ablation catheter treatment,Seeking Alpha,https://seekingalpha.com/news/3973463-abbott-gains-approval-ablation-catheter-treatment?utm_source=businessinsider&utm_medium=referral,positive,0.941779613494873
5/19/2023 3:00:00 PM,Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-tactiflex-ablation-catheter-for-treatment-of-abnormal-heart-rhythm-1032339788,positive,0.9308274984359741
5/19/2023 3:13:26 PM,Abbott Announces FDA Approval For TactiFlex Ablation Catheter ,RTTNews,/news/stocks/abbott-announces-fda-approval-for-tactiflex-ablation-catheter-1032339836,positive,0.7371156811714172
5/20/2023 3:18:00 PM,Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints,PR Newswire,/news/stocks/abbott-unveils-late-breaking-data-showing-the-world-s-first-dual-chamber-leadless-pacemaker-study-met-all-three-primary-endpoints-1032340737,neutral,0.5761110782623291
5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral,neutral,0.912303626537323
5/23/2023 2:38:34 PM,Abbott recalled baby formula claims tossed by federal judge,Seeking Alpha,https://seekingalpha.com/news/3974216-abbott-recalled-baby-formula-claims-tossed-federal-judge?utm_source=businessinsider&utm_medium=referral,negative,0.8279476761817932
5/24/2023 3:00:00 PM,European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations,PR Newswire,/news/stocks/european-study-finds-the-abbott-cardiomems-sensor-results-in-improved-quality-of-life-and-44-reduction-in-heart-failure-hospitalizations-1032348538,positive,0.9532590508460999
5/24/2023 3:22:41 PM,Abbott: MONITOR-HF Trial With CardioMEMS Sensor Meets Primary Endpoint ,RTTNews,/news/stocks/abbott-monitor-hf-trial-with-cardiomems-sensor-meets-primary-endpoint-1032348687,positive,0.8984028100967407
5/24/2023 3:37:03 PM,"Nvidia Chief Flags Dangers To US Chips Act, Disney, Shell, Gucci Allegedly Used Worthless Carbon Credits, Microsoft's Daring Attempt to Outshine Google In Search Game: Today's Top Stories",Benzinga,/news/stocks/nvidia-chief-flags-dangers-to-us-chips-act-disney-shell-gucci-allegedly-used-worthless-carbon-credits-microsoft-s-daring-attempt-to-outshine-google-in-search-game-today-s-top-stories-1032348757,neutral,0.8138488531112671
5/24/2023 4:48:47 PM,Abbott boasts of heart failure reduction data for CardioMEMS device,Seeking Alpha,https://seekingalpha.com/news/3974707-abbott-boasts-heart-failure-reduction-data-cardiomems?utm_source=businessinsider&utm_medium=referral,positive,0.548710286617279
5/25/2023 9:47:53 AM,"Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics",Seeking Alpha,https://seekingalpha.com/news/3974944-abbott-iqvia-global-fund-partners-commit-54m-to-boost-laboratory-system-for-pandemics?utm_source=businessinsider&utm_medium=referral,positive,0.8393557071685791
5/30/2023 8:30:36 PM,Quant Ratings Updated on 107 Stocks,InvestorPlace,/news/stocks/20230530-quant-ratings-1032359328,neutral,0.9320862889289856
5/30/2023 10:58:47 PM,"Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson",Seeking Alpha,https://seekingalpha.com/news/3976048-morgan-stanley-medtech-picks-medtronic-alphatec-becton-dickinson?utm_source=businessinsider&utm_medium=referral,neutral,0.8355056047439575
5/31/2023 3:00:00 PM,"Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign",PR Newswire,/news/stocks/abbott-real-madrid-and-the-real-madrid-foundation-band-together-to-beat-malnutrition-globally-through-new-campaign-1032361041,positive,0.7808177471160889
5/31/2023 5:03:25 PM,Abbott alleges former scientist in its nutrition unit stole trade secrets,Seeking Alpha,https://seekingalpha.com/news/3976296-abbott-accuses-former-nutrition-scientist-stole-trade-secrets?utm_source=businessinsider&utm_medium=referral,negative,0.6398457288742065
6/1/2023 8:13:51 PM,Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed',Benzinga,/news/stocks/mark-cuban-helping-lower-cost-of-bestselling-humira-with-cost-plus-drug-company-the-game-just-changed-1032365572,positive,0.6339818239212036
6/2/2023 2:31:17 PM,Senseonics spikes on UnitedHealthcare coverage for glucose monitoring device,Seeking Alpha,https://seekingalpha.com/news/3977157-senseonics-stock-up-unitedhealth-coverage-cgm-device?utm_source=businessinsider&utm_medium=referral,negative,0.8068069815635681
6/9/2023 4:55:00 PM,Abbott Declares 398th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-398th-consecutive-quarterly-dividend-1032381079,negative,0.5141702890396118
6/9/2023 8:02:30 PM,Abbott Laboratories declares $0.51 dividend,Seeking Alpha,https://seekingalpha.com/news/3978969-abbott-laboratories-declares-0_51-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.9251407384872437
6/12/2023 3:28:42 PM,Abbott names Philip Boudreau CFO effective Sept. 1,Seeking Alpha,https://seekingalpha.com/news/3979249-abbott-names-philip-boudreau-cfo-effective-sept-1?utm_source=businessinsider&utm_medium=referral,neutral,0.8880976438522339
6/13/2023 1:15:11 AM,Bank of America Securities Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-buy-rating-on-abbott-labs-abt-1032384711,neutral,0.920447826385498
6/13/2023 8:40:13 PM,Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB Application,Benzinga,/news/stocks/second-time-may-be-a-charm-analyst-is-bullish-as-surmodics-resubmits-surveil-dcb-application-1032387123,negative,0.6459301114082336
6/20/2023 12:15:16 PM,Surmodics spikes on FDA nod for SurVeil drug coated balloon,Seeking Alpha,https://seekingalpha.com/news/3980806-surmodics-stock-rises-fda-nod-surveil-drug-balloon?utm_source=businessinsider&utm_medium=referral,negative,0.4788888692855835
6/20/2023 3:54:53 PM,"After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval",Benzinga,/news/stocks/after-fda-rejection-surmodics-surveil-drug-coated-balloon-scores-fda-approval-1032399254,positive,0.933518648147583
6/22/2023 3:00:00 PM,Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹,PR Newswire,/news/stocks/abbott-s-freestyle-libre-2-receives-national-reimbursement-in-france-for-all-people-with-diabetes-who-use-insulin-1032404542,positive,0.8268002867698669
6/22/2023 5:26:21 PM,Abbott gains expanded coverage for glucose monitoring device in France,Seeking Alpha,https://seekingalpha.com/news/3982051-abbott-nabs-wider-coverage-freestyle-libre-2-france?utm_source=businessinsider&utm_medium=referral,positive,0.9522643685340881
6/27/2023 8:25:16 PM,GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations,Benzinga,/news/stocks/ge-healthcare-s-solid-demand-and-sensible-margin-targets-morgan-stanley-sees-potential-upside-despite-street-s-high-expectations-1032413289,positive,0.9515285491943359
6/29/2023 3:00:00 PM,Abbott Hosts Conference Call for Second-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-second-quarter-earnings-1032417840,neutral,0.9235584139823914
6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.901573121547699
7/5/2023 3:00:00 PM,Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker,PR Newswire,/news/stocks/abbott-receives-fda-approval-for-world-s-first-dual-chamber-leadless-pacemaker-1032427497,positive,0.7714130878448486
7/5/2023 3:46:15 PM,Abbott's Minimally Invasive Dual Chamber Leadless Pacemaker System Gets FDA Approval ,RTTNews,/news/stocks/abbott-s-minimally-invasive-dual-chamber-leadless-pacemaker-system-gets-fda-approval-1032427658,positive,0.9263589978218079
7/5/2023 6:23:48 PM,FDA approves Abbott dual-chamber leadless pacemaker Aveir DR,Seeking Alpha,https://seekingalpha.com/news/3985737-fda-approves-abbott-dual-chamber-leadless-pacemaker-aveir-dr?utm_source=businessinsider&utm_medium=referral,positive,0.6762605905532837
7/7/2023 10:24:04 AM,"BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names",Seeking Alpha,https://seekingalpha.com/news/3986007-btig-unveils-2h23-top-picks-dr-horton-crowdstrike-draftkings-and-abbott-among-the-list?utm_source=businessinsider&utm_medium=referral,neutral,0.9171134829521179
7/7/2023 11:44:52 AM,Top 11 technical picks for the second half of 2023,Seeking Alpha,https://seekingalpha.com/news/3985847-top-11-technical-picks-for-the-second-half-of-2023?utm_source=businessinsider&utm_medium=referral,neutral,0.9150712490081787
7/9/2023 5:06:29 AM,"PEP, ABBV, or GM: Which Value Stock Could Offer the Highest Upside?",TipRanks,/news/stocks/pep-abbv-or-gm-which-value-stock-could-offer-the-highest-upside-1032433298,neutral,0.9338462352752686
7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral,positive,0.937191367149353
7/14/2023 7:00:24 PM,"Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown",Seeking Alpha,https://seekingalpha.com/news/3987769-catalyst-watch-microsoft-activision-blizzard-drama-splunk-event-and-nasdaq-100-rebalancing-countdown?utm_source=businessinsider&utm_medium=referral,neutral,0.9405461549758911
7/15/2023 1:46:44 AM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1032448573,neutral,0.9317126870155334
7/17/2023 2:13:13 PM,"Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more",Seeking Alpha,https://seekingalpha.com/news/3987892-biggest-stock-movers-today-bridgebio-pharma-zai-lab-argenx-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.8726922869682312
7/18/2023 11:00:01 PM,"Abbott seen reporting lower Q2 revenue, due in part to less COVID testing",Seeking Alpha,https://seekingalpha.com/news/3988561-abbott-seen-reporting-lower-q2-revenue-due-in-part-to-less-covid-testing?utm_source=businessinsider&utm_medium=referral,negative,0.9733643531799316
7/19/2023 3:01:13 PM,Abbott Laboratories earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-q2-earnings-preview-1032458813,neutral,0.9313719272613525
7/19/2023 3:12:42 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3988764-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8825733065605164
7/19/2023 3:57:54 PM,Senseonics begun at underperform at Jefferies on glucose monitoring market,Seeking Alpha,https://seekingalpha.com/news/3988786-senseonics-begun-underperform-jefferies-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral,negative,0.6149194836616516
7/20/2023 11:30:59 AM,"Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M",Seeking Alpha,https://seekingalpha.com/news/3989100-abbott-laboratories-non-gaap-eps-of-1_08-beats-0_03-revenue-of-10b-beats-280m?utm_source=businessinsider&utm_medium=referral,neutral,0.6037296056747437
7/20/2023 12:20:21 PM,Abbott Q2 results top consensus as base business offsets COVID impact,Seeking Alpha,https://seekingalpha.com/news/3989128-abbott-q2-beats-consensus-as-base-business-offsets-covid-hit?utm_source=businessinsider&utm_medium=referral,positive,0.9489033222198486
7/20/2023 1:24:00 PM,"4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989180-4-stocks-to-watch-on-thursday-tesla-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9207536578178406
7/20/2023 1:38:34 PM,"Abbott Laboratories Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/abbott-laboratories-q2-profit-decreases-but-beats-estimates-1032462194,negative,0.9702814221382141
7/20/2023 1:50:20 PM,Abbott Laboratories Reaffirms FY23 Adj. EPS Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-reaffirms-fy23-adj-eps-outlook-update-1032462229,neutral,0.9206663370132446
7/21/2023 8:25:50 AM,Wolfe Research upgrades Abbott Labs (ABT) to a Hold,TipRanks,/news/stocks/wolfe-research-upgrades-abbott-labs-abt-to-a-hold-1032465148,positive,0.8070715665817261
7/21/2023 12:07:24 PM,"J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech",Benzinga,/news/stocks/j-j-abbott-labs-and-jpm-among-jim-cramer-s-top-picks-as-market-shifts-focus-from-tech-1032465409,neutral,0.5166470408439636
7/21/2023 12:19:53 PM,Abbott upgraded at Wolfe after Q2 beat,Seeking Alpha,https://seekingalpha.com/news/3989582-abbott-stock-upgraded-wolfe-after-q2-beat?utm_source=businessinsider&utm_medium=referral,positive,0.7139400243759155
7/21/2023 5:00:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-21-2023-1032466422,neutral,0.4909324645996094
7/21/2023 7:18:18 PM,Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024,Benzinga,/news/stocks/abbott-s-higher-than-expected-q2-earnings-analyst-foresees-strong-performance-in-2024-1032466675,positive,0.9540585875511169
7/23/2023 4:00:31 PM,Johnson & Johnson’s Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral,positive,0.913131058216095
7/24/2023 1:45:00 PM,Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday-1032469793,neutral,0.9058380126953125
7/25/2023 1:50:56 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), Marinus (MRNS)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-marinus-mrns-1032471743,neutral,0.6415059566497803
7/26/2023 10:20:25 AM,"Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-moonlake-immunotherapeutics-mltx-abbott-labs-abt-1032478866,neutral,0.5014858841896057
8/5/2023 8:00:22 PM,Medtech set for banner year after significant boost in H1 device approvals,Seeking Alpha,https://seekingalpha.com/news/3997951-medtech-banner-year-significant-boost-h1-device-approvals?utm_source=businessinsider&utm_medium=referral,positive,0.9480461478233337
8/8/2023 1:20:07 AM,"Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-mineralys-therapeutics-inc-mlys-eli-lilly-co-lly-1032525803,neutral,0.7570439577102661
8/11/2023 6:53:19 PM,Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval,Benzinga,/news/stocks/boston-scientific-s-farapulse-eyes-stronger-us-market-position-with-potential-fda-approval-1032547558,positive,0.9547473788261414
8/18/2023 12:31:21 AM,Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035,InvestorPlace,/news/stocks/trillion-dollar-trio-these-3-super-growth-stocks-will-dominate-the-market-by-2035-1032564852,neutral,0.7951418161392212
8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday – Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral,neutral,0.9293889403343201
8/24/2023 2:13:39 PM,U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio,InvestorPlace,/news/stocks/u-s-credit-rating-concerns-here-are-3-stocks-to-protect-your-portfolio-1032580454,neutral,0.9323480725288391
8/29/2023 4:22:54 PM,Abbott a target in proposed baby formula legislation - WSJ,Seeking Alpha,https://seekingalpha.com/news/4007173-abbott-target-in-proposed-baby-formula-legislation?utm_source=businessinsider&utm_medium=referral,neutral,0.8722710609436035
8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral,neutral,0.9078740477561951
9/1/2023 10:00:11 PM,The 3 Most Promising Healthcare Stocks to Own Now,InvestorPlace,/news/stocks/the-3-most-promising-healthcare-stocks-to-own-now-1032600808,neutral,0.6742458343505859
9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral,neutral,0.8714701533317566
9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral,positive,0.9523437023162842
9/5/2023 10:15:07 PM,BTIG Sticks to Their Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/btig-sticks-to-their-buy-rating-for-abbott-labs-abt-1032606990,neutral,0.8102794289588928
9/5/2023 10:30:00 PM,"Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes",PR Newswire,/news/stocks/abbott-to-acquire-bigfoot-biomedical-furthering-efforts-to-develop-personalized-connected-solutions-for-people-with-diabetes-1032606828,positive,0.7857195734977722
9/5/2023 10:53:32 PM,Abbott To Buy Bigfoot Biomedical ,RTTNews,/news/stocks/abbott-to-buy-bigfoot-biomedical-1032606891,neutral,0.933168888092041
9/6/2023 9:50:16 AM,"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Abbott Labs (ABT) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-abbott-labs-abt-and-thermo-fisher-tmo-1032608147,neutral,0.9084482192993164
9/6/2023 5:47:07 PM,DexCom cites rising glucose monitor use amid weight loss therapy,Seeking Alpha,https://seekingalpha.com/news/4009594-dexcom-stock-gains-cgm-use-rises-amid-weight-loss-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9152308702468872
9/7/2023 8:30:50 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abbott Labs (ABT), BridgeBio Pharma (BBIO) and Teladoc (TDOC)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbott-labs-abt-bridgebio-pharma-bbio-and-teladoc-tdoc-1032611842,negative,0.7945948839187622
9/7/2023 5:38:45 PM,"Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use",Seeking Alpha,https://seekingalpha.com/news/4010020-insulet-tandem-drop-weight-loss-drugs-hurt-insulin-use?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9519874453544617
9/8/2023 1:14:42 PM,The 3 Best Pharma Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-3-best-pharma-stocks-to-buy-now-september-2023-1032616131,neutral,0.9364477396011353
9/8/2023 3:56:55 PM,September Rally? 3 Healthcare Stocks to Buy Before Liftoff.,InvestorPlace,/news/stocks/september-rally-3-healthcare-stocks-to-buy-before-liftoff-1032616887,positive,0.737704873085022
9/13/2023 8:29:54 PM,"Abbott recalls certain Proclaim, Infinity neurostimulation devices",Seeking Alpha,https://seekingalpha.com/news/4011571-abbott-recalls-certain-proclaim-infinity-neurostimulation-devices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5921540260314941
9/15/2023 7:46:54 PM,Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch,Benzinga,/news/stocks/apple-taps-seasoned-executive-to-head-secret-team-developing-glucose-monitoring-device---stocks-to-watch-1032634559,neutral,0.7313306331634521
9/19/2023 2:00:00 PM,Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes,PR Newswire,/news/stocks/abbott-and-weightwatchers-connected-app-experience-is-now-available-for-people-living-with-diabetes-1032639654,neutral,0.8488078117370605
9/20/2023 2:00:00 PM,Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets,PR Newswire,/news/stocks/abbott-broadens-access-to-cutting-edge-biosimilars-in-key-emerging-markets-1032643126,positive,0.9134325385093689
9/20/2023 2:34:23 PM,Abbott Inks Deal With MAbxience To Commercialize Biosimilar Molecules In Emerging Markets ,RTTNews,/news/stocks/abbott-inks-deal-with-mabxience-to-commercialize-biosimilar-molecules-in-emerging-markets-1032643311,positive,0.8431673049926758
9/21/2023 6:02:00 PM,Abbott Declares 399th Consecutive Quarterly Dividend,PR Newswire,/news/stocks/abbott-declares-399th-consecutive-quarterly-dividend-1032647755,negative,0.5653847455978394
9/21/2023 6:37:40 PM,3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought,InvestorPlace,/news/stocks/3-unstoppable-nasdaq-100-stocks-just-waiting-to-be-bought-1032648036,neutral,0.8727951645851135
9/22/2023 2:48:00 PM,Abbott Completes Acquisition of Bigfoot Biomedical,PR Newswire,/news/stocks/abbott-completes-acquisition-of-bigfoot-biomedical-1032649630,neutral,0.8847699165344238
9/26/2023 8:30:00 PM,Quant Ratings Updated on 73 Stocks,InvestorPlace,/news/stocks/092623-quant-ratings-1032657450,neutral,0.9228646755218506
9/27/2023 3:00:00 PM,Abbott Hosts Conference Call for Third-Quarter Earnings,PR Newswire,/news/stocks/abbott-hosts-conference-call-for-third-quarter-earnings-1032659339,neutral,0.9299495220184326
10/2/2023 1:20:21 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abbott Labs (ABT), Eli Lilly & Co (LLY) and Rocket Pharmaceuticals (RCKT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbott-labs-abt-eli-lilly-co-lly-and-rocket-pharmaceuticals-rckt-1032670481,negative,0.7999124526977539
10/10/2023 2:06:53 PM,3 Dividend Kings Every Investor Should Own to Survive a Market Crash,InvestorPlace,/news/stocks/3-dividend-kings-every-investor-should-own-to-survive-a-market-crash-1032693057,neutral,0.8802585601806641
10/11/2023 2:53:17 PM,Jim Cramer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business',Benzinga,/news/stocks/jim-cramer-is-a-seller-of-this-company-because-elon-musk-said-that-he-doesn-t-like-that-business-1032696493,neutral,0.5322012901306152
10/12/2023 10:57:02 PM,"As Israel-Palestine Conflict Escalates, Gold Ticks Up  - ETF Winners And Losers: Medium-Cap Returns",Benzinga,/news/etf/as-isreal-palestine-conflict-escalates-gold-ticks-up---etf-winners-and-losers-medium-cap-returns-1032702063,positive,0.8611443638801575
10/12/2023 11:08:12 PM,CGDV: An Outperforming Dividend ETF with Lots to Like,TipRanks,/news/stocks/cgdv-an-outperforming-dividend-etf-with-lots-to-like-1032702142,positive,0.7498170733451843
10/13/2023 10:33:32 PM,"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets",Benzinga,/news/etf/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets-1032705050,negative,0.5841985940933228
10/16/2023 9:46:29 AM,BTIG Reaffirms Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/btig-reaffirms-their-buy-rating-on-abbott-labs-abt-1032707659,neutral,0.8120163679122925
10/16/2023 11:13:22 PM,"Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns",Benzinga,/news/etf/amid-israel-palestine-and-ukraine-gas-gold-up-big-cathie-wood-s-arkk-down-almost-4---etf-winners-and-losers-medium-cap-returns-1032709994,negative,0.9101096391677856
10/17/2023 3:01:13 PM,Abbott Laboratories is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-quarter-earnings-preview-q3-1032712436,neutral,0.9326412081718445
10/18/2023 1:33:34 PM,Abbott Laboratories Q3 Profit Beats Estimates,RTTNews,/news/stocks/abbott-laboratories-q3-profit-beats-estimates-1032716474,negative,0.6737338304519653
10/18/2023 2:54:58 PM,Abbott Laboratories Lifts Midpoint Of FY23 Earnings Outlook Range - Update ,RTTNews,/news/stocks/abbott-laboratories-lifts-midpoint-of-fy23-earnings-outlook-range-update-1032716825,neutral,0.36579328775405884
10/18/2023 5:04:06 PM,"Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday",Benzinga,/news/stocks/abbott-laboratories-nasdaq-spirit-aerosystems-and-other-big-stocks-moving-higher-on-wednesday-1032717758,positive,0.8939594626426697
10/18/2023 8:17:46 PM,Positive Growth Trajectory and Investment Returns Justify Buy Rating for Abbott Labs,TipRanks,/news/stocks/positive-growth-trajectory-and-investment-returns-justify-buy-rating-for-abbott-labs-1032718398,positive,0.8964686989784241
10/19/2023 1:15:48 PM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1032721046,neutral,0.9057888388633728
10/19/2023 2:02:29 PM,"Analysts Are Bullish on Top Healthcare Stocks: SAB Biotherapeutics (SABS), Elevance Health (ELV)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-sab-biotherapeutics-sabs-elevance-health-elv-1032721518,neutral,0.5709096789360046
10/19/2023 6:00:17 PM,Expert Ratings for Abbott Laboratories,Benzinga,/news/stocks/expert-ratings-for-abbott-laboratories-1032721841,neutral,0.8545588850975037
10/19/2023 6:48:18 PM,7 Blue-Chip Stocks to Buy on the Dip,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-on-the-dip-1032722154,neutral,0.6873158812522888
10/19/2023 8:28:20 PM,These Analysts Cut Their Forecasts On Abbott After Q3 Results,Benzinga,/news/stocks/these-analysts-cut-their-forecasts-on-abbott-after-q3-results-1032722131,negative,0.9422916173934937
10/25/2023 12:18:00 AM,Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves,PR Newswire,/news/stocks/late-breaking-data-showcase-the-benefits-of-abbott-s-minimally-invasive-devices-for-people-with-leaky-heart-valves-1032735248,positive,0.922167181968689
10/25/2023 3:27:22 AM,Abbott : Data Showcase Benefits Of Minimally Invasive Devices For People With Leaky Heart Valves ,RTTNews,/news/stocks/abbott-data-showcase-benefits-of-minimally-invasive-devices-for-people-with-leaky-heart-valves-1032735467,positive,0.9106028079986572
10/25/2023 10:17:09 AM,FDA Approves New Therapy For Rare Blood Cancers ,RTTNews,/news/stocks/fda-approves-new-therapy-for-rare-blood-cancers-1032737724,positive,0.7465950846672058
10/25/2023 8:30:00 PM,Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care,PR Newswire,/news/stocks/late-breaking-data-show-esprit-btk-drug-eluting-resorbable-scaffold-reduces-chronic-limb-threatening-ischemia-progression-compared-to-the-standard-of-care-1032740166,positive,0.9441163539886475
10/26/2023 3:00:00 PM,Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem,PR Newswire,/news/stocks/ninety-one-percent-of-young-adults-with-student-loans-say-financial-stress-is-impacting-their-wellness-abbott-launches-blueprint-of-award-winning-program-to-help-companies-tackle-this-problem-1032743944,positive,0.6942754983901978
10/27/2023 11:01:36 AM,"Analysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC), Abbott Labs (ABT) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-blueprint-medicines-bpmc-abbott-labs-abt-and-merck-company-mrk-1032750111,negative,0.6481534242630005
10/27/2023 11:20:40 AM,"Analysts Conflicted on These Healthcare Names: Bicycle Therapeutics (BCYC), Abbott Labs (ABT) and VolitionRX (VNRX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-bicycle-therapeutics-bcyc-abbott-labs-abt-and-volitionrx-vnrx-1032750128,negative,0.5755087733268738
10/27/2023 8:15:50 PM,"MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024",Benzinga,/news/stocks/medtech-giant-dexcom-spotlight-is-on-g7-us-launch-analyst-forecasts-22-revenue-gain-in-2024-1032749666,positive,0.942216694355011
10/31/2023 1:00:00 PM,Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program,PR Newswire,/news/stocks/abbott-and-damar-hamlin-team-up-to-build-heart-health-community-with-new-heartmates-program-1032758858,positive,0.7506558299064636
11/1/2023 1:28:00 PM,Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology,PR Newswire,/news/stocks/abbott-and-sherri-shepherd-millions-not-using-affordable-diabetes-technology-1032764864,neutral,0.7551631927490234
11/2/2023 2:00:00 PM,"Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV",PR Newswire,/news/stocks/abbott-receives-fda-approval-for-hpv-test-to-run-on-alinity-m-offering-primary-hpv-screening-and-assessment-of-high-risk-cancer-causing-types-of-hpv-1032770285,positive,0.8558547496795654
11/2/2023 2:48:45 PM,Abbott Obtains FDA Approval For HPV Test To Run On Alinity M ,RTTNews,/news/stocks/abbott-obtains-fda-approval-for-hpv-test-to-run-on-alinity-m-1032770593,positive,0.7329493165016174
11/2/2023 3:17:56 PM,3 Dividend Stocks That Are Investor Safe Havens,InvestorPlace,/news/stocks/3-dividend-stocks-that-are-investor-safe-havens-1032771288,neutral,0.9251014590263367
11/6/2023 8:48:54 PM,3 Dividend Kings to Buy for Royal Returns,InvestorPlace,/news/stocks/3-dividend-kings-to-buy-for-royal-returns-1032783665,neutral,0.9063794612884521
11/8/2023 12:00:00 PM,Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes,PR Newswire,/news/stocks/participants-in-abbott-s-food-as-medicine-program-showed-clinically-significant-improvements-in-managing-diabetes-1032793532,positive,0.9367004632949829
11/13/2023 3:00:00 PM,Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump,PR Newswire,/news/stocks/late-breaking-data-show-an-aspirin-free-medication-regimen-benefits-people-with-abbott-s-heartmate-3-heart-pump-1032813210,positive,0.9249517917633057
11/13/2023 6:28:41 PM,Abbott Says Aspirin-free Medication Regimen Benefits People With HeartMate 3 Heart Pump ,RTTNews,/news/stocks/abbott-says-aspirin-free-medication-regimen-benefits-people-with-heartmate-3-heart-pump-1032814175,positive,0.8126877546310425
11/22/2023 12:40:38 PM,"Analysts’ Top Healthcare Picks: Morphosys Ag (MOR), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-morphosys-ag-mor-abbott-labs-abt-1032844342,positive,0.6710079312324524
12/7/2023 10:11:15 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arvinas Holding Company (ARVN), Abbott Labs (ABT) and Owens & Minor (OMI)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-arvinas-holding-company-arvn-abbott-labs-abt-and-owens-minor-omi-1032883666,negative,0.7622258067131042
12/13/2023 12:57:06 PM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1032899045,neutral,0.9057888388633728
12/13/2023 5:00:52 PM,Where Abbott Laboratories Stands With Analysts,Benzinga,/news/stocks/where-abbott-laboratories-stands-with-analysts-1032897966,neutral,0.9183946847915649
12/14/2023 10:01:31 AM,"MDT, ABT: 2 Healthcare Dividend Aristocrat Stocks Hedge Funds are Bullish On",TipRanks,/news/stocks/mdt-abt-2-healthcare-dividend-aristocrat-stocks-hedge-funds-are-bullish-on-1032902886,neutral,0.8318912386894226
12/15/2023 5:25:00 PM,Abbott Increases Quarterly Dividend for 52nd Consecutive Year,PR Newswire,/news/stocks/abbott-increases-quarterly-dividend-for-52nd-consecutive-year-1032905469,negative,0.5560858845710754
12/18/2023 3:00:00 PM,Abbott to Present at J.P. Morgan Healthcare Conference,PR Newswire,/news/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference-1032908978,neutral,0.9324039220809937
12/19/2023 9:40:58 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Ascom Holding AG (OtherACMLF),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-ascom-holding-ag-otheracmlf-1032914124,neutral,0.9136022329330444
12/27/2023 7:37:23 PM,Silver Economy Successes: 3 Stocks Benefitting From an Aging Population,InvestorPlace,/news/stocks/silver-economy-successes-3-stocks-benefitting-from-an-aging-population-1032928709,positive,0.676877498626709
12/28/2023 1:33:14 PM,"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts",Benzinga,/news/stocks/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-street-s-most-accurate-analysts-1032929866,neutral,0.8699533939361572
12/31/2023 10:10:57 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Keros Therapeutics (KROS) and Xencor (XNCR)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-keros-therapeutics-kros-and-xencor-xncr-1032934194,neutral,0.902580738067627
1/2/2024 2:20:36 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Keros Therapeutics (KROS) and Xencor (XNCR)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-keros-therapeutics-kros-and-xencor-xncr-1032938368,neutral,0.902580738067627
1/3/2024 7:00:17 PM,Beyond The Numbers: 5 Analysts Discuss Abbott Laboratories Stock,Benzinga,/news/stocks/beyond-the-numbers-5-analysts-discuss-abbott-laboratories-stock-1032940947,neutral,0.9446669816970825
1/4/2024 8:15:28 AM,Abbott Labs (ABT) Gets a Buy from Raymond James,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-raymond-james-1032944359,positive,0.6176379323005676
1/11/2024 12:27:40 PM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1032961211,neutral,0.9317126870155334
1/19/2024 2:38:28 PM,Abbott TriClip device set for FDA panel review in February,Seeking Alpha,https://seekingalpha.com/news/4056457-abbott-triclip-device-set-for-fda-panel-review-in-february?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9166210889816284
1/19/2024 8:00:29 PM,"Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional",Seeking Alpha,https://seekingalpha.com/news/4056553-catalyst-watch-tesla-netflix-and-procter-gamble-head-into-the-earnings-confessional?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9108691811561584
1/21/2024 1:00:00 PM,"Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more",Seeking Alpha,https://seekingalpha.com/news/4056510-earnings-week-ahead-tesla-netflix-att-johnson-johnson-general-electric-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9366969466209412
1/22/2024 3:23:05 PM,"BoFA picks Johnson & Johnson, Halliburton and Tesla for options opportunity ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4056847-bofa-picks-johnson-johnson-halliburton-and-tesla-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8573930263519287
1/22/2024 7:34:59 PM,"S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?",Benzinga,/news/etf/stock-indexes-trade-at-all-time-highs-ahead-of-key-earnings-this-week-what-s-driving-markets-monday-1032984660,neutral,0.7300136089324951
1/23/2024 3:45:41 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4057415-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.855887770652771
1/23/2024 4:10:51 PM,"Samsung, Apple race to shake up glucose monitoring market: Bloomberg",Seeking Alpha,https://seekingalpha.com/news/4057426-samsung-apple-race-shake-up-glucose-monitoring-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8274732828140259
1/23/2024 7:11:06 PM,Earnings preview: Abbott slated to roll out Q4 results Wednesday,Seeking Alpha,https://seekingalpha.com/news/4057173-abbott-slated-to-roll-out-q4-earnings-report-wednesday-morning?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8467704653739929
1/23/2024 7:56:11 PM,7 Safe-Haven Stocks to Protect Your Portfolio During a Recession,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-protect-your-portfolio-during-a-recession-1032989306,neutral,0.8730661273002625
1/23/2024 8:56:53 PM,"Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst",Benzinga,/news/stocks/arterial-device-focused-inari-medical-likely-acquisition-target-shares-are-attractively-valued-analyst-1032989277,positive,0.8427152037620544
1/24/2024 12:33:04 PM,"Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4057763-abbott-laboratories-non-gaap-eps-of-1_19-in-line-revenue-of-10_24b-beats-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5552171468734741
1/24/2024 1:00:56 PM,Abbott in charts: Medical Devices and Nutrition segment maintains double-digit growth momentum in Q4,Seeking Alpha,https://seekingalpha.com/news/4057771-abbott-in-charts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.953548789024353
1/24/2024 1:13:12 PM,Abbott  Q4 beat driven by MedTech,Seeking Alpha,https://seekingalpha.com/news/4057797-abbott-stock-slips-medtech-drives-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8322364687919617
1/24/2024 1:37:22 PM,"Abbott Laboratories Q4 Profit Increases, Inline With Estimates",RTTNews,/news/stocks/abbott-laboratories-q4-profit-increases-inline-with-estimates-1032991993,positive,0.947444498538971
1/24/2024 1:38:11 PM,Abbott Laboratories Guides FY24 Adj. EPS In Line With Estimates - Update ,RTTNews,/news/stocks/abbott-laboratories-guides-fy24-adj-eps-in-line-with-estimates-update-1032991992,neutral,0.8832758069038391
1/24/2024 8:38:32 PM,"Stock Market Extends Record Highs, S&P 500 Hits 4,900 On Tech Rally, Microsoft's $3 Trillion Mark: What's Driving Markets Wednesday?",Benzinga,/news/stocks/stock-market-extends-record-highs-s-p-500-hits-4-900-on-tech-rally-microsoft-s-3-trillion-mark-what-s-driving-markets-wednesday-1032993924,neutral,0.7138470411300659
1/24/2024 11:55:47 PM,Buy Rating Affirmed for Abbott Labs on Solid Core Growth and Positive Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-labs-on-solid-core-growth-and-positive-outlook-1032994488,positive,0.9499137997627258
1/25/2024 2:31:52 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: BridgeBio Pharma (BBIO) and Abbott Labs (ABT),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bridgebio-pharma-bbio-and-abbott-labs-abt-1032995094,negative,0.9286149740219116
1/25/2024 10:50:29 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and AbbVie (ABBV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-elevance-health-elv-and-abbvie-abbv-1032996806,neutral,0.9162739515304565
1/25/2024 12:10:53 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Kura Oncology (KURA) and Exelixis (EXEL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-kura-oncology-kura-and-exelixis-exel-1032997520,neutral,0.9133087992668152
1/25/2024 12:26:51 PM,RBC Capital Sticks to Its Buy Rating for Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-labs-abt-1032997592,positive,0.6241188049316406
1/25/2024 2:00:52 PM,Cracking The Code: Understanding Analyst Reviews For Abbott Laboratories,Benzinga,/news/stocks/cracking-the-code-understanding-analyst-reviews-for-abbott-laboratories-1032996472,neutral,0.8931127786636353
1/26/2024 5:50:28 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-johnson-johnson-jnj-and-abbott-labs-abt-1032999669,negative,0.933806836605072
1/26/2024 8:11:36 AM,"Analysts Are Bullish on These Healthcare Stocks: Abbott Labs (ABT), Travere Therapeutics (TVTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-abbott-labs-abt-travere-therapeutics-tvtx-1033000235,neutral,0.5571914315223694
1/29/2024 1:07:57 AM,7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market,InvestorPlace,/news/stocks/7-agetech-stocks-to-profit-from-the-booming-longevity-market-1033003308,positive,0.8413674235343933
1/29/2024 2:10:18 AM,"Analysts’ Top Healthcare Picks: Abbott Labs (ABT), eFFECTOR Therapeutics (EFTR)",TipRanks,/news/stocks/analysts-top-healthcare-picks-abbott-labs-abt-effector-therapeutics-eftr-1033003492,positive,0.593125581741333
1/31/2024 3:56:09 PM,Abbott launches nutritional brand for GLP-1 users (update),Seeking Alpha,https://seekingalpha.com/news/4060732-abbott-launches-nutritional-product-brand-for-glp-1-users?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8129065036773682
1/31/2024 5:07:52 PM,Abbott Launches New Protality Brand High-protein Nutrition Shake ,RTTNews,/news/stocks/abbott-launches-new-protality-brand-high-protein-nutrition-shake-1033016128,neutral,0.6364004611968994
1/31/2024 11:03:00 PM,"LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer?",TipRanks,/news/stocks/lly-abt-cvs-which-healthcare-stock-do-analysts-prefer-1033017434,neutral,0.937714159488678
2/1/2024 6:22:16 PM,"Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan",Seeking Alpha,https://seekingalpha.com/news/4061498-lilly-zoetis-abbott-least-shorted-stocks-in-health-sector-till-mid-jan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7107202410697937
2/2/2024 11:40:11 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT), Sanofi (OtherSNYNF) and Siemens Healthineers AG (OtherSEMHF)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abbott-labs-abt-sanofi-othersnynf-and-siemens-healthineers-ag-othersemhf-1033025267,negative,0.9324604272842407
2/2/2024 5:20:25 PM,"Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade",Seeking Alpha,https://seekingalpha.com/news/4062258-edwards-stock-jumps-on-fda-approval-wells-fargo-upgrade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9136335849761963
2/7/2024 11:00:00 AM,7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates,InvestorPlace,/news/stocks/7-tremendous-dividend-stocks-with-double-digit-5-year-growth-rates-1033039781,positive,0.8215591907501221
2/7/2024 3:11:06 PM,Insulet gets CE Mark for Ominipod 5 with FreeStyle Libre 2 sensor,Seeking Alpha,https://seekingalpha.com/news/4063877-insulet-gets-ce-mark-for-ominipod-5-with-freestyle-libre-2-sensor?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6019042134284973
2/9/2024 6:55:19 PM,Positive Outlook for Abbott Labs on TriClip Device Efficacy and Anticipated FDA Approval,TipRanks,/news/stocks/positive-outlook-for-abbott-labs-on-triclip-device-efficacy-and-anticipated-fda-approval-1033052585,positive,0.9316767454147339
2/11/2024 11:51:00 AM,3 Groundbreaking Healthcare Stocks to Buy for Robust Gains,InvestorPlace,/news/stocks/3-groundbreaking-healthcare-stocks-to-buy-for-robust-gains-1033053334,positive,0.8651124835014343
2/12/2024 10:50:12 AM,"Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-mckesson-mck-embecta-corporation-embc-and-abbott-labs-abt-1033056910,neutral,0.9164335131645203
2/14/2024 2:01:00 AM,FDA Panel Votes In Favor Of Abbott's TriClip System To Treat Leaky Tricuspid Heart Valve ,RTTNews,/news/stocks/fda-panel-votes-in-favor-of-abbott-s-triclip-system-to-treat-leaky-tricuspid-heart-valve-1033063333,positive,0.6992468237876892
2/14/2024 10:51:24 AM,"Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Abbott Labs (ABT) and Chemed (CHE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-elevance-health-elv-abbott-labs-abt-and-chemed-che-1033066460,neutral,0.9142130017280579
2/14/2024 11:38:56 AM,Wells Fargo Keeps Their Buy Rating on Abbott Labs (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-labs-abt-1033066815,neutral,0.9057888388633728
2/14/2024 11:41:19 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Edwards Lifesciences (EW) and Coya Therapeutics, Inc. (COYA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-edwards-lifesciences-ew-and-coya-therapeutics-inc-coya-1033066810,neutral,0.918390691280365
2/14/2024 11:53:36 AM,Abbott wins FDA AdComm backing for heart device,Seeking Alpha,https://seekingalpha.com/news/4066606-abbott-wins-fda-adcomm-backing-for-triclip?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8823026418685913
2/14/2024 12:20:13 PM,"Analysts Are Bullish on These Healthcare Stocks: QuidelOrtho (QDEL), Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-quidelortho-qdel-abbott-labs-abt-1033067335,neutral,0.6399156451225281
2/14/2024 12:51:10 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Madrigal Pharmaceuticals (MDGL) and Biogen (BIIB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-madrigal-pharmaceuticals-mdgl-and-biogen-biib-1033067461,neutral,0.9086589813232422
2/14/2024 4:43:00 PM,CDC to relax COVID isolation requirements: WaPo,Seeking Alpha,https://seekingalpha.com/news/4066920-cdc-to-relax-covid-isolation-requirements?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8257278203964233
2/16/2024 3:40:26 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4068270-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9257774949073792
2/18/2024 5:00:00 PM,Medtronic Q3 in focus amid MedTech’s post-COVID gains,Seeking Alpha,https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6916518211364746
2/18/2024 8:20:31 PM,3 Cash Cows to Boost Your Confidence During the February Chill,InvestorPlace,/news/stocks/3-cash-cows-to-boost-your-confidence-during-the-february-chill-1033078339,positive,0.8716313242912292
2/22/2024 10:04:58 AM,FDA warns against use of smartwatches to measure blood glucose,Seeking Alpha,https://seekingalpha.com/news/4070135-fda-warns-against-use-of-smartwatches-to-measure-blood-glucose?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8038713932037354
2/23/2024 12:05:00 PM,Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth,InvestorPlace,/news/stocks/recession-proof-riches-7-stocks-to-buy-for-bulletproof-portfolio-growth-1033097068,neutral,0.9154767990112305
2/23/2024 7:03:31 PM,Abbott Laboratories' stock trades in the green for seven straight sessions,Seeking Alpha,https://seekingalpha.com/news/4071277-abbott-laboratories-stock-on-track-for-seventh-straight-session-of-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6441401839256287
2/26/2024 11:30:36 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-celldex-cldx-abbott-labs-abt-and-morphic-holding-morf-1033102868,negative,0.793403685092926
2/26/2024 11:45:20 AM,Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar.,InvestorPlace,/news/stocks/looking-for-growth-7-hot-trends-that-have-been-flying-under-investors-radar-1033102094,neutral,0.7569406032562256
2/26/2024 7:44:36 PM,3 Blue-Chip Stocks to Buy to Bolster Your Portfolio,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-bolster-your-portfolio-1033104264,neutral,0.6486648917198181
2/29/2024 11:50:51 AM,"Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-sensei-biotherapeutics-snse-abbott-labs-abt-and-personalis-psnl-1033118667,neutral,0.9106428623199463
3/6/2024 4:40:54 PM,"Abbott: FreeStyle Libre Systems, GLP-1 Medicines Together Is Beneficial For Type 2 Diabetes Patients ",RTTNews,/news/stocks/abbott-freestyle-libre-systems-glp-1-medicines-together-is-beneficial-for-type-2-diabetes-patients-1033138489,positive,0.6807148456573486
3/6/2024 7:43:57 PM,3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates,InvestorPlace,/news/stocks/3-dividend-aristocrats-with-the-largest-10-year-dividend-growth-rates-1033139286,neutral,0.8020398020744324
3/6/2024 10:48:40 PM,"FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's",Benzinga,/news/stocks/fda-approval-for-dexcom-s-stelo-opens-continuous-glucose-monitoring-to-masses-analyst-expects-competitive-pricing-against-abbott-s-1033139550,positive,0.899543046951294
3/7/2024 10:56:04 AM,Abbott Labs (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-wells-fargo-1033142271,positive,0.6979659795761108
3/11/2024 8:45:47 PM,Abbott recalls HeartMate Touch System over software glitch,Seeking Alpha,https://seekingalpha.com/news/4078186-abbott-recalls-heartmate-touch-system-over-software-glitch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9348849058151245
3/12/2024 9:20:08 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-incyte-incy-fortrea-holdings-inc-ftre-and-abbott-labs-abt-1033154762,negative,0.9153742790222168
3/12/2024 11:13:03 AM,Walgreens settles with New York over price gauging on baby formula,Seeking Alpha,https://seekingalpha.com/news/4078327-walgreens-settles-new-york-baby-formula-pricing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9071986079216003
3/13/2024 10:30:00 AM,SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster,InvestorPlace,/news/stocks/schd-etf-spotlight-the-top-6-stocks-inside-this-dividend-monster-1033158747,neutral,0.9299678206443787
3/15/2024 2:00:27 PM,Jury orders Reckitt Benckiser to pay $60M in baby formula case,Seeking Alpha,https://seekingalpha.com/news/4079971-jury-orders-reckitt-benckiser-to-pay-60m-in-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9363531470298767
3/15/2024 4:09:20 PM,Abbott falls after setback to Reckitt Benckiser in baby formula case,Seeking Alpha,https://seekingalpha.com/news/4080064-abbott-stock-falls-60m-jury-award-reckitt?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9548841118812561
3/15/2024 10:00:41 PM,"Perrigo has no exposure to infant formula litigation, CG says",Seeking Alpha,https://seekingalpha.com/news/4080219-perrigo-has-no-exposure-to-infant-formula-litigation-cg-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330218434333801
3/18/2024 5:04:35 PM,Reckitt unsure how many cases have been filed over Enfamil: report,Seeking Alpha,https://seekingalpha.com/news/4080676-reckitt-unsure-how-many-cases-have-been-filed-over-enfamil-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7626233696937561
3/21/2024 6:22:02 PM,3 Resilient Stocks to Protect Your Wealth During a Recession,InvestorPlace,/news/stocks/3-resilient-stocks-to-protect-your-wealth-during-a-recession-1033186337,neutral,0.7702451944351196
3/21/2024 9:26:33 PM,3 Stocks to Buy Right Now for the Coming Recession,InvestorPlace,/news/stocks/3-stocks-to-buy-right-now-for-the-coming-recession-1033186702,neutral,0.913196325302124
3/25/2024 6:04:05 PM,More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’,InvestorPlace,/news/stocks/more-than-86-of-analysts-who-cover-these-3-stocks-rate-them-a-buy-1033194410,neutral,0.8478237390518188
3/26/2024 8:47:13 AM,Abbott Labs (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-labs-abt-gets-a-buy-from-wells-fargo-1033196453,positive,0.6979659795761108
3/26/2024 11:45:00 AM,Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval,InvestorPlace,/news/stocks/winning-over-wall-street-3-stocks-earning-overwhelming-analyst-approval-1033196438,positive,0.8925063014030457
3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9371159076690674
3/29/2024 2:51:29 PM,3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List,InvestorPlace,/news/stocks/3-strong-buy-healthcare-stocks-to-add-to-your-q2-must-watch-list-1033208715,neutral,0.8121646046638489
4/1/2024 1:52:48 PM,Abbott gets FDA clearance for i-STAT TBI cartridge for concussions,Seeking Alpha,https://seekingalpha.com/news/4085621-abbott-gets-fda-clearance-for-i-stat-tbi-cartridge-for-concussions?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9156471490859985
4/1/2024 3:30:07 PM,Abbott: I-STAT TBI Cartridge Receives FDA Clearance To Be Used With Whole Blood ,RTTNews,/news/stocks/abbott-i-stat-tbi-cartridge-receives-fda-clearance-to-be-used-with-whole-blood-1033211108,positive,0.6368401050567627
4/2/2024 2:03:08 PM,Abbott wins FDA approval for heart valve repair device,Seeking Alpha,https://seekingalpha.com/news/4086362-abbott-wins-fda-approval-for-heart-valve-repair-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8641467094421387
4/2/2024 3:38:10 PM,Abbott Says FDA Approves First-of-Its-Kind TriClip Transcatheter Edge-to-edge Repair System ,RTTNews,/news/stocks/abbott-says-fda-approves-first-of-its-kind-triclip-transcatheter-edge-to-edge-repair-system-1033215117,positive,0.7276505827903748
4/2/2024 11:05:21 PM,Buy Rating Affirmed for Abbott Labs Following TriClip’s Favorable FDA Approval and Market Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-labs-following-triclip-s-favorable-fda-approval-and-market-outlook-1033216886,positive,0.9501491189002991
4/3/2024 6:00:24 PM,Analyst Ratings For Abbott Laboratories,Benzinga,/news/stocks/analyst-ratings-for-abbott-laboratories-1033219910,neutral,0.9048534035682678
4/4/2024 8:08:02 AM,Buy Rating Reaffirmed for Abbott Labs Amid Strong Growth and New Product Launches,TipRanks,/news/stocks/buy-rating-reaffirmed-for-abbott-labs-amid-strong-growth-and-new-product-launches-1033221957,positive,0.9500692486763
4/9/2024 3:10:29 PM,"Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'",Benzinga,/news/stocks/jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stock-s-been-a-horse-1033233438,negative,0.751442551612854
4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450,neutral,0.9137315154075623
4/12/2024 7:00:09 PM,"Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",Seeking Alpha,https://seekingalpha.com/news/4089283-catalyst-watch-boeing-hearing-bitcoin-halving-event-and-new-eyes-on-reddit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9150035381317139
4/14/2024 12:00:00 PM,"Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4089249-earnings-week-ahead-bac-jnj-tsm-unh-abt-slb-ual-pg-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9342080354690552
4/14/2024 9:56:08 PM,"Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",Seeking Alpha,https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8204345703125
4/15/2024 3:54:34 PM,Netflix and United Airlines to report highest move post earnings: BofA,Seeking Alpha,https://seekingalpha.com/news/4089597-bofa-picks-ppg-industries-netflix-and-united-airlines-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6894614100456238
4/15/2024 5:28:34 PM,"Abbott, Thoratec recall HeartMate ventricular systems due to obstruction issue",Seeking Alpha,https://seekingalpha.com/news/4089709-abbott-thoratec-recall-heartmate-ventricular-systems-due-obstruction-issue?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9157903790473938
4/16/2024 5:10:06 PM,Abbott Q1 Earnings Preview: Return of core business strength could benefit top line,Seeking Alpha,https://seekingalpha.com/news/4090186-abbott-q1-earnings-preview-return-of-core-business-strength-could-benefit-top-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9531357884407043
4/17/2024 7:59:17 AM,RBC Capital Remains a Buy on Abbott Labs (ABT),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-abbott-labs-abt-1033257345,neutral,0.9317126870155334
4/17/2024 11:31:30 AM,"Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges",Seeking Alpha,https://seekingalpha.com/news/4090384-abbott-laboratories-non-gaap-eps-of-098-beats-by-003-raises-midpoint-of-fy-guidance-ranges?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.737888753414154
4/17/2024 11:47:26 AM,Abbott in charts: Q1 sees strong results in Medical Devices and Established Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/4090393-abbott-in-charts-q1-sees-strong-results-in-medical-devices-and-established-pharmaceuticals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9541076421737671
4/17/2024 12:32:52 PM,Abbott posts Q1 beat on MedTech even as diagnostics slump,Seeking Alpha,https://seekingalpha.com/news/4090419-abbott-stock-slips-q1-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7654085755348206
4/17/2024 1:22:00 PM,"5 stocks to watch on Wednesday: LLY, ABT and more",Seeking Alpha,https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.927644670009613
4/17/2024 1:33:26 PM,Abbott Laboratories Reports Fall In Q1 Bottom Line,RTTNews,/news/stocks/abbott-laboratories-reports-fall-in-q1-bottom-line-1033257438,negative,0.9752029776573181
4/17/2024 2:45:00 PM,Abbott Laboratories hosts conference call for investors,Markets Insider Automation,/news/stocks/abbott_laboratories_conference-1029943629,neutral,0.9366424083709717
4/17/2024 3:52:50 PM,"ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/abt-stock-earnings-abbott-laboratories-for-q1-of-2024-1033258773,positive,0.6985978484153748
4/17/2024 4:07:53 PM,Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings,Benzinga,/news/stocks/dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings-1033258475,positive,0.7776228189468384
4/17/2024 8:09:41 PM,"Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?",Benzinga,/news/stocks/stocks-fall-as-geopolitics-economic-worries-spook-investors-chipmakers-sell-off-bitcoin-tumbles-to-60-000-what-s-driving-markets-wednesday-1033259256,negative,0.9107943177223206
4/18/2024 9:56:56 AM,Strong Q1 Performance and Growth Prospects Justify Buy Rating for Abbott Labs,TipRanks,/news/stocks/strong-q1-performance-and-growth-prospects-justify-buy-rating-for-abbott-labs-1033262046,positive,0.9478806257247925
4/18/2024 9:58:02 AM,Buy Rating Affirmed: Abbott Labs Outperforms with Strong Q1 Sales and Upward Earnings Revision,TipRanks,/news/stocks/buy-rating-affirmed-abbott-labs-outperforms-with-strong-q1-sales-and-upward-earnings-revision-1033262198,positive,0.942864179611206
4/18/2024 10:00:59 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-labs-abt-us-physical-therapy-usph-1033262193,positive,0.5008850693702698
4/19/2024 1:30:56 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-elevance-health-elv-1033264552,neutral,0.9059872031211853
4/19/2024 7:19:41 PM,At least 70% of the S&P 500 names that reported results this week topped estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4091620-at-least-70-of-the-sp-500-names-that-reported-results-this-week-topped-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8400577902793884
4/22/2024 6:50:43 AM,"Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-terns-pharmaceuticals-tern-abbott-labs-abt-and-arcutis-biotherapeutics-arqt-1033270142,negative,0.6875969171524048
4/22/2024 7:50:34 AM,Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-labs-abt-and-eli-lilly-co-lly-1033270364,neutral,0.9201853275299072
4/22/2024 12:00:00 PM,3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip,InvestorPlace,/news/stocks/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip-1033270787,negative,0.9647071361541748
4/23/2024 8:41:25 PM,Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes,InvestorPlace,/news/stocks/dividend-growth-stars-7-stocks-with-10-year-double-digit-rate-hikes-1033278029,positive,0.8532738089561462
4/26/2024 4:09:22 PM,"ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?",TipRanks,/news/stocks/abt-dhr-dxcm-which-strong-buy-healthcare-stock-has-more-upside-1033295655,neutral,0.8182680010795593
4/29/2024 1:24:45 PM,"DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo",Seeking Alpha,https://seekingalpha.com/news/4095444-dexcom-insulet-tandem-benefitting-most-diabetes-survey?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8844127655029297
4/29/2024 1:53:17 PM,Abbott gets FDA approval for Esprit BTK stent for PAD,Seeking Alpha,https://seekingalpha.com/news/4095497-abbott-gets-fda-approval-for-esprit-btk-stent-for-pad?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8382262587547302
4/29/2024 4:10:21 PM,Abbott's Dissolving Stent For People With Chronic Limb-Threatening Ischemia Gets FDA Nod ,RTTNews,/news/stocks/abbott-s-dissolving-stent-for-people-with-chronic-limb-threatening-ischemia-gets-fda-nod-1033300966,positive,0.7672152519226074
4/30/2024 10:00:00 AM,7 Defensive Stocks Built to Withstand the Market’s Worst Storms,InvestorPlace,/news/stocks/7-defensive-stocks-built-to-withstand-the-markets-worst-storms-1033305170,positive,0.7114676833152771
4/30/2024 10:20:55 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-labs-abt-iterum-therapeutics-itrm-1033306721,positive,0.48663538694381714
5/1/2024 7:57:17 PM,Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge,InvestorPlace,/news/stocks/stock-market-crash-alert-3-must-buy-healthcare-stocks-when-prices-plunge-1033315341,neutral,0.7271759510040283
5/7/2024 12:06:46 PM,RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-laboratories-abt-1033340710,neutral,0.9118766784667969
5/15/2024 3:21:16 PM,"Abbott recalls HeartMate 3 over potential blood leakage, air issues",Seeking Alpha,https://seekingalpha.com/news/4106629-abbott-recalls-heartmate-3-potential-blood-leakage-air-issues?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9391229748725891
5/15/2024 9:47:35 PM,Tudor Investment's top buys and sells in Q1,Seeking Alpha,https://seekingalpha.com/news/4107057-tudor-investments-top-buys-and-sells-in-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.894081711769104
5/16/2024 8:15:56 AM,Buy Recommendation for Abbott Laboratories Backed by Strong Sales Growth and Promising Pipeline,TipRanks,/news/stocks/buy-recommendation-for-abbott-laboratories-backed-by-strong-sales-growth-and-promising-pipeline-1033392275,positive,0.9458135962486267
5/20/2024 8:15:18 AM,Buy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth Prospects,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-based-on-strong-ep-business-and-strategic-growth-prospects-1033402951,positive,0.9519922137260437
5/20/2024 9:50:12 AM,"Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-abbott-laboratories-abt-polypid-pypd-and-goodrx-holdings-gdrx-1033403235,negative,0.7809761166572571
5/20/2024 11:20:28 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-immunocore-holdings-imcr-and-madrigal-pharmaceuticals-mdgl-1033403918,neutral,0.9191172122955322
5/20/2024 6:47:45 PM,3 S&P 500 Stocks That Have Proven Themselves Recession-Proof,InvestorPlace,/news/stocks/3-sp-500-stocks-that-have-proven-themselves-recession-proof-1033404557,neutral,0.39710932970046997
5/21/2024 2:32:23 PM,Reckitt Benckiser ticks higher amid report activist Eminence Capital takes stake,Seeking Alpha,https://seekingalpha.com/news/4108852-reckitt-benckiser-ticks-higher-amid-report-activist-eminence-capital-takes-stake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5601346492767334
5/22/2024 8:00:46 PM,Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know,Benzinga,/news/stocks/critical-insights-from-abbott-laboratories-analyst-ratings-what-you-need-to-know-1033412958,neutral,0.9356042146682739
5/27/2024 4:39:32 PM,Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches,InvestorPlace,/news/stocks/blue-chip-bonanza-3-stocks-to-ride-the-markets-coattails-to-riches-1033424830,neutral,0.7499858140945435
5/27/2024 4:46:20 PM,Reliable Rewards: 7 Dividend Stocks to Count On in Any Market,InvestorPlace,/news/stocks/reliable-rewards-7-dividend-stocks-to-count-on-in-any-market-1033424860,neutral,0.8468716740608215
5/28/2024 10:45:00 AM,Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024 ,InvestorPlace,/news/stocks/wall-street-favorites-3-healthcare-stocks-with-strong-buy-ratings-for-may-2024-1033426464,positive,0.6321777701377869
5/29/2024 6:30:56 PM,The 3 Best MedTech Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/the-3-best-medtech-stocks-to-buy-now-may-2024-1033433166,neutral,0.9321695566177368
5/30/2024 8:25:42 AM,Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects,TipRanks,/news/stocks/optimistic-buy-rating-for-abbott-laboratories-on-diverse-portfolio-and-growth-prospects-1033435660,positive,0.8646665811538696
6/3/2024 4:37:47 PM,"Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues (UPDATED)",Benzinga,/news/etf/berkshire-hathaway-chipotle-more-nyse-stocks-hit-with-trading-halts-triggered-by-technical-issues-1033446452,negative,0.893263041973114
6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9165980219841003
6/4/2024 9:35:53 AM,Buy Rating Affirmed for Abbott Laboratories Amid Lingo CGM Market Expansion Opportunity,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-lingo-cgm-market-expansion-opportunity-1033449297,positive,0.926828920841217
6/4/2024 12:21:07 PM,"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Eledon Pharmaceuticals (ELDN) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-eledon-pharmaceuticals-eldn-and-abbott-laboratories-abt-1033450389,neutral,0.9100415110588074
6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8358550071716309
6/6/2024 9:40:27 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033457301,positive,0.5521676540374756
6/6/2024 9:33:43 PM,Abbott Is Considered a Good Investment by Brokers: Is That True?,Benzinga,/news/stocks/abbott-is-considered-a-good-investment-by-brokers-is-that-true-1033459085,neutral,0.8560395240783691
6/7/2024 10:08:34 AM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Growth and Manageable Litigation Risks,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-growth-and-manageable-litigation-risks-1033461142,positive,0.9481211304664612
6/7/2024 11:10:00 AM,The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash,InvestorPlace,/news/stocks/the-dividend-darlings-3-stocks-that-will-shower-your-portfolio-with-cash-1033460743,neutral,0.9295212626457214
6/10/2024 12:50:03 PM,Abbott receives FDA clearance for new continuous glucose monitoring systems,Seeking Alpha,https://seekingalpha.com/news/4114458-abbott-receives-fda-clearance-for-new-continuous-glucose-monitoring-systems?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8982443809509277
6/10/2024 3:29:58 PM,"Abbott's Lingo, Libre Rio OTC Continuous Glucose Monitoring Systems Gets FDA Clearance ",RTTNews,/news/stocks/abbott-s-lingo-libre-rio-otc-continuous-glucose-monitoring-systems-gets-fda-clearance-1033465675,positive,0.7310235500335693
6/11/2024 9:26:02 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033468697,neutral,0.9142151474952698
6/13/2024 10:08:08 AM,"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Abbott Laboratories (ABT) and Dyne Therapeutics (DYN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-abbott-laboratories-abt-and-dyne-therapeutics-dyn-1033476155,negative,0.7128984332084656
6/13/2024 7:05:33 PM,Abbott Gets FDA Nod for Two Glucose Monitoring Systems,Benzinga,/news/stocks/abbott-gets-fda-nod-for-two-glucose-monitoring-systems-1033477443,positive,0.8210534453392029
6/14/2024 4:25:51 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4116301-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9257774949073792
6/20/2024 9:05:17 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033492716,neutral,0.8139292597770691
6/24/2024 10:16:28 AM,Buy Rating on Abbott Laboratories Amid Strong Growth Prospects and Strategic Innovation,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-amid-strong-growth-prospects-and-strategic-innovation-1033500017,positive,0.9470236897468567
6/24/2024 11:25:20 AM,TD Cowen Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/td-cowen-keeps-their-buy-rating-on-abbott-laboratories-abt-1033500534,neutral,0.9042991399765015
6/24/2024 3:25:55 PM,Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income,InvestorPlace,/news/stocks/hot-summer-dividends-3-sizzling-stocks-to-buy-for-reliable-income-1033500901,neutral,0.9036083817481995
6/24/2024 9:21:13 PM,Abbott's EPD Expansion Continues Despite FX Headwind,Benzinga,/news/stocks/abbott-s-epd-expansion-continues-despite-fx-headwind-1033501456,positive,0.9536787867546082
6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7290321588516235
7/1/2024 10:00:00 AM,3 MedTech Stocks to Buy for Healthy Gains,InvestorPlace,/news/stocks/3-medtech-stocks-to-buy-for-healthy-gains-1033518933,positive,0.7338675260543823
7/2/2024 11:00:39 AM,Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-abbott-laboratories-abt-1033523589,neutral,0.9072347283363342
7/2/2024 11:01:57 AM,Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-springworks-therapeutics-swtx-1033523577,neutral,0.9094269871711731
7/2/2024 5:02:12 PM,7 Analysts Have This To Say About Abbott Laboratories,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-abbott-laboratories-1033523740,neutral,0.9152542352676392
7/2/2024 8:45:00 PM,7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-will-have-investors-in-high-yield-heaven-1033524556,neutral,0.8748617172241211
7/4/2024 10:35:00 AM,The 3 Best Healthcare Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-3-best-healthcare-stocks-to-buy-in-july-2024-1033529151,neutral,0.878911018371582
7/5/2024 8:58:12 PM,"DexCom, Abbott to Launch First FDA Cleared OTC CGMs",Benzinga,/news/stocks/dexcom-abbott-to-launch-first-fda-cleared-otc-cgms-1033532913,positive,0.5547037124633789
7/9/2024 9:28:00 AM,Buy Rating Justified: Abbott Laboratories Poised to Surpass Q2 Expectations Amid Robust Core Growth and Solid Segment Performance,TipRanks,/news/stocks/buy-rating-justified-abbott-laboratories-poised-to-surpass-q2-expectations-amid-robust-core-growth-and-solid-segment-performance-1033539300,positive,0.9496086239814758
7/10/2024 7:22:59 PM,7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-for-positive-inflation-adjusted-returns-1033544701,neutral,0.5849413871765137
7/11/2024 8:15:19 AM,Buy Rating Affirmed for Abbott Laboratories Amidst Strong Growth and Manageable Risks,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amidst-strong-growth-and-manageable-risks-1033546616,positive,0.950738787651062
7/11/2024 9:16:13 PM,Wall Street Bulls Look Optimistic About Abbott: Should You Buy?,Benzinga,/news/stocks/wall-street-bulls-look-optimistic-about-abbott-should-you-buy-1033548448,neutral,0.883317768573761
7/12/2024 7:00:29 PM,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",Seeking Alpha,https://seekingalpha.com/news/4123992-catalyst-watch-netflix-taiwan-semi-amazon-and-hashicorp-are-in-the-spotlight?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9270133972167969
7/13/2024 2:47:00 PM,Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4124042-wall-street-closes-higher-as-financials-stocks-deliver-profits-with-a-rebound-in-investments-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9113971590995789
7/13/2024 3:00:00 PM,The 7 Most Undervalued Healthcare Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-healthcare-stocks-to-buy-in-july-2024-1033551810,neutral,0.752497673034668
7/14/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4124006-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9305751323699951
7/15/2024 12:27:33 PM,Abbott Laboratories (ABT) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-hold-from-morgan-stanley-1033556072,neutral,0.8945943117141724
7/16/2024 5:01:00 PM,"Incyte, Moderna among most shorted S&P 500 healthcare stocks in June",Seeking Alpha,https://seekingalpha.com/news/4124310-incyte-moderna-among-most-shorted-sp-500-healthcare-stocks-in-june?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8085746169090271
7/17/2024 2:51:20 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/4125062-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8825733065605164
7/17/2024 3:01:13 PM,What Wall Street expects from Abbott Laboratories's earnings,Markets Insider Automation,/news/stocks/abbott_laboratories-stock-price-quarter-earnings-preview-q2-1033563972,neutral,0.9230455160140991
7/17/2024 5:14:43 PM,Abbott Q2 Earnings Preview: Strong fundamentals to see through a good quarter,Seeking Alpha,https://seekingalpha.com/news/4125139-abbott-q2-earnings-preview-strong-fundamentals-to-see-through-a-good-quarter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9420979619026184
7/18/2024 9:05:12 AM,Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/abbott-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033567040,neutral,0.9325259327888489
7/18/2024 11:31:16 AM,"Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.4B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4125401-abbott-laboratories-non-gaap-eps-of-1_14-beats-0_04-revenue-of-10_4b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7004014849662781
7/18/2024 11:47:33 AM,"Earnings Summary: Abbott Laboratories tops consensus in Q2, raises FY2024 EPS outlook",Seeking Alpha,https://seekingalpha.com/news/4125413-earnings-summary-abbott-laboratories-tops-consensus-in-q2-raises-fy2024-eps-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.932166576385498
7/18/2024 12:00:41 PM,Abbott Laboratories in charts: Medical Devices maintains Y/Y double-digit growth momentum in Q2,Seeking Alpha,https://seekingalpha.com/news/4125421-abbott-laboratories-in-charts-medical-devices-maintains-yy-double-digit-growth-momentum-in-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.953064501285553
7/18/2024 1:05:24 PM,Abbott raises 2024 outlook after MedTech strength in Q2,Seeking Alpha,https://seekingalpha.com/news/4125472-abbott-stock-on-watch-after-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9213208556175232
7/18/2024 1:07:08 PM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Financials and Growth Potential,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-financials-and-growth-potential-1033569706,positive,0.9507032632827759
7/18/2024 1:15:00 PM,"4 stocks to watch on Thursday: NFLX, AMZN and more",Seeking Alpha,https://seekingalpha.com/news/4125483-4-stocks-to-watch-on-thursday-nflx-amzn-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9344262480735779
7/18/2024 1:36:23 PM,"Abbott Laboratories Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/abbott-laboratories-q2-profit-decreases-but-beats-estimates-1033568024,negative,0.9702814221382141
7/18/2024 1:52:04 PM,Abbott Laboratories Boosts FY24 Earnings Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy24-earnings-outlook-update-1033568058,positive,0.7718651294708252
7/18/2024 2:06:53 PM,Least shorted S&P 500 stocks in June,Seeking Alpha,https://seekingalpha.com/news/4125485-least-shorted-sp-500-stocks-in-june?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6751642227172852
7/18/2024 3:52:56 PM,"ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024",InvestorPlace,/news/stocks/abt-stock-earnings-abbott-laboratories-for-q2-of-2024-1033569690,positive,0.7139059901237488
7/18/2024 7:16:25 PM,7 Safe Stocks to Buy for Volatility Insurance,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-for-volatility-insurance-1033570022,neutral,0.9153096675872803
7/18/2024 8:05:29 PM,"VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?",Benzinga,/news/etf/vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-what-s-driving-markets-thursday-1033569954,negative,0.5287970304489136
7/18/2024 8:15:22 PM,Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance,TipRanks,/news/stocks/buy-rating-affirmed-on-abbott-laboratories-amid-strong-q2-results-and-raised-2024-guidance-1033570345,positive,0.9448807835578918
7/19/2024 10:07:48 AM,Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects,TipRanks,/news/stocks/maintained-buy-rating-for-abbott-laboratories-on-strong-financials-and-growth-prospects-1033572319,positive,0.9407118558883667
7/19/2024 12:56:30 PM,Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-abbott-laboratories-abt-1033573145,neutral,0.9139055013656616
7/22/2024 5:50:56 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-elevance-health-elv-cvs-health-cvs-and-abbott-laboratories-abt-1033576809,negative,0.7395073771476746
7/24/2024 8:18:53 PM,7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio,InvestorPlace,/news/stocks/7-trustworthy-dividend-stocks-to-steadily-build-your-portfolio-1033590875,positive,0.798680305480957
7/26/2024 2:15:20 PM,Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?,InvestorPlace,/news/stocks/dexcom-dxcm-stock-is-plunging-on-an-execution-miss-what-is-really-going-on-1033600870,negative,0.9539040923118591
7/26/2024 7:55:04 PM,DexCom reaches a multi-year low as downgrades follow guidance cut,Seeking Alpha,https://seekingalpha.com/news/4129136-dexcom-stock-falls-downgrades-guidance-cut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.966895341873169
7/27/2024 12:07:00 AM,Abbott Labs falls after jury awards plaintiff $495M in damages in baby formula case (update),Seeking Alpha,https://seekingalpha.com/news/4129212-abbott-labs-falls-after-jury-awards-plaintiff-95m-in-damages-in-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9371793270111084
7/27/2024 9:07:04 AM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-cvs-health-cvs-and-tempest-therapeutics-tpst-1033602051,neutral,0.9200308918952942
7/29/2024 8:16:29 AM,Barclays Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033605625,neutral,0.8432604074478149
7/29/2024 10:16:39 AM,Buy Rating for Abbott Laboratories Amid Manageable Litigation Costs and Strong Financial Position,TipRanks,/news/stocks/buy-rating-for-abbott-laboratories-amid-manageable-litigation-costs-and-strong-financial-position-1033606374,positive,0.9503312110900879
7/29/2024 10:51:28 AM,Analysts Offer Insights on Healthcare Companies: 2seventy bio (TSVT) and Abbott Laboratories (ABT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-2seventy-bio-tsvt-and-abbott-laboratories-abt-1033606482,neutral,0.9043883681297302
7/29/2024 1:50:18 PM,3 High-Yield Dividend Stocks That Are Looking Super Hot,InvestorPlace,/news/stocks/3-high-yield-dividend-stocks-that-are-looking-super-hot-1033606477,neutral,0.6259255409240723
7/29/2024 2:06:09 PM,"Biggest stock movers today: Crypto stocks, PBI, PHG, and more",Seeking Alpha,https://seekingalpha.com/news/4129324-biggest-stock-movers-today-pbi-phg-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.931006133556366
7/29/2024 2:50:19 PM,Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.,InvestorPlace,/news/stocks/abbott-labs-abt-stock-falls-on-baby-formula-ruling-what-to-know-1033606979,negative,0.816034197807312
7/29/2024 3:09:06 PM,Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?,InvestorPlace,/news/stocks/why-is-cognition-therapeutics-cgtx-stock-down-33-today-1033607106,negative,0.9667888283729553
7/29/2024 3:30:21 PM,Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?,InvestorPlace,/news/stocks/why-is-nls-pharmaceutics-nlsp-stock-up-48-today-1033607284,positive,0.82442706823349
7/29/2024 5:00:58 PM,Abbott likely to settle baby formula cases for $200M-$300M - analyst,Seeking Alpha,https://seekingalpha.com/news/4129595-abbott-likely-to-settle-baby-formula-cases-for-200m-300m-analyst?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9137294292449951
7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457,neutral,0.5478202104568481
8/2/2024 6:31:20 PM,"DexCom, Abbott to benefit from the multi-billion-dollar OTC continuous glucose market",Seeking Alpha,https://seekingalpha.com/news/4133543-dexcom-abbott-benefit-multi-billion-dollar-otc-continuous-glucose-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8049856424331665
8/3/2024 6:44:06 PM,CVS stores in some cities run out of COVID tests as cases spike: Bloomberg,Seeking Alpha,https://seekingalpha.com/news/4133678-cvs-stores-in-some-cities-run-out-covid-tests?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9595591425895691
8/6/2024 2:50:34 PM,Abbott to collaborate with Cadrenal on anticoagulant tecarfarin,Seeking Alpha,https://seekingalpha.com/news/4134945-abbott-collaborate-cadrenal-anticoagulant-tecarfarin?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7158508896827698
8/7/2024 12:35:41 PM,Abbott to integrate CGM with Medtronic's insulin delivery devices,Seeking Alpha,https://seekingalpha.com/news/4135909-abbott-to-integrate-cgm-system-with-medtronics-insulin-delivery-devices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6433109641075134
8/7/2024 1:23:06 PM,Medtronic wins FDA approval for Simplera CGM,Seeking Alpha,https://seekingalpha.com/news/4135964-medtronic-wins-fda-approval-for-simplera-cgm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8995899558067322
8/7/2024 2:31:01 PM,Medtronic Announces FDA Approval Of Simplera CGM; Partners With Abbott To Expand CGM Options ,RTTNews,/news/stocks/medtronic-announces-fda-approval-of-simplera-cgm-partners-with-abbott-to-expand-cgm-options-1033652368,positive,0.9367755651473999
8/8/2024 11:55:27 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033661521,neutral,0.9037943482398987
8/14/2024 5:41:54 PM,WHO declares mpox in Africa is a global health emergency,Seeking Alpha,https://seekingalpha.com/news/4139935-who-declares-mpox-in-africa-is-a-global-health-emergency?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7608998417854309
8/15/2024 3:06:09 PM,Medtronic upgraded at UBS on diabetes turnaround,Seeking Alpha,https://seekingalpha.com/news/4140605-medtronic-stock-upgraded-ubs-diabetes-unit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7982872724533081
8/15/2024 7:29:14 PM,First mpox case outside Africa reported amid ongoing outbreak,Seeking Alpha,https://seekingalpha.com/news/4140735-first-mpox-case-outside-africa-reported?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7429543137550354
8/16/2024 4:12:26 PM,Bavarian Nordic stock jumps 16% on EMA mpox vaccine update,Seeking Alpha,https://seekingalpha.com/news/4141101-bavarian-nordic-stock-jumps-on-ema-mpox-vaccine-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9088444709777832
8/16/2024 5:48:20 PM,European health authority sees mpox having low impact if precautions taken,Seeking Alpha,https://seekingalpha.com/news/4141150-european-health-authority-sees-mpox-having-low-impact-if-precautions-taken?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7506622076034546
8/19/2024 7:07:33 PM,Small-cap and mid-cap Health Care has room to rally - Roth MKM,Seeking Alpha,https://seekingalpha.com/news/4141609-small-cap-and-mid-cap-health-care-has-room-to-rally-roth-mkm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7902520298957825
8/20/2024 10:20:47 AM,"WHO official says mpox is 'not the new COVID,' calls for coordinated response",Seeking Alpha,https://seekingalpha.com/news/4141757-who-official-says-mpox-is-not-the-new-covid-calls-for-coordinated-response?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.770865797996521
8/22/2024 11:02:57 AM,Bavarian Nordic rebounds as new mpox vaccine order boosts outlook,Seeking Alpha,https://seekingalpha.com/news/4142726-bavarian-nordic-stock-gains-outlook-boost?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8126012086868286
8/22/2024 1:14:36 PM,Mpox stocks in focus as Thailand reports first case in Asia linked to new strain,Seeking Alpha,https://seekingalpha.com/news/4142799-mpox-stocks-in-focus-thailand-reports-first-case-in-asia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5467913150787354
8/23/2024 5:54:10 PM,U.S. to restart free COVID test program as cases spike,Seeking Alpha,https://seekingalpha.com/news/4143466-us-to-deliver-free-covid-tests-cases-spike?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8563349843025208
8/26/2024 3:58:52 PM,Tonix stock jumps on collaboration for mpox vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/4143842-tonix-stock-jumps-on-collaboration-for-mpox-vaccine-candidate?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5407641530036926
8/26/2024 8:20:15 PM,Labcorp considering ramping up mpox testing capacity: report,Seeking Alpha,https://seekingalpha.com/news/4143930-labcorp-considering-ramping-up-mpox-testing-capacity-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6021162867546082
8/26/2024 9:04:36 PM,"Trinity stock soars post-market on raised guidance, increased capacity",Seeking Alpha,https://seekingalpha.com/news/4143955-trinity-stock-soars-post-market-on-raised-guidance-increased-capacity?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9532179832458496
8/27/2024 12:25:43 PM,Hold Rating on Abbott Laboratories Amid NEC Litigation Uncertainties,TipRanks,/news/stocks/hold-rating-on-abbott-laboratories-amid-nec-litigation-uncertainties-1033726095,negative,0.8095055222511292
8/31/2024 9:33:09 PM,UNICEF issues emergency tender to secure mpox vaccines,Seeking Alpha,https://seekingalpha.com/news/4145755-unicef-issues-emergency-tender-to-secure-mpox-vaccines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5117928385734558
9/3/2024 11:35:34 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033744243,neutral,0.9037943482398987
9/5/2024 3:05:45 PM,Bavarian Nordic stock slides on Moderna mpox vaccine study,Seeking Alpha,https://seekingalpha.com/news/4147363-bavarian-nordic-stock-slides-on-moderna-mpox-vaccine-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8279843330383301
9/5/2024 3:37:07 PM,"Abbott launches over-the-counter glucose monitor, Lingo",Seeking Alpha,https://seekingalpha.com/news/4147380-abbott-launches-over-the-counter-glucose-monitor?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8808402419090271
9/6/2024 9:49:16 AM,Abbott Laboratories (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-wells-fargo-1033753680,positive,0.6329850554466248
9/6/2024 7:45:48 PM,Applied DNA stock jumps amid U.S. government mpox update,Seeking Alpha,https://seekingalpha.com/news/4147758-applied-dna-stock-jumps-amid-us-government-mpox-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8269884586334229
9/10/2024 9:51:01 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033760316,neutral,0.9142151474952698
9/10/2024 9:58:07 AM,Hold Rating on Abbott Laboratories Amid Lingo’s Launch: Balancing Positive User Experience with Market Challenges,TipRanks,/news/stocks/hold-rating-on-abbott-laboratories-amid-lingo-s-launch-balancing-positive-user-experience-with-market-challenges-1033760520,positive,0.8941754102706909
9/12/2024 7:17:29 PM,Morocco reports first mpox case amid ongoing global outbreak,Seeking Alpha,https://seekingalpha.com/news/4149235-morocco-reports-first-mpox-case-amid-ongoing-outbreak?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8323554396629333
9/15/2024 10:17:50 AM,Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-abbott-laboratories-abt-1033772039,neutral,0.9037943482398987
9/15/2024 1:36:00 PM,Least shorted S&P 500 stocks in August,Seeking Alpha,https://seekingalpha.com/news/4149788-least-shorted-sp-500-stocks-in-august?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.590275764465332
9/16/2024 2:49:45 PM,Moderna was most shorted S&P 500 healthcare stock in August for second consecutive month,Seeking Alpha,https://seekingalpha.com/news/4149983-moderna-was-most-shorted-sp-500-healthcare-stock-in-august-for-second-consecutive-month?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8436502814292908
9/17/2024 11:52:23 AM,Senseonics Eversense 365 glucose monitor cleared in the U.S.,Seeking Alpha,https://seekingalpha.com/news/4150260-senseonics-stock-gains-on-fda-nod-for-eversense-365?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7625424265861511
9/18/2024 10:36:34 AM,Abbott Laboratories (ABT) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-wells-fargo-1033780375,positive,0.6329850554466248
9/19/2024 9:05:49 AM,Buy Rating on Abbott Laboratories: Undervalued with Strong Growth Prospects Despite NEC Litigation,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-undervalued-with-strong-growth-prospects-despite-nec-litigation-1033783088,positive,0.9532350897789001
9/19/2024 4:22:40 PM,Abbott a new overweight at Piper Sandler; at attractive entry point,Seeking Alpha,https://seekingalpha.com/news/4151231-abbott-new-overweight-piper-sandler-attractive-entry-point?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9399719834327698
9/19/2024 5:20:13 PM,Abbott Laboratories declares $0.55 dividend,Seeking Alpha,https://seekingalpha.com/news/4151296-abbott-laboratories-declares-0_55-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9257774949073792
9/26/2024 2:27:27 PM,Piper Sandler’s Triple Select Stocks for September,Seeking Alpha,https://seekingalpha.com/news/4153735-piper-sandlers-triple-select-stocks-for-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9192052483558655
9/30/2024 9:07:31 AM,Wells Fargo Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-remains-a-buy-on-abbott-laboratories-abt-1033807258,neutral,0.9142151474952698
9/30/2024 7:44:27 PM,"Abbott, Reckitt trial over infant formula safety starts in Missouri: report",Seeking Alpha,https://seekingalpha.com/news/4154711-abbott-reckitt-trial-over-infant-formula-safety-starts-in-missouri-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8740665316581726
10/3/2024 8:15:16 AM,Buy Rating on Abbott Laboratories: Strong Performance and Positive Outlook Amid New Product Launches,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-strong-performance-and-positive-outlook-amid-new-product-launches-1033817795,positive,0.9548743963241577
10/4/2024 10:10:54 AM,WHO approves first mpox diagnostic test for emergency use,Seeking Alpha,https://seekingalpha.com/news/4156362-who-approves-first-mpox-diagnostic-test-for-emergency-use?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8712428212165833
10/4/2024 12:10:21 PM,"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Altimmune (ALT) and Steris (STE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-altimmune-alt-and-steris-ste-1033821800,neutral,0.9099294543266296
10/7/2024 10:05:52 AM,Buy Rating Affirmed for Abbott Laboratories Amid Strong Performance and Favorable Market Trends,TipRanks,/news/stocks/buy-rating-affirmed-for-abbott-laboratories-amid-strong-performance-and-favorable-market-trends-1033824701,positive,0.9508317708969116
10/8/2024 4:38:24 PM,"Abbott started at outperform by Oppenheimer, diversified portfolio cited",Seeking Alpha,https://seekingalpha.com/news/4157059-abbott-started-at-outperform-by-oppenheimer-diversified-portfolio-cited?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.545927107334137
10/11/2024 8:56:18 AM,Buy Rating on Abbott Laboratories: Swift Clinical Advances and Strategic International Expansion,TipRanks,/news/stocks/buy-rating-on-abbott-laboratories-swift-clinical-advances-and-strategic-international-expansion-1033838296,positive,0.8161213994026184
10/11/2024 7:00:23 PM,"Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil",Seeking Alpha,https://seekingalpha.com/news/4157956-catalyst-watch-netflix-earnings-lenovo-tech-event-paris-motor-show-and-eyes-on-oil?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9386246800422668
10/13/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4157923-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-pg-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9303746819496155
10/14/2024 2:42:56 PM,Earnings Scorecard: 7 out of 8 S&P 500 companies deliver EPS wins this week,Seeking Alpha,https://seekingalpha.com/news/4157977-7-out-of-8-sp-500-companies-deliver-eps-wins-this-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.816309928894043
10/15/2024 6:02:21 PM,Abbott Laboratories Q3 Earnings Preview: Profit boost expected,Seeking Alpha,https://seekingalpha.com/news/4161998-abbott-laboratories-q3-earnings-preview-profit-boost-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8516650795936584
10/15/2024 6:35:59 PM,Moderna continues to be the most shorted S&P 500 healthcare stock in September,Seeking Alpha,https://seekingalpha.com/news/4162080-moderna-continues-to-be-the-most-shorted-sp-500-healthcare-stock-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4814412295818329
10/15/2024 10:00:02 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4161921-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330109357833862
10/16/2024 11:32:31 AM,"Abbott Laboratories Non-GAAP EPS of $1.21 beats by $0.01, revenue of $10.64B beats by $90M",Seeking Alpha,https://seekingalpha.com/news/4163981-abbott-laboratories-non-gaap-eps-of-1_21-beats-0_01-revenue-of-10_64b-beats-90m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6362866759300232
10/16/2024 11:48:24 AM,"Earnings Snapshot: Abbott Laboratories beats consensus in Q3, tightens FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4164066-earnings-snapshot-abbott-laboratories-beats-consensus-in-q3-tightens-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9240420460700989
10/16/2024 11:59:35 AM,Abbott in charts: Medical Devices sales sustain double-digit Y/Y growth with an 11.7% rise in Q3,Seeking Alpha,https://seekingalpha.com/news/4164147-abbott-in-charts-medical-devices-sales-sustain-double-digit-yy-growth-with-an-117-rise-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9550213813781738
10/16/2024 12:21:26 PM,"Abbott raises earnings outlook as MedTech, Pharma drive Q3 beat",Seeking Alpha,https://seekingalpha.com/news/4164061-abbott-stock-slips-despite-q3-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8627923130989075
10/16/2024 12:58:00 PM,"4 stocks to watch on Wednesday: INTC, MS and more",Seeking Alpha,https://seekingalpha.com/news/4164649-4-stocks-to-watch-on-wednesday-intc-ms-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9222428202629089
10/16/2024 1:34:20 PM,"Abbott Laboratories Q3 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/abbott-laboratories-q3-profit-increases-beats-estimates-1033850935,positive,0.9387333989143372
10/16/2024 1:47:28 PM,Abbott Laboratories Boosts FY24 Earnings Outlook - Update ,RTTNews,/news/stocks/abbott-laboratories-boosts-fy24-earnings-outlook-update-1033850980,positive,0.7718651294708252
10/16/2024 4:21:34 PM,Least shorted S&P 500 stocks in September,Seeking Alpha,https://seekingalpha.com/news/4166027-least-shorted-sp-500-stocks-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6412530541419983
10/16/2024 7:55:12 PM,Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-growth-prospects-and-strategic-positioning-drive-buy-rating-1033853121,positive,0.889696478843689
10/16/2024 8:25:11 PM,Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges,TipRanks,/news/stocks/cautious-outlook-on-abbott-laboratories-amid-mixed-financials-and-legal-challenges-1033853132,negative,0.9262685775756836
10/16/2024 8:35:11 PM,Abbott Laboratories: Strong Financial Performance and Growth Potential Justify Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-financial-performance-and-growth-potential-justify-buy-rating-1033853141,positive,0.8619629740715027
10/16/2024 8:35:21 PM,Abbott Laboratories: Balanced Prospects Lead to Hold Recommendation Amid Market Adjustments,TipRanks,/news/stocks/abbott-laboratories-balanced-prospects-lead-to-hold-recommendation-amid-market-adjustments-1033853140,positive,0.9387431740760803
10/17/2024 9:36:48 AM,Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook,TipRanks,/news/stocks/abbott-laboratories-buy-rating-reaffirmed-amid-strong-medical-device-performance-and-positive-long-term-growth-outlook-1033855406,positive,0.9525552988052368
10/17/2024 10:29:54 AM,Abbott Laboratories: Strong Buy Rating Driven by Robust Growth Prospects and Operational Improvements,TipRanks,/news/stocks/abbott-laboratories-strong-buy-rating-driven-by-robust-growth-prospects-and-operational-improvements-1033855721,positive,0.9408988356590271
10/17/2024 10:31:11 AM,Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential,TipRanks,/news/stocks/travis-steed-reiterates-buy-rating-on-abbott-laboratories-amid-promising-growth-and-under-ownership-potential-1033855713,positive,0.8122113943099976
10/17/2024 10:32:01 AM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-abbott-laboratories-abt-1033855705,neutral,0.9061751365661621
10/17/2024 10:46:51 AM,RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-abbott-laboratories-abt-1033855802,neutral,0.9118766784667969
10/17/2024 10:48:34 AM,Abbott Laboratories (ABT) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-piper-sandler-1033855778,positive,0.5491982698440552
10/17/2024 10:48:42 AM,Goldman Sachs Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/goldman-sachs-remains-a-buy-on-abbott-laboratories-abt-1033855776,neutral,0.9234120845794678
10/17/2024 12:05:47 PM,Oppenheimer Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1033856376,neutral,0.8572916388511658
10/17/2024 12:08:01 PM,Citi Keeps Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-abbott-laboratories-abt-1033856346,neutral,0.9074901938438416
10/19/2024 1:30:00 PM,Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4175834-over-60-of-companies-that-reported-earnings-this-week-beat-eps-and-revenue-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5201920866966248
10/24/2024 1:10:27 PM,Abbott initiates clinical trial of its CardioMems in advanced heart failure,TipRanks,/news/stocks/abbott-initiates-clinical-trial-of-its-cardiomems-in-advanced-heart-failure-1033887963,neutral,0.7335690259933472
10/25/2024 5:34:10 PM,Apple reportedly tests a blood sugar app,Seeking Alpha,https://seekingalpha.com/news/4206329-apple-tests-blood-sugar-app?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8509774208068848
10/28/2024 6:25:27 PM,"Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott",TipRanks,/news/stocks/raymond-james-says-edwards-early-tavr-data-also-positive-for-medtronic-abbott-1033904067,positive,0.9422356486320496
10/30/2024 7:30:10 PM,Edwards Life says pivotal study for Evoque hit one-year goal,Seeking Alpha,https://seekingalpha.com/news/4225583-edwards-lifesciences-hit-main-goal-evoque?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7029521465301514
10/31/2024 2:20:04 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033922447,neutral,0.8139292597770691
10/31/2024 2:20:06 AM,"Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-united-therapeutics-uthr-abbott-laboratories-abt-1033922446,neutral,0.4751727283000946
10/31/2024 9:02:23 PM,"Abbott jumps as jury says company, Reckitt not liable in infant formula case",Seeking Alpha,https://seekingalpha.com/news/4231746-abbott-jumps-as-jury-says-company-reckitt-not-liable-in-infant-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6365126371383667
11/1/2024 9:20:18 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-bristol-myers-squibb-bmy-abbott-laboratories-abt-and-merck-company-mrk-1033936132,negative,0.7605414986610413
11/1/2024 11:55:11 AM,"Abbott, Mead Johnson secure win in infant formula trial, Reuters reports",TipRanks,/news/stocks/abbott-mead-johnson-secure-win-in-infant-formula-trial-reuters-reports-1033937199,neutral,0.5252480506896973
11/1/2024 12:12:35 PM,Oppenheimer Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1033937779,neutral,0.860661506652832
11/1/2024 12:55:57 PM,"Morning Movers: Apple dips, Amazon gains after earnings",TipRanks,/news/stocks/morning-movers-apple-dips-amazon-gains-after-earnings-1033937927,negative,0.870512843132019
11/1/2024 1:12:35 PM,Abbott shares rise following baby formula verdict,Seeking Alpha,https://seekingalpha.com/news/4233379-abbott-shares-rise-following-baby-formula-verdict?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6449881792068481
11/1/2024 3:00:13 PM,"Biggest stock movers Friday: AMZN, INTC, ABT, and more",Seeking Alpha,https://seekingalpha.com/news/4232637-biggest-stock-movers-friday-amzn-intc-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.909888505935669
11/4/2024 11:46:13 AM,Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating,TipRanks,/news/stocks/abbott-laboratories-legal-victory-strengthens-future-outlook-and-supports-buy-rating-1033944528,positive,0.9527600407600403
11/4/2024 12:26:23 PM,Abbott price target raised to $149 from $143 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-149-from-143-at-barclays-1033945017,positive,0.9433051347732544
11/5/2024 10:35:25 AM,Abbott price target raised to $149 from $143 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-149-from-143-at-barclays-1033951682,positive,0.9433051347732544
11/6/2024 4:56:17 PM,"Tandem, Insulet draw bullish views at Bernstein ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4256070-tandem-insulet-stocks-rated-bullish-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8682629466056824
11/17/2024 6:50:37 AM,First mpox case linked to African outbreak reported in U.S.,Seeking Alpha,https://seekingalpha.com/news/4298232-first-mpox-case-african-outbreak-reported-us?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6968551278114319
11/17/2024 2:36:26 PM,Wells Fargo Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034027537,neutral,0.6807262897491455
11/19/2024 5:45:42 PM,Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules,TipRanks,/news/stocks/trump-trade-president-elect-seeks-to-kill-biden-fuel-efficiency-rules-1034038710,negative,0.7241331934928894
11/20/2024 9:57:32 AM,Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1034041869,neutral,0.8106676936149597
11/20/2024 3:06:06 PM,Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor ,RTTNews,/news/stocks/insulet-says-omnipod-5-aid-system-now-compatible-with-abbott-s-freestyle-libre-2-plus-cgm-sensor-1034042208,positive,0.7979446649551392
11/20/2024 3:43:32 PM,Insulet's Omnipod 5 now compatible with Abbott's FreeStyle Libre 2 Plus,Seeking Alpha,https://seekingalpha.com/news/4312299-insulets-omnipod-5-now-compatible-with-abbotts-freestyle-libre-2-plus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.605710506439209
11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7575292587280273
11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9368929862976074
11/23/2024 7:48:06 PM,WHO extends mpox emergency; Canada reports first clade I case,Seeking Alpha,https://seekingalpha.com/news/4325199-who-extends-mpox-emergency-canada-reports-first-clade-i-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8505131006240845
11/25/2024 5:15:10 PM,Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories,TipRanks,/news/stocks/strategic-initiatives-and-innovations-drive-buy-rating-for-abbott-laboratories-1034062647,positive,0.7331221699714661
11/26/2024 8:11:25 PM,"Judge denies Abbott request for retrial, lower damages in $500M baby formula case",Seeking Alpha,https://seekingalpha.com/news/4337061-judge-denies-abbott-request-for-retrial-lower-damages-in-500m-baby-formula-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8842268586158752
11/27/2024 4:21:49 PM,‘Bunker’ and ‘Booster’ stocks in the U.S. – Which would perform better in a downturn vs. upturn?,Seeking Alpha,https://seekingalpha.com/news/4340374-bunker-and-booster-stocks-in-the-us-which-would-perform-better-in-a-downturn-vs-upturn?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5655573010444641
12/3/2024 10:46:39 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034091545,neutral,0.8139292597770691
12/3/2024 11:47:42 AM,Piper Sandler Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/piper-sandler-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034092013,neutral,0.8045165538787842
12/10/2024 3:10:25 PM,"ADA guidelines ‘a positive step’ towards coverage, says Wells Fargo",TipRanks,/news/stocks/ada-guidelines-a-positive-step-towards-coverage-says-wells-fargo-1034120812,positive,0.9053623080253601
12/11/2024 12:46:27 PM,Oppenheimer Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/oppenheimer-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034125527,neutral,0.7630217671394348
12/13/2024 4:05:49 PM,Abbott increases quarterly dividend 7.3% to 59c per share,TipRanks,/news/stocks/abbott-increases-quarterly-dividend-7-3-to-59c-per-share-1034136621,positive,0.8996683955192566
12/13/2024 4:19:43 PM,Abbott Laboratories raises dividend by 7.3% to $0.59,Seeking Alpha,https://seekingalpha.com/news/4386424-abbott-laboratories-raises-dividend-by-73-to-059?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8977124094963074
12/17/2024 1:18:38 PM,Abbott Completes In-human Left Bundle Branch Area Pacing Procedures Using AVEIR CSP Pacemaker ,RTTNews,/news/stocks/abbott-completes-in-human-left-bundle-branch-area-pacing-procedures-using-aveir-csp-pacemaker-1034145202,neutral,0.8063260912895203
12/18/2024 3:37:04 PM,Least shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387575-least-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6016122102737427
12/18/2024 9:15:27 PM,Abbott Laboratories (ABT) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-piper-sandler-1034153489,positive,0.5491982698440552
12/20/2024 6:10:56 PM,"Analysts Are Bullish on These Healthcare Stocks: Veru (VERU), Ascendis Pharma (ASND)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-veru-veru-ascendis-pharma-asnd-1034163825,neutral,0.6879838109016418
12/23/2024 12:35:16 PM,Abbott Laboratories (ABT) Receives a Buy from Wells Fargo,TipRanks,/news/stocks/abbott-laboratories-abt-receives-a-buy-from-wells-fargo-1034168340,positive,0.7100810408592224
12/23/2024 9:15:37 PM,Abbott in settlement with DexCom over continuous glucose monitors,Seeking Alpha,https://seekingalpha.com/news/4390352-abbott-settlement-dexcom-continuous-glucose-monitors?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8871091604232788
12/24/2024 10:30:08 AM,"DexCom, Abbott agree to settle patent litigation",TipRanks,/news/stocks/dexcom-abbott-agree-to-settle-patent-litigation-1034171025,positive,0.704572319984436
12/24/2024 3:15:22 PM,"Abbott, DexCom settlement ‘not a complete surprise,’ says Wells Fargo",TipRanks,/news/stocks/abbott-dexcom-settlement-not-a-complete-surprise-says-wells-fargo-1034171972,positive,0.6828129887580872
12/30/2024 10:35:11 AM,Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-reaffirms-their-buy-rating-on-abbott-laboratories-abt-1034179399,neutral,0.8106676936149597
1/2/2025 11:41:01 AM,Abbott price target raised to $136 from $128 at Evercore ISI,TipRanks,/news/stocks/abbott-price-target-raised-to-136-from-128-at-evercore-isi-1034186788,positive,0.9446403980255127
1/3/2025 8:00:09 PM,"Catalyst Watch: CES, M&A votes and the Supreme Court tackles the TikTok case",Seeking Alpha,https://seekingalpha.com/news/4392381-catalyst-watch-ces-ma-votes-and-the-supreme-court-tackles-the-tiktok-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8224062323570251
1/6/2025 5:52:14 PM,"FDA issues first draft guidance on use of AI in drug, medical device development",Seeking Alpha,https://seekingalpha.com/news/4392790-fda-issues-first-draft-guidance-use-ai-drug-medical-device-development?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9278177618980408
1/7/2025 12:06:05 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034197494,neutral,0.8139292597770691
1/8/2025 1:46:42 AM,RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034202967,neutral,0.5079269409179688
1/8/2025 11:56:55 AM,Bernstein Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/bernstein-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034205502,neutral,0.8178604245185852
1/8/2025 11:31:17 PM,Abbott price target lowered to $135 from $138 at Bernstein,TipRanks,/news/stocks/abbott-price-target-lowered-to-135-from-138-at-bernstein-1034208056,negative,0.6405333876609802
1/13/2025 10:26:27 PM,Insulet Omnipod 5 insulin system available in five more European countries,Seeking Alpha,https://seekingalpha.com/news/4394746-insulet-omnipod-5-insulin-system-available-five-more-european-countries?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8089600205421448
1/16/2025 11:10:11 AM,"Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Gilead Sciences (GILD) and Abbott Laboratories (ABT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insmed-insm-gilead-sciences-gild-and-abbott-laboratories-abt-1034235445,neutral,0.9201869368553162
1/16/2025 4:30:04 PM,Least shorted S&P 500 stocks in December,Seeking Alpha,https://seekingalpha.com/news/4395791-least-shorted-sp-500-stocks-in-december?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5818331837654114
1/17/2025 8:00:19 PM,"Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility",Seeking Alpha,https://seekingalpha.com/news/4396184-catalyst-watch-netflix-earnings-monster-beverage-event-drug-data-and-quantum-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8700590133666992
1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772,neutral,0.4902459383010864
1/18/2025 6:05:00 PM,14 out of 20 names post earnings beat with blockbuster wins from banks-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4396193-14-out-of-20-names-post-earnings-beat-with-blockbuster-wins-from-banks-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5247626900672913
1/19/2025 1:12:00 PM,"Earnings week ahead: JNJ, NFLX, AAL, UAL, AXP, ABT, VZ, PG, and more",Seeking Alpha,https://seekingalpha.com/news/4396093-earnings-week-ahead-jnj-nflx-aal-ual-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.933464527130127
1/21/2025 1:48:23 AM,Abbott Laboratories (ABT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/abbott-laboratories-abt-gets-a-buy-from-rbc-capital-1034246834,neutral,0.7834472060203552
1/21/2025 5:45:00 PM,Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/4396470-top-seeking-alpha-quant-picks-in-technology-ahead-of-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5815476179122925
1/21/2025 6:45:12 PM,Notable companies reporting before tomorrow’s open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034251583,neutral,0.9220908284187317
1/21/2025 7:01:41 PM,Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025,Seeking Alpha,https://seekingalpha.com/news/4397028-abbott-laboratories-set-for-stellar-q4-2024-earnings-amid-optimism-for-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8932476043701172
1/21/2025 11:00:20 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4396897-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330109357833862
1/22/2025 12:03:37 PM,"Abbott Laboratories Non-GAAP EPS of $1.34 in-line, revenue of $11B misses by $30M",Seeking Alpha,https://seekingalpha.com/news/4397216-abbott-laboratories-non-gaap-eps-of-1_34-in-line-revenue-of-11b-misses-by-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7170628905296326
1/22/2025 12:05:29 PM,"Abbott sees Q1 adjusted EPS $1.05-$1.09, consensus $1.12",TipRanks,/news/stocks/abbott-sees-q1-adjusted-eps-1-05--1-09-consensus-1-12-1034255250,positive,0.608917236328125
1/22/2025 12:05:36 PM,"Abbott sees FY25 adjusted EPS $5.05-$5.25, consensus $5.16",TipRanks,/news/stocks/abbott-sees-fy25-adjusted-eps-5-05--5-25-consensus-5-16-1034255248,neutral,0.7359472513198853
1/22/2025 12:06:10 PM,"Abbott reports Q4 adjusted EPS $1.34, consensus $1.34",TipRanks,/news/stocks/abbott-reports-q4-adjusted-eps-1-34-consensus-1-34-1034255235,negative,0.445218950510025
1/22/2025 12:11:30 PM,Abbott sees FY25 adjusted operating margin 23.5%-24.0% of sales,TipRanks,/news/stocks/abbott-sees-fy25-adjusted-operating-margin-23-5--24-0-of-sales-1034255220,neutral,0.5022855401039124
1/22/2025 12:23:44 PM,Earnings Snapshot: Abbott Laboratories Q4 misses revenue estimates; initiates Q1 and FY25 outlook,Seeking Alpha,https://seekingalpha.com/news/4397229-earnings-snapshot-abbott-laboratories-q4-misses-revenue-estimates-initiates-q1-and-fy25-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9674532413482666
1/22/2025 12:27:57 PM,Abbott in charts: Medical Devices sales reach all-time high in Q4,Seeking Alpha,https://seekingalpha.com/news/4397233-abbott-in-charts-medical-devices-sales-reach-all-time-high-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.932185709476471
1/22/2025 12:51:58 PM,Abbott Laboratories slips after Q4 topline miss,Seeking Alpha,https://seekingalpha.com/news/4397224-abbott-laboratories-stock-slips-q4-miss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9631792306900024
1/22/2025 1:04:30 PM,"Abbott Laboratories Q4 Profit Increases, Inline With Estimates ",RTTNews,/news/stocks/abbott-laboratories-q4-profit-increases-inline-with-estimates-1034253924,positive,0.947444498538971
1/22/2025 1:22:20 PM,"Abbott Q4 Profit Meets View; Sees Q1 Below Market, Growth In FY25 - Update ",RTTNews,/news/stocks/abbott-q4-profit-meets-view-sees-q1-below-market-growth-in-fy25-update-1034254025,positive,0.6497440934181213
1/22/2025 1:55:22 PM,Morning Movers: Netflix shares rise following subscriber blowout,TipRanks,/news/stocks/morning-movers-netflix-shares-rise-following-subscriber-blowout-1034255934,positive,0.65787273645401
1/22/2025 2:47:47 PM,"4 stocks to watch on Wednesday: PG, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4397307-4-stocks-to-watch-on-wednesday-pg-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9242684841156006
1/22/2025 3:00:23 PM,Abbott sees FY25 tax rate 16%-17%,TipRanks,/news/stocks/abbott-sees-fy25-tax-rate-16--17-1034256340,neutral,0.7872676253318787
1/22/2025 5:05:34 PM,"Netflix, Seagate, J&J report quarterly beats: Morning Buzz",TipRanks,/news/stocks/netflix-seagate-j-j-report-quarterly-beats-morning-buzz-1034256527,neutral,0.9156374335289001
1/22/2025 7:05:22 PM,Abbott Laboratories’ Growth Prospects and Market Leadership in MedTech Justify Buy Rating,TipRanks,/news/stocks/abbott-laboratories-growth-prospects-and-market-leadership-in-medtech-justify-buy-rating-1034256870,positive,0.7972864508628845
1/22/2025 7:05:23 PM,Abbott price target raised to $140 from $139 at BTIG,TipRanks,/news/stocks/abbott-price-target-raised-to-140-from-139-at-btig-1034256869,positive,0.9457522630691528
1/22/2025 11:35:22 PM,Strong Performance and Promising Growth: Josh Jennings’ Buy Rating on Abbott Laboratories,TipRanks,/news/stocks/strong-performance-and-promising-growth-josh-jennings-buy-rating-on-abbott-laboratories-1034257202,positive,0.6380695104598999
1/23/2025 9:57:07 AM,Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT),TipRanks,/news/stocks/mizuho-securities-reaffirms-their-hold-rating-on-abbott-laboratories-abt-1034259287,neutral,0.8014084100723267
1/23/2025 10:40:08 AM,"Abbott price target raised to $148 from $146 at UBS, shares remain undervalued",TipRanks,/news/stocks/abbott-price-target-raised-to-148-from-146-at-ubs-shares-remain-undervalued-1034259540,positive,0.9395806789398193
1/23/2025 10:57:27 AM,Strong Performance and Promising Growth: Rick Wise’s Buy Rating on Abbott Laboratories,TipRanks,/news/stocks/strong-performance-and-promising-growth-rick-wise-s-buy-rating-on-abbott-laboratories-1034259605,positive,0.7672303915023804
1/23/2025 10:57:35 AM,Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook,TipRanks,/news/stocks/abbott-laboratories-solid-performance-in-key-sectors-but-hold-rating-due-to-mixed-outlook-1034259604,negative,0.6056711673736572
1/23/2025 11:05:42 AM,Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating,TipRanks,/news/stocks/abbott-laboratories-strong-performance-and-promising-outlook-support-buy-rating-1034259771,positive,0.9514654874801636
1/23/2025 11:26:22 AM,Abbott price target raised to $138 from $135 at Bernstein,TipRanks,/news/stocks/abbott-price-target-raised-to-138-from-135-at-bernstein-1034259855,positive,0.9386383295059204
1/23/2025 11:38:39 AM,Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034259997,neutral,0.8139292597770691
1/23/2025 11:40:23 AM,"Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Arrowhead Pharmaceuticals (ARWR)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-arrowhead-pharmaceuticals-arwr-1034259971,positive,0.553694486618042
1/23/2025 11:56:16 AM,RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-abbott-laboratories-abt-1034260128,neutral,0.5079269409179688
1/23/2025 12:30:11 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1034260730,positive,0.5521676540374756
1/23/2025 12:30:56 PM,Abbott price target raised to $135 from $130 at Stifel,TipRanks,/news/stocks/abbott-price-target-raised-to-135-from-130-at-stifel-1034260723,positive,0.9427859783172607
1/25/2025 6:46:00 PM,Over 80% of companies deliver EPS wins this week-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4398494-over-80-companies-deliver-eps-wins-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6900730729103088
1/27/2025 9:35:58 AM,Barclays Remains a Buy on Abbott Laboratories (ABT),TipRanks,/news/stocks/barclays-remains-a-buy-on-abbott-laboratories-abt-1034271285,neutral,0.9153512120246887
1/27/2025 10:35:04 AM,Abbott price target raised to $158 from $149 at Barclays,TipRanks,/news/stocks/abbott-price-target-raised-to-158-from-149-at-barclays-1034271597,positive,0.9431104063987732
1/28/2025 5:10:52 PM,Abbott price target raised to $150 from $145 at Argus,TipRanks,/news/stocks/abbott-price-target-raised-to-150-from-145-at-argus-1034278978,positive,0.937262773513794
1/28/2025 5:16:04 PM,Argus Research Sticks to Their Buy Rating for Abbott Laboratories (ABT),TipRanks,/news/stocks/argus-research-sticks-to-their-buy-rating-for-abbott-laboratories-abt-1034279020,neutral,0.8060528635978699
2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7119130492210388
2/3/2025 9:00:22 AM,Elon Musk’s X Adds More Companies to Ad-Boycott Lawsuit,TipRanks,/news/stocks/elon-musk-s-x-adds-more-companies-to-ad-boycott-lawsuit-1034302159,neutral,0.9095667004585266
2/5/2025 6:15:15 PM,FDA advises diabetes device users to check alert settings,Seeking Alpha,https://seekingalpha.com/news/4403792-fda-advises-diabetes-device-users-to-check-alert-settings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8860114812850952
